630 result(s) have been found!
| Accession | Name | Sequence | Source/Organism | Mechanism | Assay Type | Cell Line | Cancer Type | Activity |
|---|---|---|---|---|---|---|---|---|
| dbacp00003 | Citropin modified peptide-3 | GLFAVIKKVASVIGGL | Amphibian skin secretions | Penetration and disruption of the membrane | Sulforhodamine B assay | Colon tumor cell line | Colon cancer | IC50 : 6 M |
| dbacp00012 | Citropin modified peptide-5 | GLFDVIKAVASVIGGL | Amphibian skin secretions | Penetration and disruption of the membrane | Sulforhodamine B assay | Colon tumor cell line | Colon cancer | IC50 : 5 M |
| dbacp00021 | Citropin modified peptide-7 | GLFDVIKKVAAVIGGL | Amphibian skin secretions | Penetration and disruption of the membrane | Sulforhodamine B assay | Colon tumor cell line | Colon cancer | IC50 : 5 M |
| dbacp00039 | Enkephalins7 analogue-8 | YA* | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | HT-29 | Colon cancer | 9.8% inhibition at 10-6 M |
| dbacp00040 | Enkephalins7 analogue-8 | YA* | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | HT-29 | Colon cancer | 1.6% inhibition at 10-5 M |
| dbacp00041 | Enkephalins7 analogue-8 | YA* | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | HT-29 | Colon cancer | 5.4% inhibition at 10-4 M |
| dbacp00042 | Enkephalins7 analogue-8 | YA* | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | HT-29 | Colon cancer | 26.5% inhibition at 10-3 M |
| dbacp00043 | Enkephalins7 analogue-8 | YA* | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | SW-620 | Colon cancer | 12.9% inhibition at 10-6 M |
| dbacp00044 | Enkephalins7 analogue-8 | YA* | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | SW-620 | Colon cancer | 16.5% inhibition at 10-5 M |
| dbacp00045 | Enkephalins7 analogue-8 | YA* | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | SW-620 | Colon cancer | 28.1% inhibition at 10-4 M |
| dbacp00046 | Enkephalins7 analogue-8 | YA* | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | SW-620 | Colon cancer | 58.2% inhibition at 10-3 M |
| dbacp00047 | Enkephalins7 analogue-8 | YA* | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | CaCo-2 | Colon cancer | 3.5% inhibition at 10-6 M |
| dbacp00048 | Enkephalins7 analogue-8 | YA* | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | CaCo-2 | Colon cancer | 22.7% inhibition at 10-5 M |
| dbacp00049 | Enkephalins7 analogue-8 | YA* | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | CaCo-2 | Colon cancer | 18.9% inhibition at 10-4 M |
| dbacp00050 | Enkephalins7 analogue-8 | YA* | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | CaCo-2 | Colon cancer | 26.4% inhibition at 10-3 M |
| dbacp00063 | Enkephalins7 analogue-9 | YSA* | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | HT-29 | Colon cancer | 4.9% inhibition at 10-6 M |
| dbacp00064 | Enkephalins7 analogue-9 | YSA* | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | HT-29 | Colon cancer | 8.9% inhibition at 10-5 M |
| dbacp00065 | Enkephalins7 analogue-9 | YSA* | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | HT-29 | Colon cancer | 3.4% inhibition at 10-4 M |
| dbacp00066 | Enkephalins7 analogue-9 | YSA* | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | HT-29 | Colon cancer | 20.8% inhibition at 10-3 M |
| dbacp00067 | Enkephalins7 analogue-9 | YSA* | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | SW-620 | Colon cancer | 10.5% inhibition at 10-6 M |
| dbacp00068 | Enkephalins7 analogue-9 | YSA* | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | SW-620 | Colon cancer | 21.9% inhibition at 10-5 M |
| dbacp00069 | Enkephalins7 analogue-9 | YSA* | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | SW-620 | Colon cancer | 11.8% inhibition at 10-4 M |
| dbacp00070 | Enkephalins7 analogue-9 | YSA* | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | SW-620 | Colon cancer | 17.9% inhibition at 10-3 M |
| dbacp00071 | Enkephalins7 analogue-9 | YSA* | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | CaCo-2 | Colon cancer | 3.7% inhibition at 10-6 M |
| dbacp00072 | Enkephalins7 analogue-9 | YSA* | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | CaCo-2 | Colon cancer | 16.5% inhibition at 10-5 M |
| dbacp00073 | Enkephalins7 analogue-9 | YSA* | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | CaCo-2 | Colon cancer | 8.4% inhibition at 10-4 M |
| dbacp00074 | Enkephalins7 analogue-9 | YSA* | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | CaCo-2 | Colon cancer | 14.5% inhibition at 10-3 M |
| dbacp00090 | Enkephalins7 analogue-10 | YSA* | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | HT-29 | Colon cancer | 0.7% inhibition at 10-6 M |
| dbacp00091 | Enkephalins7 analogue-10 | YSA* | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | HT-29 | Colon cancer | 8.3% inhibition at 10-5 M |
| dbacp00092 | Enkephalins7 analogue-10 | YSA* | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | HT-29 | Colon cancer | 10.5% inhibition at 10-4 M |
| dbacp00093 | Enkephalins7 analogue-10 | YSA* | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | HT-29 | Colon cancer | 21.8% inhibition at 10-3 M |
| dbacp00094 | Enkephalins7 analogue-10 | YSA* | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | SW-620 | Colon cancer | 10.7% inhibition at 10-6 M |
| dbacp00095 | Enkephalins7 analogue-10 | YSA* | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | SW-620 | Colon cancer | 10.0% inhibition at 10-5 M |
| dbacp00100 | Citropin modified peptide-11 | GLFDVIKKVASVIKGL | Amphibian skin secretions | Penetration and disruption of the membrane | Sulforhodamine B assay | Colon tumor cell line | Colon cancer | IC50 : 5 M |
| dbacp00109 | Citropin modified peptide-13 | GLFDVIKKVASVIKKL | Amphibian skin secretions | Penetration and disruption of the membrane | Sulforhodamine B assay | Colon tumor cell line | Colon cancer | IC50 : 5 M |
| dbacp00118 | Citropin modified peptide-14 | GLFDVIAKVASVIKKL | Amphibian skin secretions | Penetration and disruption of the membrane | Sulforhodamine B assay | Colon tumor cell line | Colon cancer | IC50 : 5 M |
| dbacp00137 | Enkephalins7 analogue-15 | YSA*G | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | HT-29 | Colon cancer | 5.4% inhibition at 10-6 M |
| dbacp00138 | Enkephalins7 analogue-15 | YSA*G | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | HT-29 | Colon cancer | 7.4% inhibition at 10-5 M |
| dbacp00139 | Enkephalins7 analogue-15 | YSA*G | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | HT-29 | Colon cancer | 9.5% inhibition at 10-4 M |
| dbacp00140 | Enkephalins7 analogue-15 | YSA*G | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | HT-29 | Colon cancer | 15.7% inhibition at 10-3 M |
| dbacp00141 | Enkephalins7 analogue-15 | YSA*G | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | SW-620 | Colon cancer | 13.6% inhibition at 10-6 M |
| dbacp00142 | Enkephalins7 analogue-15 | YSA*G | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | SW-620 | Colon cancer | 20.4% inhibition at 10-5 M |
| dbacp00143 | Enkephalins7 analogue-15 | YSA*G | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | SW-620 | Colon cancer | 14.4% inhibition at 10-4 M |
| dbacp00144 | Enkephalins7 analogue-15 | YSA*G | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | SW-620 | Colon cancer | 23.4% inhibition at 10-3 M |
| dbacp00145 | Enkephalins7 analogue-15 | YSA*G | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | CaCo-2 | Colon cancer | 2.2% inhibition at 10-6 M |
| dbacp00146 | Enkephalins7 analogue-15 | YSA*G | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | CaCo-2 | Colon cancer | 4.2% inhibition at 10-5 M |
| dbacp00147 | Enkephalins7 analogue-15 | YSA*G | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | CaCo-2 | Colon cancer | 6.4% inhibition at 10-4 M |
| dbacp00148 | Enkephalins7 analogue-15 | YSA*G | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | CaCo-2 | Colon cancer | 6.2% inhibition at 10-3 M |
| dbacp00152 | Citropin modified peptide-15 | GLFAVIKKVASVIKGL | Amphibian skin secretions | Penetration and disruption of the membrane | Sulforhodamine B assay | Colon tumor cell line | Colon cancer | IC50 : 5 M |
| dbacp00170 | Enkephalins7 analogue-16 | YRA*G | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | HT-29 | Colon cancer | 7.6% inhibition at 10-6 M |
| dbacp00171 | Enkephalins7 analogue-16 | YRA*G | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | HT-29 | Colon cancer | 3.8% inhibition at 10-5 M |
| dbacp00172 | Enkephalins7 analogue-16 | YRA*G | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | HT-29 | Colon cancer | 12.4% inhibition at 10-4 M |
| dbacp00173 | Enkephalins7 analogue-16 | YRA*G | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | HT-29 | Colon cancer | 22.4% inhibition at 10-3 M |
| dbacp00174 | Enkephalins7 analogue-16 | YRA*G | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | SW-620 | Colon cancer | 17.0% inhibition at 10-6 M |
| dbacp00175 | Enkephalins7 analogue-16 | YRA*G | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | SW-620 | Colon cancer | 13.5% inhibition at 10-5 M |
| dbacp00176 | Enkephalins7 analogue-16 | YRA*G | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | SW-620 | Colon cancer | 13.5% inhibition at 10-4 M |
| dbacp00177 | Enkephalins7 analogue-16 | YRA*G | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | SW-620 | Colon cancer | 25.3% inhibition at 10-3 M |
| dbacp00178 | Enkephalins7 analogue-16 | YRA*G | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | CaCo-2 | Colon cancer | 8.1% inhibition at 10-6 M |
| dbacp00179 | Enkephalins7 analogue-16 | YRA*G | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | CaCo-2 | Colon cancer | 6.9% inhibition at 10-5 M |
| dbacp00180 | Enkephalins7 analogue-16 | YRA*G | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | CaCo-2 | Colon cancer | 8.1% inhibition at 10-4 M |
| dbacp00181 | Enkephalins7 analogue-16 | YRA*G | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | CaCo-2 | Colon cancer | 8.6% inhibition at 10-3 M |
| dbacp00185 | Citropin modified peptide-16 | GLFAVIKKVASVIKKL | Amphibian skin secretions | Penetration and disruption of the membrane | Sulforhodamine B assay | Colon tumor cell line | Colon cancer | IC50 : 5 M |
| dbacp00204 | Enkephalins7 analogue-17 | YA*GFM | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | HT-29 | Colon cancer | 3.3% inhibition at 10-6 M |
| dbacp00205 | Enkephalins7 analogue-17 | YA*GFM | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | HT-29 | Colon cancer | 11.0% inhibition at 10-5M |
| dbacp00206 | Enkephalins7 analogue-17 | YA*GFM | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | HT-29 | Colon cancer | 7.9% inhibition at 10-4 M |
| dbacp00207 | Enkephalins7 analogue-17 | YA*GFM | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | HT-29 | Colon cancer | 23.7% inhibition at 10-3 M |
| dbacp00208 | Enkephalins7 analogue-17 | YA*GFM | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | SW-620 | Colon cancer | 12.2% inhibition at 10-6 M |
| dbacp00209 | Enkephalins7 analogue-17 | YA*GFM | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | SW-620 | Colon cancer | 15.5% inhibition at 10-5 M |
| dbacp00210 | Enkephalins7 analogue-17 | YA*GFM | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | SW-620 | Colon cancer | 24.7% inhibition at 10-4 M |
| dbacp00211 | Enkephalins7 analogue-17 | YA*GFM | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | SW-620 | Colon cancer | 29.0% inhibition at 10-3 M |
| dbacp00212 | Enkephalins7 analogue-17 | YA*GFM | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | CaCo-2 | Colon cancer | 3.0% inhibition at 10-6 M |
| dbacp00213 | Enkephalins7 analogue-17 | YA*GFM | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | CaCo-2 | Colon cancer | 8.4% inhibition at 10-5 M |
| dbacp00214 | Enkephalins7 analogue-17 | YA*GFM | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | CaCo-2 | Colon cancer | 18.5% inhibition at 10-4 M |
| dbacp00215 | Enkephalins7 analogue-17 | YA*GFM | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | CaCo-2 | Colon cancer | 10.6% inhibition at 10-3 M |
| dbacp00219 | Citropin modified peptide-17 | GLFAVIKKVAAVIKKL | Amphibian skin secretions | Penetration and disruption of the membrane | Sulforhodamine B assay | Colon tumor cell line | Colon cancer | IC50 : 5 M |
| dbacp00238 | Enkephalins7 analogue-18 | YA*GFM | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | HT-29 | Colon cancer | 16.2% inhibition at 10-6 M |
| dbacp00239 | Enkephalins7 analogue-18 | YA*GFM | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | HT-29 | Colon cancer | 6.6% inhibition at 10-5 M |
| dbacp00240 | Enkephalins7 analogue-18 | YA*GFM | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | HT-29 | Colon cancer | 5.1% inhibition at 10-4 M |
| dbacp00241 | Enkephalins7 analogue-18 | YA*GFM | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | HT-29 | Colon cancer | 14.5% inhibition at 10-3 M |
| dbacp00242 | Enkephalins7 analogue-18 | YA*GFM | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | SW-620 | Colon cancer | 26.4% inhibition at 10-6 M |
| dbacp00243 | Enkephalins7 analogue-18 | YA*GFM | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | SW-620 | Colon cancer | 13.1% inhibition at 10-5 M |
| dbacp00244 | Enkephalins7 analogue-18 | YA*GFM | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | SW-620 | Colon cancer | 14.6% inhibition at 10-4 M |
| dbacp00245 | Enkephalins7 analogue-18 | YA*GFM | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | SW-620 | Colon cancer | 38.4% inhibition at 10-3 M |
| dbacp00246 | Enkephalins7 analogue-18 | YA*GFM | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | CaCo-2 | Colon cancer | 17.7% inhibition at 10-6 M |
| dbacp00247 | Enkephalins7 analogue-18 | YA*GFM | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | CaCo-2 | Colon cancer | 10.9% inhibition at 10-5 M |
| dbacp00248 | Enkephalins7 analogue-18 | YA*GFM | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | CaCo-2 | Colon cancer | 12.1% inhibition at 10-4 M |
| dbacp00249 | Enkephalins7 analogue-18 | YA*GFM | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | CaCo-2 | Colon cancer | 8.1% inhibition at 10-3 M |
| dbacp00254 | Citropin modified peptide-18 | GLFAVIKKVAAVIRRL | Amphibian skin secretions | Penetration and disruption of the membrane | Sulforhodamine B assay | Colon tumor cell line | Colon cancer | IC50 : 5 M |
| dbacp00263 | Citropin modified peptide-19 | GLFAVIKKVAKVIKKL | Amphibian skin secretions | Penetration and disruption of the membrane | Sulforhodamine B assay | Colon tumor cell line | Colon cancer | IC50 : 5 M |
| dbacp00272 | Citropin modified peptide-22 | GLFKVIKKVASVIGGL | Amphibian skin secretions | Penetration and disruption of the membrane | Sulforhodamine B assay | Colon tumor cell line | Colon cancer | IC50 : 5 M |
| dbacp00285 | Enkephalins7 analogue-23 | YGGFMA* | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | HT-29 | Colon cancer | 9.2% inhibition at 10-3 M |
| dbacp00286 | Enkephalins7 analogue-23 | YGGFMA* | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | CaCo-2 | Colon cancer | 11.08% inhibition at 10-5 M |
| dbacp00287 | Enkephalins7 analogue-23 | YGGFMA* | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | CaCo-2 | Colon cancer | 47.0% inhibition at 10-3 M |
| dbacp00294 | Citropin modified peptide-23 | GLFKVIKKVAKVIKKL | Amphibian skin secretions | Penetration and disruption of the membrane | Sulforhodamine B assay | Colon tumor cell line | Colon cancer | IC50 : 5 M |
| dbacp00614 | [ribosomal protein uS5]-alanine N-acetyltransferase | MPHTPSRLLAEGPRVGIRHFTLADGPEFTARARESKDLHHPWLFPPDSPQTYEAYAARLIEDRTKAGFLVCERDTAGTSEGTRGGGPIAGFVNINNIVEGGFLSGALGYGAFAHAAGRGLMREGLDLVVRYAFGPMRLHRLEINVQPGNAASIALARACGFHLEGFSPRMLHIDGAWRDHQRWALTAETAASG | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp00714 | 2,3-dihydroxybenzoate-AMP ligase | MTETQPTWSEAESARYRAAGHWQGVTFGARLRQAGAEHAQRVALVDGNRRWTYADLDAEADRVAAGLRGLGVERGDRVVLQLPNCAEFVLAWFGLQRLGAVPVHAMPGHRSREIGHLVRLSDAVACVVPDLHARFDHRRLMSDVRAELGPDGPLRHVVVVGDPGPYDGFVPFDALRESGGRGPSAPVSDSDSADPDPGGLALLLLSGGTTGLPKLIPRTHDDYAYNARACAGVCALDTRSVYLAVLPLGFNFTFACPGVLGTLMAGGTVVIAPDPSPQTAFALIEREGVTLTSLTPPLVPHWTDEAASGSWDLGSLAVVQVGGARLPEDHARRLGPALGARVQQVFGMAEGLINLTRLDDAEDLVCTTQGRPASPDDEILVVDAGGRPVPDGTAGELLTRGPYTLRGYYRAEAHNRTAFTPDGYYRSGDVVRRLPSGHLVVVGRIKDQINRGGEKIPAVEVEEELLTHPAVTAAALVGVPDERWGERSVAFVVCTGTAPGAREVAAHLASRGLAGYKAPDEIVQVPGLPLTAVGKVDKAALARRSEG | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp00719 | 3A | LTAEHYAAQATS | Not found | Cell cycle arrest or apoptosis of cells | Immunoprecipitation assay | HCT-116-p53+/+ | Colon cancer | IC50 : >100 µM |
| dbacp00766 | A specific Eps8/EGFR Inhibitor Peptide 327 | EFLDCFQKF | A specific Eps8/EGFR Inhibitor Peptide 327 | Immune response to tumor cell recognition | Lactate dehydrogenase (LDH)-release assay | Colo320 | Colon cancer | IC50 : 83.10 ± 1.41 μM |
| dbacp00768 | A specific Eps8/EGFR Inhibitor Peptide 327 | EFLDCFQKF | A specific Eps8/EGFR Inhibitor Peptide 327 | Immune response to tumor cell recognition | Lactate dehydrogenase (LDH)-release assay | SW620 | Colon cancer | IC50 : 102.35 ± 4.66 μM |
| dbacp00813 | A5 | KAQIRAMECNIL | Cyclin B (285-296) | Apoptosis inducing | MTT/MTS assay | HCT-116 | Colon cancer | Not found |
| dbacp00837 | ABC transporter ATP-binding protein | MTPPKDSTMDPLVRLDGVHVRHRARSGGLLRRDSVHALTDVGLEVRRGEILGLVGESGCGKSTLARVVTGLQRPTEGRVSFRGRDLWTMSGAERRTGFGAAVGVVFQDASTALNPRLPVRRILRDPLDVHDRGTRAEREERVEELLDLVGLPGHTLQALPGQLSGGQRQRVAIARALALEPELIVADEPTSALDVSVRAQILNLLVDLRARLGLGMVFISHDVQTVRHLADRVAVLYLGRVVEEGGASEVLGASRHPYTEALLSATPSLLERPERIVLHGPVPSATNPPSGCPFRTRCWKADDACATAFPAAAEGPGGHRWHCVHPRESGVPREATSAK | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp00842 | ABC transporter ATP-binding protein | MTTTGPPTRSDADTPALDVEGLCVELSTPSGTVRAVDGVSFSVRRGRTLALLGESGCGKSMTALSVVGLLDPAAAVTGGAVRVRGDDTLRMSPAQRRRLAGPVLSIVFQDALTALNPVQPVGRQIGEPFRIHRRLSRRQAREKAIELMTRVGIPEPRQRARSYPHQFSGGMRQRLLIAMAVALAPDVLIADEPTTALDVTVQAQIMRLLRDLQDERDMAVVLITHDLAVVAQRADDVVVMYAGTVVENGPVRDVFAAPRHPYTRGLLDSVPEDSVRGRPLPAVPGSPPELSAVPAGCVFQARCPLVRERCVRERPVPRPAGEGRSAACHFSEELDRA | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp00847 | ABC transporter ATP-binding protein | MTTQTKPEEAPAAAAGNAFLSVRDLKVHFSTEGGVVKAVDGLSFDLERGKTLGIVGESGSGKSVTNLAVLGLHDRRKTAVDGSITLDGQELTDASEKQLETLRGKKMAMIFQDALTALSPYYTVGRQIGEPFMKHNGASKKDARVRAIDLLQKVGIPHPQKRVDDYPHQFSGGMRQRAMIAMALSCDPDLLIADEPTTALDVTVQAQILDLLKDLQQEFGSAIIMITHDLGVVGnMADDILVMYAGRAVERGSVREVLKTPQHPYTWGLLSSMPNLSSDVNEPLMPIPGSPPSLMNPPSGCAFHPRCGFTDLVPGGRCSGERPTLDLGRGAACHLTGDQRQQVFIEKIQPRLG | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp00852 | ABC transporter ATP-binding protein | MLLEVRDLHVEFHTRDGVAKAVNGVSYGVDAGETLAVLGESGSGKSVTAQTVMGILDVPPGRITAGEILFEGRDLLKLKEEERRKVRGAEMAMIFQDALSALNPVLTVGAQLAEMFTVHRGMSRKDAHAKAVELMDRVRIPAARERVRQYPHQFSGGMRQRIMIAMAMALEPKLIIADEPTTALDVTVQAQVMDLLAELQRELRMGLILITHDLGVVADVADKIAVMYAGRIVETAPVHDIYKAPAHPYTRGLLESIPRLDQKGQELYAIKGLPPNLTRIPPGCAFHPRCPMAQDVCRTDVPPLYDVTESDAERGSACHFWRECLHA | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp00857 | ABC transporter ATP-binding protein | MTEPSKSGAAVGEPTGDAPGSNAFLEVRDLKVHFPTDDGLVKSVDGLSFQLERGKTLGIVGESGSGKSVTSLGIMGLHTAGQYGRRKAQISGEIWLDGTELLSADPDHVRKLRGRQMAMIFQDPLSALHPYYTIGKQIVEAYRIHHDVDKKTARRRAVEMLDRVGIPQPDKRVDSYPHEFSGGMRQRAMIAMSLVNNPELLIADEPTTALDVTVQAQILDLIRDLQKEFGSAVIVITHDLGVVAELADDLLVMYGGRCVERGPAEKVFYEPRHPYTWGLLDSMPRLDRDQQERLIPVKGSPPSLINLPSGCAFNPRCPYADVPKDDVTRTVRPELTEIGSKHWAACHMSQEQRERIWTEEIAPKL | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp00862 | ABC transporter ATP-binding protein | MSAVRPPAAPAPDGGHILDLDDLGVVFTTETGTVRAVRGVSLHVAPGETLALVGESGSGKSTVALAAMGLLAGNARATGRAVVDGTDIVGADEEQLSGLRGKTVSMVFQEPATALDPLTRVGRQIAEVIRNHRRVSAADAAAHAVELLRRVGIPEPEQRARAYPFQLSGGQRQRVVIAMAIANEPALLIADEPTTALDVTVQAEILDLLRRLAAETGTGVLLVTHnMGVVADFADRVAVMYQGAVVETGPVEDVLLRPTHDYTKRLLSAVPRLSVSEAAGAGDTAEPAGAGSAGAGSAGAESVEEPAVELRDVSVVFGRGKQAVHALRGVSFAVRPGETLGLVGESGSGKSTASRVALGLVAPTAGSVTLFGADLARTRARARRALRAGVGVVLQDPVASLDPRMTVGECVAEPLRVHRRTLSGRERESLVGDVLDRVRLPREVARRAPRELSGGQRQRVSLARALVLGPRLLVADEPTSALDVSVQEAVLEVIGELQEELGFACLFVSHDLAVVQQFARRVVVMRAGRAEEQGLTSATLLNPETDYTRRLLAAVPVPDPVVQRGRRAERLATLAAGRTEEQG | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp00867 | ABC transporter ATP-binding protein | MSLVEVTGLSVAFGSVRAVEDLSFRLEKGAALGLVGESGSGKSTVASALLGLHRGTGAVVDGSVRVAGTDVGAASERELRGLRGGKAAMVFQDPLSSLDPYYAVGDQIAEVYRVHHPASRRAARARAVEVLDRVGIPDAARRSRSRPHEFSGGMRQRALIAMALACEPDLLVADEPTTALDVTVQAQILDLLHALREETGMGLLLVTHDVGVAAESVDEVLVMRHGRAVEHGPVGSVLGSPAEAYTRRLLKSVPRVDTPRPPAPPAGAVADDASRDGVVLEATGLRRVFGRGSKAFTAVDDVSLEVRRGEALGVVGESGSGKTTLGRMLVGLLEPSAGEVRLDGAAVTGVRPDVQMVFQDPVSSLNPRRSVGESVADPLRARGERGPAVRARVAELLERVGLDPAHYDRYPHEFSGGQRQRVGIARALAAGPRVLVCDEPVSALDVTTQAQVVELLDELRRELGLALVFIAHDLAVVRRVSDRLAVMRHGRVVEYGPADGIYESPGDPYTARLLAAVPVLDPGLAALRRAERREPAVT | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp00872 | ABC transporter ATP-binding protein | MLSVEGLHVAFPGRRGGADARAVDGVDLDIRRGEIVALVGESGCGKTTLARSLLGLVRPVRGRVTFDGAPLAHSARALKAYRRRAQLVLQDPSGSLNPRHTVYDIVAEGLRIHGRPGDERTAVAEALSRAGLRPPERFFLRYPHELSGGQRQRVVIAGALVLRPELLVADEPVASLDASVRGEILALLLRLRTELGLAALVVTHDLGLAWNIADRVAVMYLGRIVETGAVEQVLTAPRHPYTRALLSVLPEAPGDPVVLTGEPPDPSNIPTGCRFHARCQVLADGTAERAGVADACRSREPAVLHGGGESQVACHWALAAPREVSPAGPAPR | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp00877 | ABC transporter family substrate-binding protein | MSHVRVGPRAVTRSVAFLTAGVLAVPALAGCTSDEPAGKPLAAQDVAAAPRSRVADGGTLRWAVDSVPETLNAFQADADDTTNRVAQAVLPSMYRTDDTGRPARNPDYLESAEVVDTEPKQVVVYKLNQQAVWSDGREIGAADFAAQWRALSGKDSAYWTARNAGYDRIEKVERGAGDLEVKVTFSRPYADWQSLFTPLYPKDVTGTPDAFNDGARRELKVTAGPFAVQKVDTKDDEVVLAGNPRWWGEPAKLEQIVLRAVPRDKRVSELVAGKLDLAEVDPETADEVGLAAGPRDAGTGTPLMGPQGTPAAGAPGSPLAGDRGRSAAQALRSWALANGSDEEAAEEEVLAREERRETEAKAQRRQRALSGFEVRKSLEPAYTQLALNGADGPLADERVRRAVARALDRKKLAEAVLKPLGLPAEPVGSHVALAGQPAYADGSGALGDQNAKEARALLADAGWVPGGPVKKTEKGEKAAGAEGDGEKEKDGKKSEDGDDGDDGTYIVGEDGKNPGDGGDGENGEGGAKADAESGEKHSSGKNTAQGGAPGAYAPKGTAAPAAAAAPVAKDGKALTLRFVLPSGPGSEALRTVAGRVSDMLDEIGIDTAITKVPDESYFKDHIASGAYDLALYSWPATAFPATDARPVYAKPVPAADGSLNVAQNYTRVGTDQVDQLFDRAMSTLDRKEARDLLRKADSRIWAAAGSVPLYQRPQLTAARKGLANAGAFGFETPVYEDMGFLKKGAQGPRPAASPSS | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp00882 | ABC transporter permease | MLHYALRRCGWTLVQLAVLSLVVFLLTDLLPGDAATVDFNEQAGLDQVAQLREQMGLDRPLVERFADWAHGLLTGDLGTSLVGGGPVRDVLSSSVPVTAALAVVTLVLLVPLAVAVGLLTGLRAGSRTDRTVSAVTLTLTSVPDFVLALLLVGVFALRLGWLPSTWVGADDVWWQRPELFVLPVAVLLARTVCVLSRQIRAGTVTALHAGYTVQARRLGVPPARLVLRHVLPNAAVPGVQELARTGDQLLGGVLVVEAVFAVPGTATALVEAVQNRDVPTVQGLTLTLAAVACLLNLAADLVSHRLAPRTEVLR | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp00887 | ABC transporter permease | MLRYALRRSGWTLVQLAALSVIVFLLTDLLPGDAATVDFNEQAGLEQVAQLREQMGLDRPAVERFADWAHGLVTGDLGTSLVGGAPVSEVLTSSIPVTAALAAVTIMLLVPLAVGVGLLTGLRAGSRTDRVVSAVTLTLTSVPDFVLALLLVGVFALRLGWLPSTWVGADDGWWKRPELFVLPVAVLLARTVCVLSRQIRAGTVTALDAGYTVQARRLGVPPARLVLRHVLPNAAVPGVQELARTGDQLLGGVLVVEAVFAVPGTATALVEAVQNRDVPTVQALTLALAAVACLLNLAADLVSHRLAPRTEVLR | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp00892 | ABC transporter permease | MNLLAFAGRRLAGAAVLLVLLSAAVFAVTAVLPGDAVSAVAGVDASAAQRADVRAGLGLDRPAAERYAAWAADAVRGDLGHGFVGERPVTDILATRLPNSLLLAGLTLAVTAPLAALLGLWTGLRGGGTADRVVSTGAQVLAAIPEFVVAALLVAVLAVWAGVLPRVSVVPLGGTPLDAPRALVLPVLTLSAVGLAVATRLLRVSVADAAATPYCEAARLGGVRGIRLAVRHVLPNAAGPAVQALTLTTGALVGSAVVVENVFDYPGIGRELQLAVAARDVPMVQGIATALVAVMLLVLLLGDVCARLIGAREGHGR | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp00897 | ABC transporter permease | MDLGTSEAATLEQPPGPDGTNPHERPRSLWTDAWHDLRRNPVFIISALVILFLVVISLWPSLIASGSPLKCDLAKAQEGSQPGHPFGFNGQGCDVYTRTVYGARTSVAVGILATLGVALLGSVLGGLAGFFGGAGDAVLSRITDVFFAIPVVLGGLVLLSVITSNTVWPVIGFIVLLGWPQISRIARGSVITAKQNDYVQAARALGASNSRLLLRHIAPNAIAPVIVVATIALGTYISLEATLSFLGVGLKPPSVSWGIDISAAAPYVRNAPHALLWPSGALAVTVLAFIMLGDAVRDALDPKLR | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp00902 | ABC transporter substrate-binding protein | MSILRNRTATAAIVAVAAGALTLTACGGGDSDSSSKDNSKQKEDAKSQSKPVQIGDAQASTGPAPDVEGAKSGGVATVYQATDFSHLDPGQIYVSDGKLLSRLIFRGLTQYDEDENGNLTVVGDLATDAGKESDGGKTWTYTLKDNLKDENGNPINSADFRNTVERLYSNYITDGPTFLQQWLSGDGTTYRDAYQGPDKGKHLPDDVLETPDDKTIVFHFDTPRPDLPQMLTMPGYQLVPEETDTKEKYDSAPVSVGPYKISDFKPGKSMTLVKNTQWDPKSDSVRHQYLDGFNISMNHDDEDQTKTLLADQGEAKNAMMFTGQVATTQLQKVVGDKQAMENRTIQGYAPYVWQLNFnMDRIKDKKLRDAISLALPSDAVFKADGGAYGGEVANSLMSPTTPGYDEKFDPFNREKKPNGDVEAAKKLIKEGGFEGKSLVYAYGNTPERQKQAVLIATALEKIGLDIQKKEIDSATWYEQVGKVKNGYDLYMTGWGQDWPSASTVFPPVYDGTQIQDGASNYSHINDDHVNSEIKRIQKITDTDEATKAWAELNEYISKEVNPAAPIYYTKVFQIFGSNIGGIRYSSDSSYVDVTRVFLKK | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp00907 | ABC transporter substrate-binding protein | MPVTPTRRSVLAAAVATGAGLLTGCSSANSGSSSPKKGGTLSAAFPGAGVKETMDPHAQRQFVDIARHKAVFDKLVELDSTLRPVPRLARSWSSDDEARVWRFELREARFHDGHVLDADDVLYSLSRILDPDAADHLAKNSLSHVDLANCRKVGRRGVEIALTRPNAELPSQLAMTGTPVVRDGWDDPSKPVGTGPFRFASFTAGRGFTGRRFDDHWNGAPHLDEVRILSAESEARAAAVRSGEVHFAHEMTPTFARTVAHDGRVRVVATKRSGVQGFALKTDRAPFDDPDAALAVKLLVDRKRLVDVVCAGRAEIGNDLYGKGYTYYPDGLEQREQDVAEARRLLRRTGLYNKKVTFYTSTAADGFAQAAHLFTEQAGEAGLKVEVVNGPPESYFTDALSKGTVTNHRCGAMTIPTYIGERLLSDAPQNQTAWKHEDFDDDFTAARAEVDDEKRTARYRSVQTTLRDRGGLVLWGHPEWLNAVSRTAHGVKEAPPNTVDWARFDTVWLD | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp00912 | ABC transporter substrate-binding protein | MRYTGAIGVVTATATGLTACGGPASTGGGAGGAGGGGDTVGAGISYPLSTGFDPMITSGATPYAAnMHIFEGLVDLDPATLVARPALATGMPQKINATTYRAVLREGATFHDGSPVTANDVVFSFERVLDEGNASLMAQFVPFVDKVTAVDRSTVEFKLKYPFALFPSRISVVRIVPEKIAGADAKSFDSRPVGSGPYRFVSAVREDKIVMEAYDKYNGPHPAKAGKLVWRLISDPSARVSALKSGRVQAIEDVPYIDVAGFTGKDEVESVQSFGLLFLMFNCADPRFKDKRVRQALHYALDTEKIISTALLGNAEAATGYVPASHPDHHRAATVYGHDPARARKLLAEAGVGKLSFTLLLTDNGWVKDIAPLMKESWAAVGVDAALDIQQSPAQYAKIDQGDFDALAAPGDPSVFGNDADLLLRWFYYGFWPEKRYGWQGSKAYKQTRSLLDKAASEGDEARRKELWGRVTDLVADEAALYPVLHRKLPTAWREGTLTGFEPLPTTGLSFLDVGRA | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp00917 | ABC transporter substrate-binding protein | MRGATHAKWAACAAAAALAATACGGGGGGGNGGGDSGAVLSSSWGDPQNPLEPANTNEVQGGKVLDMIFRGLKRYDPESGEAQnMLAEKIETSDSQNFTVTVKDGWTFSNGEKVTAQSFVDAWNYGASLKNNQRNAYFFAYIDGYEKAHPEDGGKQSADTLSGLKVTGPRTFTIKLSQKFSTFPDTLGYPAFAPLPKAFFDDHDAWLKKPVGNGPYQVDNYTRGSQMSLRKWEQYPGDDKAQNGGVDLKVYTDNNTAYTDLMAGNLDLVDDVPAAQLKNVKNDLGDRYINTPAGIIQTLAFPYYDDAWNKSGSEKVRKGLSMAINRKQITDTIFQQTRTPATDWTSPVLGEDGGYKAGLCGEACEYNAEEAKKLVKEGGGLPGGQVKITYNADTGSHKQWVDAVCNSINNALDNDKACVGNPVGTFADFRNQITDRKMSGPFRSGWQMDYPLIQNFLQPLYYTNASSNDGEYSSQKFDDLIDKANGETDTAAAIKSFQQAEEVLRDDMGAIPLWYQNGSAGYSDRLSNVKLNPFSVPVYNEIKVG | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp00922 | ABC transporter substrate-binding protein | MTTQRTSGRRKQAMAAAAVVAALLTTAACGGGDSDSGGSKNGAAGFDAANNKIAQADQVKKGGELKFASTQDADSWDTTRGYYGFMWNFSRYYARQLVTNTPAPGEKGAGVSPDLAADVAKVSDDGKTYTYTLRDGVTWEDGKPITSKDVKYGIERGWAQDVLAGGPTYLKEVLDPDGKYEGPYKDKSADKLGLKSIETPDDKTIVFKLPEANSDFEEMLALTSASPVRQDKDTKSKYGLHPFSSGPYKFESYNPGKDLTLVRNTEWKQDSDPVRKAYPDKISIKFFTNANELDQRLIAGDYDIDLAQTGLSPQGRTSALKEHEGNVDNPVSGYIRYAVFPQSVKPFDNIHCRKAVLYGADHVSLQTARGGPQAGGDIGTnMLPPAVPGSEAQKYDPYEMAGANKNGNIEKAKEELKACGQPNGFKTTIAVRNNKPVEVATAESLQASLKKVGIEVGIDQYDGSQTAGIIGSPSNVKKKGYGIIIMGWGPDFPSVQGYGKPLWNSEFIQESGNNNYALIDDKEIDGLFDKYGTELEDSAKADIAKQINHKVMEGAYYLPFVFEKFINWRSSRVGNVYTSDGYSGMYDFVNIGLKSSSK | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp00927 | ABC transporter substrate-binding protein | MPVTPTRRSVIAAAVATGAGLLLPGCSSAGSGSSSPKKGGTLSAAFPGAGVKETMDPHAQRQFVDIARHKAVFDKLVELDSTLRPVPRLARSWSSDDEARVWRFELREARFHDGHALSADDVLYSLSRILDPSAADHLAKNSLSHIDLANCRKVGKRGVEIALDRPNAELPSQLAMTGTPIVRDGWDDPTKPVGTGPFRFVSFTAGRSFTGRRFDDHWNGAPHLDELRILSAESEARAAAVRSGEVHFAHEMTPTFARTVAHDSRVRVVATKRSGVQGFALKTDRAPFDDPDAAMAVKLLVDRKRLVEVVCSGRAETGNDLYGKGYTYYPDGLEQRERDVAEARRLLKRTGLYNKKVTFYTSTAADGFAQAAHLFTEQAGEAGLKVEVVNGPPESYFTDALAKGTVTNHRCGAMTIPTYISERLLTDAPQNQSAWKHDDFDDAFTAARAVVDDDERTARYRSVQTTLRDQGGLVLWGHPEWLNAVSSSVQGVKEAPPNTVDWARFDTVWLA | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp00932 | ABC transporter substrate-binding protein | MITHDQHRRGRTAPRPWRARLLAALGACALLLASGTVAPSASAENGDGDGGGGGDKVLTVAVAQSVDSLSPFLAVRLVSTSIHRLTYEYLTNYDAEDNHVIPGLATEWKSSPDKLTWTYTIRSDSRWSDGERATAEDAAWTFNTMMTDPAAATANGSFVGNFAKITAPSPTQLVIRLKKPQATMTALDVPIVPKHVWEKVDDFSEYNNDKDFPVVGNGPFVLTDYKPDSYVRLKANKDFWRGAPKFDELVFRYYKDQDAAVAALRKGEVSFVAGSPSLTPAQADSLKGEENIRVNDAPGRRFYALATNPGARAKDGTKFGNGDPSLLDRRVRNALFKAVDRKAIVDKVFQGHAVEGAGYIPPRFSSYFFEPSAGQELAYDPQQAAELLDEAGYRTGADGKRLGKDGKPLDYRVLCHATDPNDKAVGKYLQEWWGELGISVTLDCLDNVTDPWLAGEYDLAFDGWSVNPDPDFVLSIHTCDALPATPKDTGATDNFICDKEYDELYARQLAEYDAGKRAGIVKQLESRLYDTGYMNVMAYPNAVEAYRTDQIESITTMPAAAGNIYGQDGYWSWWSAVPADSGDSSGGSSSTGTVIGIAAGVVVLAGLVVLFAVRRRATADDRE | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp00937 | ABC transporter substrate-binding protein | MRSLRRPRLLAPFLLTPLIAGCFASGGGDSGDGGGKGGDGDRLRVALAFPPAENLSPYGADATLLSRLGVTEGLTALDANGSAAPALAESWRRDGEKTWEFTLRDATFQDGSDVTPDAVADSLGQAVRAKPAPAALAGVGLTAEAGGERVVRVTTAEPDPVLPLRLSSPSLAILSAKAYEEKGGKADPVGTATGPFRLTKVNGATSASLDRFDDYWGGRAQAAGIDARFVADGTARANALRTGELDIAEAVPVAQAASLDEGTRRDTATTRTTSLLFNASSGTFKDAGLRAAARGAVDTSVFAKDVYEGYGDPGAGIYGPAVTWAEGKRSAPVGRAGAGKPGGDDVIDLATYDNRPELPEAAQVVKQQLEKAGFTVKLTVREYSRLEADALDGKFDAFVLARNTLLDTGDPVAVLASDYTCDGGFNIAQLCDKDVDRAVADAERIADTAKRQDAAMAAEARILGSDAVVPLVHQRIITGVADSVQGVILDPYERTLVGTGTRR | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp00942 | ABC transporter substrate-binding protein | MRHPSRRTRRAAAALTVSLIVTAGAAACGPEDNDAKSGGADGDPQKGGTLTVLNAVPQTDFDPARLYTSGGGNVPSLVFRTLTTRNREDGAKGTEVVPDLATDTGRPNKDATVWTYTLKEGLKYEDGTKITSADVKYGIERSFAAELSGGAPYLRDWLIGGADYQGPYKDKGKGLDSIETPDERTIVFRLNKPEGEFPFLATQTQFAPVPKSADKGTKYEEHPVSSGPYKVVRNENDGERLVLERNEHWSEKTDAERKAYPDRIDVRSGLDSSVINQRLSASQGADAAAVTTDTNLGPAELAKVSGDKELAARVGTGHFGYTNYIAFNPKVKPFDDPKVRQAIAYAVDRTSVINAAGGSSLAEPATTYLPNQKSFGYTAHDHFPAGESGDPAKAKELLKEAGHADGLTVTLTHSNAKDFETSPEIATALQDALQKAGITVELEGLEDNDYRDTIHDAKSEPGFFLAHWGADWPSGGPFLAPIFDGRQIVRDGANFNTGFLDDKSVNDEIDAINKLTDLDEAAQRWGALDKKIGEKALTVPLFHPVYKRLYGKDVKNVVISDWTGVLDVSQVAVK | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp00947 | ABC transporter substrate-binding protein | MSRQFDRRAFLRRGAAGAAALAVGPGLLAACSTDAPGADREGAGSSPRSGGTLRAAFVGGGASETLDFFNGPSALDLVRARAWHGTLGNLDPEGPDGVRYGVLKGIDVSDDLSAYTLHVRPGVRFTDGSELTSADILHSLSVLAGRSTLPVYRLAAANFDLASAKADGDLKVVLPTLRPIADGRMILCQGNFLVVKDGTRAFRKGMPSCGPFRLTEFTAGQGSAFERYDDHYGHVPLLDGLELRSIADSTARAGALTGGEVDFAHDLSPVTARTLTDDAKVRLVPTGSPYLVGLSFQMnMAVEPFDDPRVREAFKLAVDRETMVKTVFYGNAETGNDLPAMGFPDYAGSLPRRTHDPERARKLLKEAGADGTEVRLTTGPETPGMVEMATLFVEDLKKVGVKASVRELPAGQLYADFAAYAALPLAGSYQMPIPALSTYQMSTAGGSPSAFGWKDAETDALVAKARAASDPAEAKELGTLAQRTRWEKGNQVLPVFKPNLNAQAEGVAGIREDLFEQFPGFSQASLA | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp00958 | Acid phosphatase | MPDRSKRPPARAAAGTRALRAAVAAVLAGALGLGALTTGGTAAAAPSAPASASGEASGGTDYTKLVDPFVSTAGDDGNDLPGAQAPHSLAKVNPMTVPDRNHSGYDYNEDHIAGFTATNLDGVGGSGGGGDLLVVPTSEQYDKRPATSTYAHPYSHDDESASPGSYRVGLGSDAGTIDAEMTATTRTALERYAFPDGARPQLVLDLANNFTSRTRSTLDATRLKDGTTAISGLVAGSFNGASYRLYYYATTNVPVTSLRSWGDDGALGGATARDGTDTGAVLGFDPADGDDVELRITLSPISAEQAATDQHNEVAGRGFEEVRAQTEAEWNSTLGTVAVEASRKADPDSTLTKQFYTHLYRMYALPVNATSTSGTYRGVDGAVHKANGFTYYDGWSTWDDFRKYSVTAYIDPAGYRDMVQSAVILFADARSTGKSLGSLTHSVPTVRWERLPVVIADALSKGYKDFDRLDEAYPALKSYAGYYTGTELRQGYVAGDPGTTVQRGYDQWALSLVADALGEDADAKKLREQATMATDNLVKPGAWTADDGTEVGLLTPRDGEGAWQGVDYEKFEEAKLYQGTLWQYHWYDAYDMGGLIEAMGGEKAGRAAIRHMFGEDSDADDGSAMLHSNANEIDLQAPYLFNYVGEPSLTQKWVRAIYTGETWNRYIATGSTGEAPSSGGEFRPPVKTKAYELAPDGFLPTMDNDAGTMSTMFVAAALGLFPVTAGSSQFQIGSPFFDSTTVHYAGGAEFTVEADGVSPDNYYVQGARLNGKRFSNTWLDYSQIVAGGTLKFDMGSAPSSWGARTEPAYSLNTDTGDGDDGSAPGRGTTVVSARPDSVDTAADGTVKGNIELRLSGKASFAAREGTSLTRSGAAGVTGLPDGVEADLRVTGRRTASLRLTGATQTDARLGLTFRDRAFAHGVPASTVTGAGVSVTDPLVVSAAVVHRGSLGALVEEASLVREGNYSDGSYGVFRTALERARTVLADADAATGTLMAAHDALKSAIDALTLDEGGYAVLQAEDPDSMEGPSLVKEAYHSDGDLGGVTEGAWEQYTNLDFGGVAPRGVSVRYANAQAPEAEPSSVDIHAGDAEGPVVATVSLPGTGGWQYYTTVRAAVTDPQALLEASTATFVFHAPSGQQWVSNFDWYQFSPAEPASSSPVTTLATLTTANATATGDGSLPLKLTNGVFENVTNGAWAEWRGTGLGDGADTVTVSYDKPRSRAASDSHIELRLGGRDGPAAVDVPLEYTGSGWGTVATTSVRLDPETFGGAQDVYAAFVSGTQTDAQPYVANVYSLTLTRETDAPVVFDATAFGASSGGGLKSEPATWDGAGSATSLGGTYDGAWLDYGDIDFGTEPKNTVTFTYVNNSARCGTGSAVEIHLDSFDADAPGTPDATVPLPVTGSSWSSGGTTSLTLPEAITGTHSVHLRLTTNADSSHPYVANLGRVAFDHVEAPAETDLSALRKAVEQYGGLAEHKDRYGTIDFGVFVRELAAARALLDAGDATQLEADLQTRGLTLAANQLVPLPRLKLENLVATASARADERYTDASWKAFTTALTAAKETVADDAASDATLTARYTSLDRAMSALRTKHRTVPAAPGAVSATASGTSVQVTWSAPEDDGGSPVTGYEVTLGGGRQVEIADPASRSTVFTRLADGTSHTARVRAVNALGDSAPSAPTRPVVTGDNRPQTPTVTGVVTDGKRVRVTWRPAGDGGFPVLGYTVALDDGTTAHVSGTTDSALLTTAGGAKAHTATVTARTLAGTSADPAPKAAATAGTGTATSTGTATGTGTAAASDPADYEPAPFPDDVLDAAYPSDEWPRTGDGGDYFTNLLSGFDDLGPGTLGANGELPEGSELGAENDEITVAVNNAATQKQVDRAEVDASNSATVTMADGLGSRLGPIYGEALKEGQLPKTSALFSRVAENLDTHDAAKNRWNYLRPYVRLGFAGDGGRIYESEDSSYDGLAKQGSYPSGHTYGGYEAGTILATLLPDLAPSILARTSEYGDNRLVLGFHYPLDVMGGRITAQATVAHRWADPAFGKLLQQAHTEIENVLLARCEEEGYGDTLTACAGDPYAGLGTAETVDLYTRRLSYGFSQVGEAGQALQAPSDAAALLITAFPDLTEEQRTQVVEQTATDSGLPLDLTGTGGPSWQRINLAAAMAADVTVGADGSVTVTNFPDATRAAVADASALTVEGVPLDGFDPGVGTYVVDWPEHGRIPAVGAVAAKSGARVKVTDGSRTVSSSRPGFTARTVTVTSADGEHSRTYTVGFQRTDHDHRPPWSGGPGGPGGHGDPWDRGGHDGPDGTGLWSPAREWEDARGR | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp00965 | Acyl-CoA synthetase | MTPGHGSTVDGVLRRSARRTPARVAVEYRDRTWTYGELDTAVSRAASVLLDEGLSPGDRVASYVHNSDAYLIAFLACARAGLVHVPVNQNLTGDDLAYILRQSGSGLVLTDPALAARLPGASRTLSLRDTDDSLLARLAAAPAYDGPEPAAEDLVQLLYTSGTTALPKGAMMTHRALVHEYLSAITALDLGAGDRPVHALPMYHSAQTHVFLLPYLAVGATNIVLDAPDGDRLLDLVEAGRVDCLFAPPTVWIGLANRADFATRDLTGLRKAYYGASIMPVPVLERLRARLPDLALYHCFGQSEIGPLAAVLGPDEHEGRMGSCGRPVLFVDARVVDEDGKDVPDGTPGEVVYRSPQLCDGYWDAPEETRAAFRDGWFHSGDLAVRDADGYFTIVDRVKDVINSGGVLVASRQVEDALYTHDAVAEAAVIGLPDERWIEAVTAVVVPRAEVTEDELIAHARAELAAFKAPKRVRFVDALPRNASGKILKRELRDRFTAS | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7µM |
| dbacp00970 | Acyl-coenzyme A thioesterase THEM4 | MSGTSPGLQPPADAVKPVRHPEAPAPGELLGAHYGQCFGCGGDQPHGLHLQARAGEGVSITAEFTVRPAHQGAPGLAHGGVLASALDETLGSLNWLLRTIAVTGRLETDFRRPVPVDTTLYLEAEVTAVAGRKIYSTVTGRIGGPDGPVAVRADALFVEVKVDHFVENGRDEEIRAAMDDPDQVRRARAFEVNP | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp00975 | Acyltransferase papA3 | MRMTDIQRCEIRPGRLVEWTLSPRTLDIAAGLPEDARPPAYIQESHIRTARSVREGGLFVPTWLGAAFDIPGAVDLDVLQEALRSWTLRHETLRSGFRWSGESGDTMRRFTLEPDAVSLHREDVGDFPDAADLAGHLQDRFDRVADALRWPNLIYTAVVRDDGVSVYMAFDHSNVDAYSIYRIPAEVGELYAAGIAGRTVPQPRVGSYVDFCEAERADADRIDADHDIVARWREFIRRCDGRLPSFPVDLGLRPGGALPEQRLLREPLVDAADAAAFEAYCRPYGGSLVGVLAATALIVHEIGGESVYRTVVPFHTRSRSQWSESVGWYVGGAPIEVPVDRAHDFPAALRTVRAELQANRRMSRMPIDRVLRLLGTDFRPGSPDLYSIVSYVDARDVPGAGDWAEQTAYAMLRVSYGDQVCAWVTRLPEGLWFASRYPDTDIAHKNLRLYVERLRDVITGIGQKPTD | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp00985 | Adenosyl-hopene transferase HpnH | MAMPLRQSIKVATYLAEQKIRRRDKFPLIVELEPLFACNLACEGCGKIQHPAGVLKQRMPVAQAVGAVLESGAPMVSIAGGEPLMHPQIDEIVRQLVAKRKYVFLCTNAMLMRKKMDKFKPSPYFAFAVHIDGLRERHDESVAKEGVFDEAVEAIKEAKRRGFRVTTNSTFFNTDTPQTIVEVLNFLNDDLKVDEMMISPAYAYEKAPDQEHFLGVEQTRELFKKAFSGGNRARWRLNHSPLFLDFLEGKVDFPCTAWAIPNYSLFGWQRPCYLMSDGYVPTYRELIEKTDWDKYGRGKDPRCDNCMAHCGYEPTAVLATMGSLKESLRAMRETVSSNRE | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp00994 | Allantoate amidohydrolase | MSFHSMWAELLPVGRSSASGGYRRYAWTGADSDCRTWFREQAQARGLAYETDRNGNQWAWLGDPAAGNAVVTGSHLDSVPDGGAFDGPLGVVSAFAALDELRGRGARFTRPLGIVNFGDEEGARFGLACVGSRLTSGALTAEQAHRLTDADGITLPQAMEAAGHDPDTLGPDPERLARIGAFVELHVEQGRALDLSGDRVGIASAIWPHGRWRFDFRGEANHAGTTRLTDRHDPMLPYAEAVLAARREAQLAGAVATFGKVAVEPNGVNAVPSLVRGWLDSRAADQEDLDAVVAGVEKAAREYAAAHGVDLGVECESFTPVVDFDHALRDELARILGKEADLRVPVLGTGAGHDAGILSGRVPTAMLFVRNPTGVSHSPAEHAAEDDCAAGVHALADVLEGLART | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp01011 | Amidohydrolase | MSESTTPPPTVLLRRGEVHSPADPFATAMVVERGQVAWVGSEGAADAFADGVDEVVDLDGALVTPAFTDAHVHTTATGLALTGLDLSGASDREAALALVRDFAAARPGDRVLLGHGWDAARWPEGLPPTRAELDDATGGRPLYLSRIDVHSAVVSTALLDLVPDGAARADGPLTGDAHHAVRAAALGAVTPAQREEAQRAALAHAASLGIGTVHECAGPEISAEDDLTGLLRLSAGEPGPRVVGYWAERDVDKARELGAVGAAGDLFVDGSLGSHTACLHQPYADAGHTGTAHLDAADVAAHVVACTEAGLQAGFHAIGDAAVAAVVEGVRTAADKVGLARVRAARHRVEHAEMLTPETVAAFAELGLTASVQPGFDALWGGEDGMYAQRLGVERARTLNPYAALLRAGVPLAFGSDSPVTPLDPWGTVRAAAFHRTPEHRVSVRAAFTAHTRGGWRAIGRDDAGVLVPGAPADYAVWRTGELVVQAPDDRVARWSTDPRSGTPGLPDLTPGRELPVCLRTVVGGRTVHVRPGE | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp01016 | Amidohydrolase | MTDRAVLHVKGRVLVGPEEVRDEVWVIDGRISYDRPAGAADVRTVEGWALPGLVDAHCHVGLDRHGAVPADTAEKQALSDREAGTLLLRDAGSPSDTRWIDDRDDLPKIIRAGRHIARTRRYIRNYAWEVEPDDLVAYVAQEARRGDGWVKLVGDWIDRDLGDLSACWPRGAVEAAITEAHRLGARVTAHCFAEDSLRDLVEAGIDCVEHATGLTDDTIPLFAERGVAIVPTLVNIATFPALADGGESRFPRWSAHMRRLHERRYDTVRNAYDAGIPVFVGTDAGGALAHGLAGAEVAELVTAGIPPVEALSATTWAARRWLGRPGLEEGAPADLVVFDRDPRADVRVLTDPRRVVLNGRVVG | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp01021 | Amidohydrolase | MTPTPHEKPKPGAARGEPADLVVTGCTVLVHDERERIGFEQDAAVVVREGAVDSVTTAAAGAAVPAAERIDARGQVALPGLINCHTHAPMAALRGLAEDLPTEEWFNDVVWPVESNLTARDVVLGTRLACAEMIRAGVTTFADSYFHMDAVAAVVDRCGMRAQLGQAYFSSQGPAGLEASVEFALRLRDGSGGRITTALAPHAPYTVTDADLAETARLARAHGLPVHLHAAENLDQTHTSLARHGATPIGVLERTGILDTDVLIAHGTGITDADLPLLARAGGRTAVATAPRGYLKFAWPTTTPVRALRDIGIPVGLATDGAASNNSLDVWESMALTSLIQKSTEGDPRWLTSRQALHHATVQSAHAVGLGDAVGRIAPGRRADLILVDLTGPHTQPVHDLAATLVHSARSADVRTTIVDGRVLMRDRELLTVDVPGTVRELGERLPALTDRGHGRRIQEYDT | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp01026 | Amidohydrolase | MLTIHAAERVRRTWDSASLEGGAVAVEGGRVAAVGPLAELAERFPGARVRRWPGVLGPARVHEGPLPDAPTPREQVHAVLKLGAVAVLAEYAGSRELRAAAERNDVAVLERARPAALVDLGRADLAVLDDGGACIATVCAGRLVHRRR | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp01031 | Amidohydrolase | MHLDALYTNGRFTTLDASRPTAHTVGVFAGRVVGLDDEVAGCTADRVHDLRGAPAVPGFNDAHQHLSMRGRRLLQLDLHTGTVPTLDALYAAVRERAARLGPDEWLFGAGYDQNKIGAHPTAAALDEAAQGRPVWLEHVSCHMGVANTAAFARAGFTDRTGVPDVAGGHVERDTGGRAAGLLQETAQHLVTRAFRPTPVDSIVAAIAAGNDKGVTEGITSVTEPGIAAADHVGHGPADLHAFHRAVEEGVLSIRTTVMPYMTVLHDAGPAGGGDTWFGLDTGLRSGFGDDRLKIGATKIATDGSLIGRSAHMCCGYHDEPDNSGFLLFDEDRLHHMINEAHRCGWQVAAHAIGDAAIDVVLDAFEAAQAAHPRPDARHRIEHFAVASDEQVRRLVAGGVVPVPQGRFVSEIGDGMITALGPERATRCYRMRSLLDAGAVLPGSSDAPVAHGSPLLGIHDMVNRRTAGGAPLAPAEAVTAEQALYAYTVGSAYAEHAEDRKGRLAPGMLADFAVLSDDLLAVDPGRIGALSVGATVIGGRVVHDAGALD | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp01036 | Amidohydrolase | MNAAGNSSGLGTGRPGTPVVFRNGTVLTMDDRRTLHRGADVLVVGERIEAVGPLPAVPEGTREIDATGGIVMPGMIDTHRHMWQTAMRGYGADWTLTQYFVWYYLEHGTHFRPEDVYAGNLLAAVEALDSGVTTTVDWSHGLQTVEHADAALDALDEVPGRFVLAYGNIRAAPWEWTAAPEFRAFVDRRFGGDRTGLQLAFDVTGDPDFPEKAAFEAARELGVPVTTHAGVWGATNDDGIRLMHEHGFMGPDTVYVHAATLGADSYHRIAATGGSVSVSTESEQSCGQGYPPTWALRAHGIPVSLSTDTSVWWSGDLFSAMRATLGADRAREHLEAHAGGETVTHSHLRAEQVVDWATRGGAKALGLDDRVGSLEAGKRADVVLVKNDHSPVMFPLLNPYGHVALQAQRGDVHTVMAGGRLVKHEHRLIGVDLAKVRRTVDSTVEHLRSRLGAEAWEQGMNPDVPETKMLDNPYTYTGYRTAATHGG | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp01041 | Amidohydrolase family protein | MSRCRCVAMSPCRRDVAVSLCRDPGWVRACRGMAWTCRKPGPWGGRDAVVRRMPSVGSLLTGHRADSGGnMSRFAVANTRVFTGTHVADASVVVVEDGTIAEVGHEAPEGVEKIDGVGGTLLPGLIDAHTHTDEDGLRTALSFGVTTELDMMSVPDAMEPLRKKARAEFDVADVRTASWGLAHPDGHPHQLRRGLGDPVWPTATVPGEAAAFVDGRLSEGADYIKIMVEDGDVFGTSLPLVPYDVVVAVVEAAHERGVMALVHALGAAATRVAVEAGADGVTHLHHDEVISDDLVVRMREQGMFVISTLAVTASGASDGAGPRLGADLRVASRLDAEWRDNLGREFGWNAHLPTALRSAGLLHAAGVEILAGTDAAHLGAPGIAHGASLHDELRLLEAAGLSPVEALTAATRRTADRFGLTDRGRIEPGASADLVLVDGDPTSRLSSTLNTRAVWRRGHRLALGGATAERAA | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp01046 | Amino acid adenylation domain-containing protein | MNHTARGMMRTPALSTGLARAVHERAGLTPHAPAVSDGGRTLDYAALDAEAAGAAAALRALRVGPGDAVAVALPRSWQLVCVMLGVLRLGARVVPVDLQSPAERRDHVLADSGAVVHVHTGDAPHGLPPGVAAVPVDGLLRDGRDAVDRPSPPDTAPPVSFVFYTSGTTGRPKGVEVRDAGILRLARPGYLRLEETERFACLANPAFDALSFEVWVPLLTGGCCVVLADDDVQSPERLAEVLLRERVDTAFVTAALFNAVVATVPDCFAGLGQLLIGGEQLNARAVRSWYRHNAGSGTRLYNGYGPTECSTFALCHPIPRDLDTPVVPIGRTLPETGATLVVPGTTREAAPGEVAELLLSGAGLAAGYRNLPEESARRFVPLSRPDGPPVVHYRTGDLVRRDARGDIEYIGRADRQVKVRGFRIEPGELEQRILAHPAVRQAHVCTRRAGGDGPNELLAYLVVDSALTWAEFDRHLAAHLPAYMRPHHLYRIDAVPRTANGKADQAALLARTDPPWRPDGDAAEVTDPVQRELLEMAGRVLGLPDLRPGDTWIACGGDSLTALRLRFEIRRRWNRDLPQSLVLRGDLAALAEAVRAAPDTDAPGYPSASAAGAGSAPATSEQQRLWLIQQQSPHSRAYDVRLAFAVEGDVDVPALRRASSRLVARHPALRTAFEAAPEGLLQVVGEPYDPWVPAERPYASPGVVAGGVPDPGAPQGAFFAEPFDLSRPRMLRMGLLPAESGSGSVLLLHLHHIAVDGWSVNVLLRDLSDGYAAALAGGEDAPDRAAPAPTPLDFAVWQEQWRAEPAYDALRTGLLAHYADRTEPGRAVPQPAPHLADRPGAALLHTQLDVVRRAALDRLCGAAGLTRFQVLLAVYAWALYGVTGDARPRVAAPVAGRPVREFEDSVGMFANTVLLPLDVSPRRELRQELLRLGRDTQEVLERQDVALADVVQGQGPLRRAGSPFDFLFVLENTDFDSLELPGCETSPRWPVPAGAKCPVTLSVIERPDGLACQWEYAPEHFTPERAAALAELFRRGVDALAEEHSATGTVADLVAGHRGSLPEPGRGESRAWAWTTVAEGFALQVARTPSDPALMTAEGPVDYRTLDAWAAALAADLRATAGARDAEGPCHVALFLEPSVEHVVALLALARLNLTAVPVDPSYPPALLRQILEQTDPLCVLLPPGDQSAFDAVDPRGRLGLPRRTVTLSAAPDPALPDPPHRGERPLYTLFTSGSTGTPKGVRVYDRTLCNLLQWQAASGGLGGAAATQQFSMLSFDVSFQEIFGTLCSGGCLHLVRPGLRQDVPALLDRLEAAGIERLFLPFVALQMLAEHAVHLGRYPSRLREVVTAGEQLVCTDAVRRWFAGMPGSRLFNQYGPTETHVVSSLCLDGDPSRWPERPAIGGPVANAVLHVVDEAGLPVPPGCPGDLLLGGVIDAPCYLGDGRLNEERFTELPGQGLFYRSGDRARFDSDGLLHFLGRADDQVKLSGHRLEPGQVEAALLRHPAVVGAVVAVDGGELVACLRCGDAAPSPAELREHLAGLLPAHVRVARYRLLAELPRTPSGKLDREAALRAPSRELPGAHRAADGPSSGREAALAAAFEEATGSAIGPDQTYFEAGASSLDLMRFHLRCTTVLGLPLTVADLFEHVTVRRLARFLDTDAGAGTGGGAGAGMSTGTATSTSVGAGTGDHAGAAAGAGAGDLTGAAAGAEGIAVVGMAVRAPGAPDLAAFWELIASGAGGIEYFDAPEGIVGARSQMDGLLAFDPERFGISRQEARLMDPQQRHLLMACVEALAHAGLADTGAARVGLVAGAGENTYFQAMLREADPAHLPDGFQLALHHDKDFLATKAAYHLGLTGPVLAAQTACSSSLVAVHLAAGMLRQGDADVMLAGGVLVDTSLSQGYRYRPQHILSADGHCRPFSDDADGTVGGSGTGVLVLKPLSRARADGDTVYAVITGSAVNNDGSAKLGYSAPSLAGQRAAVRTALRRSGRPGSDVAYVEAHGTGTRLGDPVEAEALRQALGTTEPDHCALTSVKSQIGHLGAAAGAVGLIRAVLSVHHGVIPPTRGFRALNPEIGPDPTPFYVPTEALPWPARRDRVAAVSSFGIGGTNAHVVLEGGSAAGPPDAADSGAADQEVVPLVVLSAAGAVRLRSDASRIADYLERRPEAYGQVLRHLQAGRPQERLRAAAVCPTPLSAVDWLRAAAASSAEPGAGERPAAPPRDPVAAAECRSVSELADAWLAGRTVAWPEGSAQAPWDFPPPSFDLADFHFGRASAAHSAPAPSGAPAAAPSGALAAARTPERLPEAQWLHQPQWVRLRRAATVPRGDRARTLVVVAEGPADAALVDAFAAGHRRVVWVRASADRARTGADRFEADPADPAHLRYVLDAVTEDGPPGVDWVHMLPLSVDGPVHATSVDRAAWACLDTPAALLRAVSGRPYAALLRPWWVSRGARPVHGDVSRPETALLAGVTEVGPQEGAPRGHWVDLPGTGPWAAQLAALFAEPETAGLPRQLALRQGCWWEQVLLPVAAAPDHEGEPLPASEGDHLILGGTGGLGTGIAAWLLAHTPGRVLLLSRRPRLPEVLAPWAERVELVDADLAVEPTAEVAVRIASRTTGLASVVHAAGVAAGGLVARRDAEDMRKALAPKLRGALLVEQLIEEHRPALAVYCSSMSAHLGGVGQFDYAAANALLDAFARYGGPGGGTTARSALAWDVWRETGMAVRTLHSDARHRAHLGVGLTVDEGQRVFARAVGLGLPHLLVSTTDVEESRVFYEGAGHDASDVPAARLPGAPAGDRAPAPDSARELLAEQLCILLGVDRLDPDASLYDLGADSLTLLSVIEAVDRSFGVELDLGSLSHRVSLDEIVARLDEARGEADRTQDSQDHLNPEEGKDEDGDEVTLTVWQQGAGRDVVCLVHPVGGDVQAYRFLAAALDPGATVALIADPGLRGRELPRWTIAERAHHYLAALRARFPETTWRWHLAGWSFGAWVAAGMAAEAESAGRPARSLHLLDPPPPGSGSVFQEYDERQLKTVFAAELGLGGEETGPGRQADTYADRLTRCCLANVHSMAAHRLPRITVTATRLWLARDPVEGLPSLGTPGEQRARWRAHLPEPTAAEVLDTTHYGVVRPPHAAAVAHAVNEAVHEAVAEGSTGGSAAR | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp01051 | Amino acid adenylation domain-containing protein | MRRSSLAPARGPATVFAGKRTRGPVPAGRRSPSRTNCVDVRATSGGEPAEPRFSRRCDCNSGPPSQWPGPFTPRRTAPAGRAITSTTRRTCGSRSRGRPTRAAAPAPSPPLGRTGTPSARHSGRPDSAACRAAGRSARRNRVLTASVPRRGGELASVVAFANRRAGNTRRSPLTWSSAPPNDWLRLPHPRAGVAEYARSHPWQPFQHGRRPHLTATHTPHASSPGSQDDGFPPPLSFGQERLWTLAQTAGAVAAYNEPMAFRIRGPLDRALLGRALDVVVSRHETLRTRFVDVDGEVRQVVGPPESGLPLRVEDLSGAPDAEARLADHQREECETPFDLRRGPLVRGRLITLAPSDHALLLTLHHAVSDGRSGQVLTRELGVLYGALLRGEEQPLPPLPEQFAAHCRRQRAWVNGPEAAGQAGFWREYLDGAPPLLALPTDRPRPPRQSHEGDRVHVRFDADLTAALRAAARKEKCTLFAAVLAGWHILLSRLSGQPDGVVGIPVEGRRGSAASGLIGFYVNSLAHRVDLSGNPTGAEALRDVRASLRSVLRHQDLPFAHVVEAVNPRRSLSHGPLFQTMLTWGASRKDFLELAGTRVEPLAIDFAPAKFDYTLYLHEEDGGLVGYLDYARALFDRGTVERHLRYLTRVLRQLADDPGRRVADLVLLDDREHGELLAKGHGPVAPSPAADLVELFEEQVRGRPHGPAVVAGGTRLDYAALDRRANRLAHSLLARGVRPQQVVGLHCGRTAELLVGIWGILKAGAAYLPLDPGQPAARLRTIVEEATPALVLSDLGDPPGPWLPLGQVAAEGERDDPPGVAIGPSHLAYVIYTSGSTGRPKGVAVTHGNVVNLIGNWLDQYGAIPGEPSSAWASIGFDASVHELFLPLTTGAVLHVVPEDLRGDPEALLDWMREREIVHAYLPASYITWIDEDPGGRLRGLALRQVTTGAEPLPEMALHRMREVLPGLRVCYVYGPTETTVYSITYNQPQALGRRCPIGRPVRNTLVHLLDQGRRPVPPGVTGEVYIGGAGVARGYLNRPDLTDERFLPDPFVPGGRVYRTGDLARLLPDGDYEFVGRVDDQVKLRGFRIEPGEVAAALREVPGVTEAAVLADRDEAGETRLVAGVARAGGGSPLLPHEWRAALSERLPDYMVPSLFAEFERLPLNRSGKLDRQALLAHARSALSAAQVNTHAPRDRVEMSLYRIWRQVLVHPGMGITDDFFAVGGTSLSAIKVAHLVREEFGHDLPIREVLEHPTIERLAARVREGVPAKGDDSLIEFRAGGGAGRVVCVHPAGGTAFCYLPLATALPEGIGVQGVQALGLNPGEEPLASVESMAEHYLRLVRPEPGEALVLCGLSYGGLVAHEMGRRLAEAGHDRSAVVLLDTHGTDDPAERAAFAPVGADDFRARLVRFNGMYPGIDDAQIDRYFRIYNHNRAAARDHTPRSTAAPLLLVQADAEAPSPAEAAAVEERQRRFWGERALAGLVVERVEGGHWDVLEGERVSRIAALITDELARLDGRSV | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp01056 | Amino acid adenylation domain-containing protein | MTDSPSAAHRDKVAIIGIGCRLPGHAGDHRSFWRNLIEGRDCLVPTPADRYDTTTLGSRDRAKPGRLTGGRGGYIDGFDEFDPHFFGISPREAEHMDPQQRKLLEVSWEALEDGGQRPAELAGRDVGVFIGAFTLDYKILQFADLGFETLAAHTATGTMMTMVSNRISHCLDFRGPSVSIDTACSSSLVAVHLACQSLQRGESELALAGGTLLHLAPQYTIAETKGGFLSPDGRSRAFDASADGYVRAEGVGVVVLKRLSDALRDGDPVHAVVIGSGVNQDGRTNGITVPSADAQATLIERVCAEAGVTPGSLQYVEAHGTSTPVGDPIEARALGRVLAQGRAPGARCYVGSVKTNIGHTEAAAGVAGLIKTALALRHRRIPPHLNLEQPNPAIDFAALPFEIPTAPVDWPEHQGPARAGVNSFGFGGTNAHVLLEEAPPRPPEEPRATARTPSLSVLPLSARHASGPAELAAGVRRELAAGVSLADLGHTLAHRRQHFEERLAVVHSPLGPPGSLDEVLAACERGEQHPRAVRGRLREPGAPRLVWVFTGMGPQWWGMGRELLDAEPVFREAVERCDREVRRQAGWSLLDELTRPEAESRMAETWLAQPANFAVQAGLAALWEHHGVRPDAVVGHSTGEIAAFHQAGVYGLEDAVRIALARSALQHRLAGTGVMLAANLSEEEAERLVRPYRDHVSVAAVNSPASVTLSGDRDTLRELAGRLEREQVFARFLDVEVPYHSVRMDPIEAELREALTGIAPRAAGLPLYPTAREGRARGPELDAVYWWENVRRPVRFRAAVDRLVDDGYTLFLEIGPHPVLGHSIRECLEGRAVEGVTLPSIRRREDEPERFARSLAELYTLGVDVDWSVLQPVGRPVPLPGYPWQRERYWVEPAPVEQIRLGRLDHPLLGRRASALQPTWESRLDTERLPYLADHRIEDSTVFPAAGYLEMAAQAVRALTGGDTATLADVEFSRALFLPDGEATTVQLAFAPEEAGFTIASLAGSGTGTPDRTVHASGVVRTGQPRRLAQPLDTGAVRARAGRRLDREACYGELAALGYHYGPAFRAIDEVWTGPGEALSLIRPTPGMGDGAADCHVHPVLLDACFQTMLTAMTPDDGRSAGIRLPAGIAELRLDAVGDRAALWAHATVTAESDEELVGDLALYAEDGTPLGRIGGFRAAAVDRGASSVKLGTIDGWLAEVVWEEAPTEAETPTEAPEDVGTAEGSGAGPGGSPAPGLVVFADEGGLGARMAEAVVARGGRCRLVRPGSRYRSGARHVTVRPDSAADLRRLFAELGPGFGAVVHLWNLDLPPLDTVGAADLDGIGTLGGYSLVLLAQVLPEAFPQGRLHIVTRGAQAVVPGEPVEPFGAPAWGIGRVLWQQELTGHSGKLIDLDPAGGPGEPEVLLRALTTDDGEGEIALRSGRRHLSRLRPPAGLTRPLPLRLRADGAYLVTGAFGALGRLLCRTLVRRGARRLVLLGRTGVPARGAWRGLDPGGPEGRRVAFLRELEALGAEVLVAAVDVTDAAAMEGWLAGRRAAGLPPVRGVFHLAGQVRDVLLPSLDREAFDAGYGPKAHGGYLLHRLLRDEPVEHFVLFASVASLLTTAGQVNYAAGNAFLDALAHHRRALGLPALSLDWGPWATGMIEELGLVAHYRDARGMSSLAPEAGMAVLERVIGQDRAQLLVAAVVDWPVFLSWYPTPPPLVSALAAAAAREVPAGQGGSLLAAFRAADEAARTALVAERFAALAAGVLRVRPEQVDADARLGSLGLDSLLAMELRARTHTELGVSLPVVALLSNGPVSELTERLHAGLTELAAAGGPVAETAVELFTDEACYPLTHNQQALWFLRQLNPDGFAYNIGGAVEVRAELDPELLFDAFRTLIARHPSLRVNITTEDGRPVQRVRPEAVADTGLLDVSGLPWDEVRARLVAEYRRPYDLERDPLVRLRLFRRAPDRWVLMKAVHHIVSDAISTFVFIEELFEVYHGLRTGRPAELAPVRARYLDFLNRRNRFLAGPEARRMLEYWREHLPREVPALELPTDRPRPPVQTDNGASEFFQLDDELSARVQTLAREHNVTVFTVLLTAYYLLLHRWSGQDEIVVGSPVTGRTEEELASVYGYFVNPLPLHVSLAGEPSVAELLGRVRDTVLGGLDHQEYPFVLLVEELGLQHDPSRSAVFQAMFILLTHKVGVERFGYTLEYIELPEEEGQFDVTLSAYEDRSDGRFHCVLKYNTDLFDAATVRRMAAHYQNLLDGLTRAEGERPAGRLPMLGAGERERIVTGFGGVGRRIDHDVPVHELIGKIAAQFPEAVAVSVPGGRRLGYRELDQRSRRVAASLRERGVGAGTVVAVRLAKSPELVIALLAVWRAGGAYLPLDPDHPAERLAELMENAGATLVLTDGRRGGAARLPGRPVTLDELDRPGTEERPEPAVDLDQTAYVIHTSGSTGRPKAVRVSHRNLASVFVAWQQEYRLDTDVRVHLQMAGLSFDVFTGDLVRALSSGGTLVLVDRDLLFDTARLYRTMRAEGVDCGEFVPSVARGLLAHCEREGLGLEFMRLVIVGSDAWRADEHHRLVALCGPGTRVVNSYGLTEATIDSAYYEGPAEGLEPGRMVPVGRPLPNSELYVLDRHGEPVPPGVAGELWIGGAGVADRCLGDPERTAERFVTLEPGGEPVRLYRTGDLGHWDAEGVLHLLGRRDGQVKVRGHRVETGEIEARLAARPELAQVCVTVRRDETGENVLCAYCVPAPGAAADARELRRHLAEQLPTYLIPAHFTELSALPLTANGKVDLDALPKPRAEAGPERYEPPVTLYETRMAAHWRSLLGLERPGLRDDFFEAGGSSIKLIQLIHHLRTEFNASVPVGRLFKTSTLHGMARTLEDVVTGRLPGAEPYLWFNPGADPAATVFCLPPAGGHGLVYRQLAARLPEHRFAAFNYLSGPDKAARYADLAEELHPGGPYTLFGYSLGGNLAFEIAGELERRGRAVDLVLIMDSYRMAEAVALGEEHLAEFEAELTEHLRRHTGSEIVARETVEQAREYLAHCAAHPSLGVLDAPIAVISDQDKLLRFAVDEPGGWHGGTAAGCTVREGHGRHAEMLDGSFLDGNAELVRALLTGGAANGRA | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp01061 | Amino acid adenylation domain-containing protein | MRVDGGLLPKPCTTRGPGSDHGPHPGHRRPGRLLAARGISPRIGAAKVTVTVGEVLALVADRLVLPAEQLDPERSFVAAGADSLSLMALARAVQSEFGVRVSVRELFTGVDTPQKLAEAVAGRAMNRSAPAVPAASAAPAQVPTTALATEPVGHAPVAQPPAPTGDALESALALFTDQLQLAGKMMTRFSELTSEQLRVLRGLHPGPAVGASPALPAAQPAPETDLTDDVATAEPLPATGTTRRPPAGAPRTGTPDPAPAGTTARTSPDFSLYFFGDYPAPDSAVAYQHLLQAAEYADELGFHALWLPERHFHSFGALFPNPSVLAASLATRTSRIRLHAGSVVLPLHNPIRVAEEWAVVDNLSGGRVGLGFASGWHSTDFVLAPENYGRQRDIMYEHLETFRSLWSGRSVAMTSGDGRPTEVSLHPRPVQGDDVPLFAAVLSNPESYERAARAGLGVVTNLMTQSVEDLATNIARYRAARAAHGHDPATGRVVVLVHTYLEPDAERARQEARKPFCDYLRSSIDLFDNAANSLGIDVDLLATHQDDLDYVLDLAYERYCETRALIGNAAEVRPVLDSLTAAGADEIGCFIDFGVPPERMLGGLPELDRLRAASTEPRAEAAPVPAAAPRTAAVTALQRQLWLLDRMTPGSHTYYEPKALFIEGPLDTEALRGALRRVVARHPQLRAVFRERADRLEQVVLDAVAVDCPVTELPGHDDTAALLRLRDLEDETDFDLATGPLIRARIGRLDGERHLLYLVAHHAVLDALSTRILCRDLAAYYRAWPGEPTDLPELPPWPATVQESSTADGLAYWQRDLADASPLTLATDRPRTAGHEVRGATLVHEIDGELRGGIRSLARAEGCTPFMALLGAVSATLGRFAAQDDIVIGTAVTNRPEDAADVVGMFVETVALRLDLSGGIGFRELLHRVKARTTAAMDHRGVPFDQIVEVVNPDRSSGANPLFQAAVEYEEELGSVFEDTGLTAEFREVPRKHAPFGLTFYFSDRAAGIRCTVEYDAGLFDESTVRRIAEYIEKLLRRSVDAPDAALCELLALTARDEWSLAGFQGERTETEPATLHGLFEEQAALTPDALAVAGVGDPLTYAQLDAAANRLARRLADRGLAEGEVAAVSVSRGPGLATAVLAVLKCGAAYVPVDLALPAERRAFMLSDSGARLVVADGTLDGDTADTLPCPVQWLEDVAPSDTDEPLGRTVDDEATAYLFYTSGSSGRPKPVAVPHRGPVNLIRWQLRTLGALRTAQWASAGFDVSVQEIFSTLASGQALITVDDETRYDPAAVAAQLRHFEVERMSVPFTPLKYLARELKAVPSLRQLLISGEKLTLTPELRELAAHCPELSLYNQYGPTETSVVVTSHRVNPATETVVPIGRPVDNVTLAVVDDSGRPVPVGVPGELVIGGVAVSHGYHGNPDATARGFFRTPDSGERRYRTGDLVRWRDDGVLEYIGRIDEQVKIRGYRVEPEEAQWALGRLDGVREAVVLARPGESGDTELAAFVVLSPAHAPDGDWSAPLRAQLATVLPHYLVPQSWVRLDRIPYGATGKLARGELLTLRAEPALAATDVELSDLEPTVHKLWAVELGVDTIAPDTSFFDIGGNSLSAVRLLERVLTEFGQRIPVADFFAAPTIRGVAHRLTVLQGEER | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp01066 | Amino acid adenylation domain-containing protein | MVPGAARPGHALREPPRGRSHPLRRLPVLHRPGRDRGVRGGTGRPVRRLRRRTARFRDGRRGQQVSRTARKIEDILPLAPLQEGLLFHSVYDEGELDPYVVQMSFDIDGALDTAALRTAAEKLLARHANLRVAFRQRKSGDWAQLVMREVPLPWTERDLSALPETDRAEAAAGLIAAERATRFDVTRPPLLRFTLLRLGADRHRLVLTNHHLLLDGWSLPVLMGDLFALYDAGGDDSALPRVRPYRDYLTWLEDQDRDAARDAWRDTFADLVEPTLVAPGADRAAVAGAEVRAELPREETAALTELARGRGLTLSTVVQSAWAIALSKHLGRDDIVFGTTVSGRPPEIDGVERMVGLFINTLPSRVRLRAAEPLAGLVARVQREQAALTPHQHLGLAEIQRTVGHGELFDTSMVFQNYPVNRSGTAGTGIGAAISLAPGKNREATHYPLLLIAAARDSMTFRLNHRPDLFDAATAQQILDRFVRVLRALVTDPEQPVGRLDLLTDRERDSVLREWNDTAHDVPDATVLGLFRAQADRTPQAPAVTSAGRTLTYAELDARSSRLAHLLAEHGAAPERFVAIALPRDCDTVVALLAVLKTGAAYLPVDPDYPAERIAFMLADTEPALLLTTRELAPGIPDSGAPRLLLDDPAHTGDLAARPDTAPTVPIPPGLPAYVIYTSGSTGRPKGVVIEHRSLGAYLQWARDAYPAMTGTSLLHSPISFDLTVTALYTTLVSGGLVRVADLDERAAEGPGATFLKGTPSVLALLEALPAEASPSELIMLGGELLLGEVADRWRARRPDADLLNVYGATEATVNSVQYRIPAGAPAPTGPVPVGRPFWNTQVYVLDSGLRPVPPGVPGEAYIAGTGLARGYWRRAALTSERFVANPYGPAGSRMYRTGDVLRWNHDGRLEFVGRGDGQVKLRGYRIELGEIEAVLAGHEGVTQAAVLLRQDQPGDKRLVAYAATAGASVPADALRALAADRLPDYMVPSAFVVLDAFPLTPNGKLDRRALPAPDYGPQAGGGRAPRSPREDILCTLFAEVLGVGSVTIDDDFFALGGHSLLATKLVSRIRSALGAEMAIRQLFETPTVAGLSGALDTGNGAARTPVTAVLPRPERLPLSHAQRRLWFLHRFEGPSAAYNSPVALRLSGALDRAALEHALADLTARHETLRTVLAEDAEGPHQVVLDEARPSLAVVSSDATRLAADLSEAAGHAFDLASEPPLRATLFEVGGDEHVLLLLTHHVATDAWSRAPLARDLTAAYAARMRGAAPQWAPLPVQYADYSLWQRDVLGTEDDPDSEAGRQLDYWGKTLAGLPQELSLPFDRPRPAVASHRGDVVTFELPPELHDRLARVARDSRTSLFMVLQASLATLLSRLGAGTDIPLGTPIAGRTDDALDDLVGFFVNTLVLRTDVSGDPTFAELLERVRTADLAAYAHQDMPFERLVEAVNPERSLSRHPLFQTMLNLNNAGPVEALDEIAKLPGLTVHHEPVETHRVKFDLGFSFAESHSTTGTPGGLRGALQYSTDVFDRSTAEALVQRMVKVLEWVVASGNGSRVSEVEVLEEAEREQILSGWQGASRPVRGASLPQLIAEQAERTPDAVAVECGDRALTYGELDAWAGRVAGWLQGQGVGRGTFVAVKLPRSVELVVALLAVTKAGAAYVPVDPEYPQERVAHILSDATPALVIDDTAMLEQETDGPFDTVRIDPHDPVYVIYTSGSTGRPKGVVVEHASVGAYLERAREVYPDASGTALLHSSVAFDLTVTALYTPLVSGGRVVLTDLDEHAATTGQPTFMKVTPSHLGMLEALPEEVSPSGTLITGGEALVGEALAAWRAAHPDVTVINAYGPTEATVNCTDFRIEPSDVMGSGPVPIGRPFWNTRAYVLDDHLRPVPPGVTGELYVAGIVLARGYHNRPDLTAERFTADPYGPPGTRMYRTGDTARWTHTGQLTYTGRTDDQIKLRGFRIELGEIQAVLMTHPHITQATVIVREDQPGDQRLTAYTVNTAGTDTTTDDLAAHTAAHLPAYMIPSHFITLDQLPLTPNGKLDRNALPTPQYGPQNENGRAPRTPHEQALCTLFADILGTDTVTIDDDFFHLGGHSLLATKLVSRIRTDIGAELPIRQLFETPTVAGISAALADKARAARRGVVAVDPRPARIPLSYAQQRLWFLNRFEGPSATYNAPVALRLTGALDQEALRQALADVVTRHESLRTVFAEDAEGAHQIVRGPADARPEFTIVETDEARLRDDLAWAAGHPFDLAAEIPFRASLFALSEEEHVLLLLTHHIVSDAWSRAPLARDLTAAYAARVRNAAAPEWAPLPVQYADYSLWQRDILGTEDDPTSEITRQLDYWTHTLTGLPDQLELPYDRPRPAVATYRGDRIPFDIPAELYERVGEVARRVQASPFMVLQAALAALLTRLGAGTDIPLGTPIAGRTDEALDDLVGVFLNTLVLRTDTSGNPTFAELVDRVRERNLGAYAHQDLPFERLVEAVNPERSLARHPLFQVLLTLNNTDYQGALDSLGDLPGLRAEREPIESSVAKFDLAFGYTERRDPHGRVTSLHGVLEFSTDLFDRRTAGALVDRLLRFLDHAVTTPDVKVGDIEILAGAERGRLLELWNDTAREVPERSVVELFEERVASNPLAEAVVAGEEALSYEELDARAERLARVLVERGAGAERFVAVALPRSVDLVVALLAVWKTGAAYLPLDTEYPAERLAYMLDDANPVLLLTTSDLTPVLPEEPAVPRLLLDTPETTEALSRPAGDRSLTRPALANPAYVIYTSGSTGRPKGVVVPQGALVNFLTAMRDRFELGAGDRLVAVTTVGFDIAGLELFVPLLSGASITLAERDVVRDPAALCRLVRSAGASVMQATPSLWRAMLAEDASALAGVRVLVGGEALPADLAEALVQRAMSVINLYGPTETTIWSTEWPVTAEGARRPRIGRPIANTRVYVLDGTLRPVPAGVPGELYIAGDGVVRGYHGRPGLTSERFVADPHGPSGTRMYRTGDLVRWTVDGELEYLSRVDDQVKLRGFRIELGEIEAVLAGHERVAQAAVLVREDRPGDRRLVAYLVPAAEAVETAEVRAHLAAHLPDYMVPSAFVTLDSFPLTPNGKLDRRALPAPDYDQGTSEGRAPRTPREDILCTLFAEVLGAGSVTIDDDFFALGGHSLLATKLVSRIRTVLDTEIAVRRLFEAPTVAELAAVLDNATGTRKPLRAPVSRPDRVPLSYAQRRLWFLHRFEGPSATYNLPVALRMTGTLDQEALRLALADVVDRHESLRTVFAEDAEGPYQIVQDTAEVSLTVTATDEEHLPEDVDRASRAPFELSEEPPLRAFLFELGEDEYVLLAVVHHIAGDAWSMGPLAQDLTSAYAARVRGAAPEWAPLPVQYADYSLWQRDVLGSEDDPDSEAGRQLEYWKNSLSDLPAELSLPFDRPRPATASYVGDRVTFELPEDVYGGLVRVARAGRSSLFMVLQTALATLLSRLGAGTDIPLGTPIAGRTDDALDKLVGFFVNTLVLRTDVSGDPTFAELLERVRTADLAAYAHQDLPFERLVEAVNPERSLSRHPLFQTMLTLNNTDQGAASAVASLPGLEVSSRPVGIGAAKFDLSFRLAERRPTSESESATLGGALDYSTDLFDRETAQSITERFVRVLTALAQDPDRRVSEVEVLEEAEREQILSGWQGASRPVRGASLPQLIAEQAERTPDAVAVECGDRALTYGELDAWAGRAAGWLQGQGVGRGTFVAVKLPRSVELIVALLAVTKTGAAYVPVDPEYPQERVAHILSDATPALVIDDTAMLKQKTGKPFDGVRIDPHDPVYVIYTSGSTGRPKGVVVEHASVGAYLERAREVYPDASGTALLHSSVAFDLTVTALYTPLVSGGRVILTDLDEHAATTGQPTFMKVTPSHLGLLEALPDEISPSGTLITGGEALLGEALASWRATHPDVTVINAYGPTEATVNCTDFHIQPGEPVPSGPVPIGRPFWNTRAYVLDDHLRPVPPGVTGELYVAGIVLARGYHNRPDLTAERFTADPYGPPGTRMYRTGDTARWTHTGQLTYTGRTDDQIKLRGFRIELGEIQAVLMTHPHITQAAVIVREDQPGDQRLTAYTVGTDTTTADLAAHTAAHLPAYMIPSHFITLDQLPLTPNGKLDRNALPTPDYNQHTSEGRAPRTPHEEALCTLFADVLGTDTVTIDDDFFHLGGHSLLVTKLVSRIRTSLGAELPIRQLFETPTVAALSAVLGNDTAPSRPTVTAVDPRPARIPLSYAQQRLWFLNRFEGPSATYNIPVALRLTGALDQEALRQALADVVTRHESLRTVFAEDADGAYQIVREPADARPDLHVIETGPEEVEERLRDAARRGFDLSAASGELPFRVTLFEVGDGEHVLLLLLHHIVSDAWSRAPLARDLTAAYAARVRNAAAPEWAPLPVQYADYSLWQRNILGTEDDPTSEITRQLDYWTHTLTGLPDQLELPYDRPRPAVATYRGDRIPFDIPAELYDGVAALARDTQASPFMVLQAALAALLTRLGAGEDIPIGTPVAGRTDEALDDLIGVFINTLVLRTDTSGRPSALTLIERVRNQTLEAYAHQDLPFEQLVEAVNPERSLARHPLFQVLLAFNNTDTAAVEDAVAKLPGLSVSRATADTGVGKFDLSFAFAEQAGSGTGLQGVLEYSKDVFDRETVETLGLRYLRLLRAMVDAPQKPVDEAVLLDEAESRTLLSGWNDTACEVPGRSTVELFEERAASDPAAEAVVAGTHSLSYGELNDRADRLARVLAAHGAGAERFVAVALPRSTDLVVTLLAVWKTGAAYLPLDTEYPAERLAYMLDDANPVLLVTTSDLSPLLPASTQVPRVLLDEPGLQEELAAPAGPGPLRGIHDPSASAYVIYTSGSTGRPKGVVVPHGPLVNFLTAMQRQFPLGANDRLLAVTTVGFDIAGLELFLPLLTGASAVIAERDTVRDPGALCTLIRTSGATTMQATPSLWRAVLAEDPTVLTSRHVLVGGEALPADLATALTRHAASVTNLYGPTETTIWSTHWPATSDTAHHPRIGHPIANTQIYLLDHTLQPVPTGTPGELYIAGHGVVRGYHNRPGLTAERFTANPHGPAGTRMYRTGDLARWTPDGTLEYLARVDDQVKLRGFRIELGEIETALTAHPHVAQAAVLVREDRPGDPRLVAYLTPTAHQPIPTTDLRQHLATHLPDYMLPTAYITLDAFPLTPNGKLDRRALPAPDYATHTEGGRAPRTPREELLCTLFAEVLGTDTVTIDDDFFTLGGHSLLATKLVSRIRTVLDTELAIRQLFEAPTVARLAGVLDSSAAARGRLVAAPRPARVPLSHAQQRLWFLQHLEGPSDAYNVPISLDLTGELDQEALRLALADVVDRHESLRTVVVEDGSGAAHQVVLGREQTRVPLAVERVASDAEVDARMRRAAGYVFDLASEIPLRATLFAVGEEGVTDRWALLLLTHHIASDAWSRGILIRDLVAAYAARTTTGRAPDLAPLPVQYADYSLWQRDVLGSEDDPGSEARRQLDHWKRALSGLPEELSLPFDRPRPAVASYRGDRVAFDLPQDVYERLVRVGREQGASLFMVLQAGLAALLTRLGAGTDIPLGTPIAGRTDDALDDLVGFFVNTLVLRTDTSGDPTYAELVDRVRAESLAAYAHQDLPFERLVEAVNPERSLSRHPLFQTMLSFDNAGRAATHADLAGLAVSGRTLGAPAAKFDLSFELAERPAGPDRAADLSCALDYSTDLFDRGTAQDVADRFVRVLTALADDPGRRIGETEILGRDERRRMLVEWNETAVQHADRTPVHVLFEERAAAEPEALAVVSGEERLSYGELNARANRLAHRLLGRGVGRESRVAVFQERSAELIVATLAVLKAGGVYVPIDPQQPASRSEFILRDTGAVALLTDRDPGDLPFAVDVPVLDVGPGTDLSGEADTDPGVPTDAEQLVYVMYTSGSTGTPKGVANTHHNVVHLAADRYWRGGRHERVLMHSPYAFDASTFEIWTPLLTGGTVVVAPAGRLDAADLAAAISGHGVTGLFVSAGLFRVLAEERPECFRGVREIWAGGDVVSPTAVRRVLETCPGTVVANEYGPTETTVFSAVNPLRDPAEVPEAVVPIGRPLWNTRLYALDERLRPVPVGVPGELYIAGSGVARGYLGRAALTAQRFVADPFAGAGERMYRTGDVVRWLADGRLEFLGRVDDQVKLRGFRIEPGEVEAVLAGRPEVSQAAVVLREDRPGDKRLVAYVVAGAAAEPEALRAHVAGTLPEYMVPSAVVLLDGLPLTLNGKLDRRALPAPDYGADTERRGPRTEREKVLCGLFADVLGLAEVGVDDGLFDLGGDSIMSIQLVSRARRAGLELSVRAVFEHRTVAALAEVVTETDTTVTEEPGAGIGDVPLTPIMRWFLERGGPVDGFNQSRLVQVPASLRLPDLTAALGALLEHHDALRARLTDGSERRLEIRGPGAVDAGSVVRRVDAAGLDDDTLQDLVRGETVAARERLDLGAGRVVQSVWFDRGDSRPGLLLLIVHHLVVDGVSWRILVPDLAEAHRAVVAGRPVELQPVGTSLRRWAQRLTEVAGDPARTAEADWWRSVLRPADPLLGRRPLDTARDTYASARHLTLTLPVAVTERLLTRVPAVFRAEVNDVLLAAFALAWARRGGGRGAGVLLDLEGHGREEELVGGADLSRTVGWFTSLHPVRVDAGPADLADAFAGGPAAGAVVKRVKEQLREVPEKGIGYGLVRHLNPRTAPGFAGLPTPQVAFNYLGRFTTAGVENAGSEAVPDWTVLATASGVGGTDPRVALAHPLELNARTNDGPRGPELSATWSWAGGILDEDEVRELAELWFRALEALADHAENPEAGGLTVSDVSLSLLDQSEIELLEDEWRNL | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp01071 | Amino acid adenylation domain-containing protein | MPTPDRRSAPPPEHRPLLAAQEGIWAGQQLDTESPAYNTAEYLRIAGPVDTAVFDRALHRVVAETEALNATFDIDDTGRPRQATTPAGDWRTHIADLTAEPDPHAAALAWMDRDTARAVDLTRGPVFGHALLRTGPQEHLWYHRVHHIALDGFGLSLVARRVAEVYSGLMAGDPVPESGFGTLDSVREEEAAYLASARHTQDRAYWTDRYADHPPVATPADRSALPARTFHRHVTDLGPAAAHRLRTGARELSVTWSEVLLAVTAAHLHRLTGAPEIVLSLPATGRLGSVSLRVPATVRNILPLRVPVAPDDGLRDLAPRVSRELRAGLPHQRYRYERLRRDLKLVGGGRRLSGPGVNIMPFEYDLRFAGHPSTVHNVSAGPVDDLAVNVYDRGDGTGLRVAVDANPDLYTEAETAAFQEGLLALLEQALTDPGRPLGGPRAHRTVAVLDGGPLPAPARPVLSLIADHATRGGGAVAVEHAGERLTYARLLGAARDVARRVTALGVAGGDVVAVALPRGTDAVTAVLGVLMSGAAYCPLDPKAPAERTARLLADTAPALVLTTADRAADFADHTVLPLHEPDPAPAGAHTPSAKGDSAGAGSTARRRSELGPLDGNESQEPGPRHFAAPAVEDPAYVLHTSGSTGRPKGVQVSHGALAHFVAAATHRYGLRREDRVLQFAPLHFDASVEEIFLTLCAGATLVIRPDDMTESVPGFLDACARLRVTVLDLPTAYWHEVAHTVSTGAAALPRAVRTVVVGGEPALPERVERWRKAVGTSVALLNTYGPTEATVVATVADLHDPGLGTGDVPVGLPLPGTRAAVLDGELYLLGPALADGYRPEVPDSARFAPLTALPDGPRAYRTGDLVRIGEDGQLRHLGRADDEFKISGQRVQPAEVESALLFHPGVREAAVAGQVLPDGTRRLVARLVPEGPAPSAADVREHLRARLPAAMVPSAVEFVGRLPRTGSGKIDRAALAAPPARRAPTTGSPLEQTVTGVWCRILGIDAVAVDDDVFDLGAQSLQAIQAANRLGTELGRDVKVAWLFQHPTAGGLARFLAQGPQPRAAGPAGLPPALLADARLDPDIRPGTRSAPRDAPRRILLTGATGFVGAHLLAQLLSDTGAEIVCTVRAADVPEATGRVHAALARHGITLDERTSARLTALPADLAHPGLGLPPDTLAGLAASCDAVFHNAATVSIMRDYANLRAANVESTRRLVRLAAVHATPLHYVSTLSVAPPASRAPEVPEAFLPPHEGLRHGYQQSKWAAERLLQQAAERGLPVTVHRLGRVIGRAGTGGVNERDFLWSVLRAGIPEGIVPELFEDEIWTPVDFVARALVHLSLTPDTAATGPVFHHATLPRVRLADVYDWVRAYGYPVRALPLARWRERLPRSADVAATTLAFFDAAELDAAGPDSTELGFSEPDSTGPDFTGRDSHDRTTATDLRLGHVRADRVRAGLVGSGITCPPVDRALFFRHLDHCVTAGVLPAPAGRPVSRSGPAAK | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp01076 | Amino acid adenylation domain-containing protein | MMEPTARLVLLSPKHLTDLRRRTGDHSDAALATACAIGLSYWATGQSPAGLDLTAATLFGDVLGWADNGGAAPEGWGVAADGRTITLPEGVVPDDAQLALDDLADFPGRPLGTIGPAGPTARLENLARWNDTDADRERPTLMEMFLEQARARPGAVAVVDERRTLTYRELSDRSAQLAHRLRERGLSDEDVVGISLERSADMVVGLLGVLRAGCAFVPLDPHWPAERRAVVAADARVAVQLNASGEPAPHEPEAVPVDLADWRHGDRPTEGPDPTVRGDALAYVIFTSGSTGRPKGAMIRHEAISERLLWQVHEILDFGHDDASLFKAPLSFDISINEIFLPLVCGARLVVLRPGGERDPHHLLGVIAEQRVTFTYLVSSMLDVLLEMAGDTGRLDSLRHVWCGGEVLTPELYERFRTQLDIPLYHGYGPAETTIGVSHVVYRGAAERLSTSIGRANPNTRLYVLDDELRPVPVGVGGELYAGGLLLGRGYVNAPGLTASRFVANPFADDGSRLYRTGDLARFAPDGSLDFLGRADNQIKIRGMRLEIEDVEAGLAEHPGVRHTCVVPKKNTAGGTYLVGYVIPAAGHGSLRPDEVKAWAAEHMVEYMVPTHVVVTDAFPLTANGKLDRQALPEPTVAASAARPPGTENERAVCTAVAAVLQLDEVGTDQDFFRLGGDSILAISLLSALRDAGLYVTARQIFTHSTVGALAAVASREDTAAVDHRDTPTGTVVGPPVVQWLGETTGAIDGFVQSVVLNTPAALTADALDEILTALVRRHPMLRARLVRGDRWGFDIPDEVPAGALWQESDRPLDSCTALATEALDPAGGAMLRAVWRRSARQLVLVAHHMVIDGVSWRVLMEDLATAWRQYASGAPVELPVEGTSFRRWTGLLERAASDADGQYFRRPLPAADEPVGRRALTEDDTVARERIRTVETGAETTAAVLGTVPAAFHAGVGDVLVTALAVALARRRRDLGQDQTFAHLELEGHGREAAFVAPSAGFEPELSRTVGWFTTLFPVVVDPGTAPDLTAPEYLATALKAVKEDLSRVPDNGISYGALRYLNRVAFDAPAPQVLFNYLGRFDAGAPGDWQLAGSTGQLGEKRDPAMRLPRALEFNAVAEPGPDGEYRLVTTVSWPEGLFTDQDIDALAGHFQDALTGLAALERGGHSPADFRPLRLTQADVDDLDGPALRDILPLTPLQEGLYFHSVYDDETAGSYVEQQLLTLDGDVDADRLATAATRLLTLHPGLAARFTALADGRVVSVLESGHHAPFTTLDRPGITDEEIRDLAERDRRAGFDLATGPLMRYTLIRAGAGRHVLVQTVHHIVADGWSVPPMLRTLLAEYHRPGSAHPLGGFPEHVRRLAALDDRESDRVWREQLAGLPGPSLIAEGHTPSDRFADTATTPGIDVDAAARAAGVPLSVAVHSAWALTLGGILHSEDVVFGSTVSGRDADVPGIQnMVGLLINTVPVRARWSADTTAAELLAQVRAHQSAVLPHQHVSLARTARHTGTGPLFDTLVVFDVATDVGALREPGDTLVVTDIVNEGAPHYPLTLVVERTPDGTPRFNAVHDAALLRESQVQDILHTFTRTLTTLLTSPDTPVAAPVPHTARRAPAVAPATLGDLLDAAARRDPAATAVTQCSLDGATRSLTYGELTEAKDGLAAVLRAAGAGPGRLVAVAVPPSVEQVVALTAVTGAGGAYVPLDAAHPDERLEYILADAAPQVVLVDREQRERFTRLLERAGVPARVLVQGDEPAPADDGPASPAGWHDPAYVIYTSGSTGRPKGVVVPHSGVVTLLAHTQADMGFGPDDVWVQFHSFSFDFAVWELWGALAHGGELLVPEYALTRSPVDFHRLVREHRVTVLNQTPSAFHRFIEADRHAGEPLPALRRIVFGGEALDLGRLRDWVDRHGTATPELVnMYGITETTVHVTHRVLTDADFGPGDAPSPIGTPLPGLVVHLLDDRLRPVPPGRVGAVYVAGDQVSLGYLGRPGLTAGRFVADPFTGDGSRMYHTGDLARRTLDGELHFAGRADDQVQLKGFRVEPGEVEAALRDLDGVSDAAVTVADGGDHLVAHVVGRAPGDLTALLAARLPAHMIPGRVLSVDALPLTVNGKLDRKALAERAANAPLPDGALHRTDSGSAAPDGPAVLDTVVRVFAETLPGSTPDADTDFFAAGGDSIVAITLINRARAAGLSVTPRDVFLLKTPRALAEHLTASTPPPATPEPVRREDGPLPPTPIILRQRELGGSLARFAQARTLLAPEGTAFADVERAARAVVAAHPALRLRLRVDHGVWSLRTEADREVTVVRADGTDPTAAADEAASRLDPESGDVAAFSWLAANRTLVVTVHHLAVDAVSWLILLDDLAGALRGTPVPAPTTSYAEYAEALTHRAAHAAPGLGHWTTALQAPTPLPPPEALRETTAVLAPGISDRLTRTAPTALGLGLTELLCGALRTALTRIQPSPTDLAVDLERHGRVPALEHHDYTRTVGWFTAVAPVRLTPHTDPVAAAREVTERRPDEREHVAYGLLRYLNAQTAPLLTARPQVLFNYLGRGAESEAPRLAGGDRGSPYAVEVNAWTDAATGSLHAVFTLAEGIPDTLTAHWLAALEQLADSAATAERTAPVTPLQRGLYFQSQLTGPTGHYVAQSWFTLERRLDTDALADAMAHVIARHPVVGAGFTTDDDGNPVQVLGAGRRVPVRTVEAATDAEAEALRLADRDTGFDPAEPPLVRLTVVRLPGDRDGLLLSYHLLLWDGWSRETVLRDLFDAYEDILAGTPLDTAPATPRFEDHARALAARDPAPAERFWSEHLAPLSGPTLLAGPAPSLSDDLPHALVHTLTAAESERLRETARTHGVTLNSVLTGAFGLLLGAHTGRADAVFGVTVSGREGEGASGVVGVLLNTVPMWTRARPHDTVRAYLTAVQASRVAAMEHEHLGLGEIQRAAGHDTLFDNLFVLQNFLDLDAFAEMNARHGITSVQADDSTHYPFTWVVTPGDRLTVKLEHRDHDAGRARRLLDDYLRVLADLAASDGPLGALPGPAPAPAPGARTDIGTDTVVDRFDRAADRNPRRVALVAHGSTLTFAELRDRSRAVAGVLVRRGIGPETTVGIAVPRSLDSIVALFAVLRTGAAYVPLELDHPDERIAAIVADARPDVILTVGTVAPRLTGDLIELDRPLPEAEPYVTFAPDDPHRLRHPAYIIHTSGSTGKPKGVVTEYAGLTnMLVNHRRRIFEPVLAEHGHRTFRIAHTVSFAFDMSWEELLWLADGHEVHVCDEELRRDAPRLVEYCAEHAVDVVNVTPTYAQQLVAEGLLDDPARRPALVLLGGEAVTPALWRRLAETEGTVGYNLYGPTEYTINTLGVGTFECPDPVVGVAIDNTDVHVLDPWLRPLPDGVPGELYVSGIGIARGYLGQTAQTAHRFVACPFGAPGERMYRTGDLVTRRPDGNLTYLGRTDQQVKIRGHRVELGEVEAVFTAHPAVRFAAAVAQPDPQVDGAHRLAAYLVLDGADLATVAAEVGAGLPDFLRPTHYARVDGIPLTVNGKADTRALPEAKPLGALTTAGERPPATETETTVCEFFAEALDLDDDEVSAVSDFVSLGGHSMLAVRLTGLLRREYGPVITIRDLFTLRTPEAIARHLDDH | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7µM |
| dbacp01081 | Amino acid adenylation domain-containing protein | MQETAPDPVAGRQPAPAAGPEDAVAALAHACAAALASDPASVRLAARLKVASVLLGRASPAPDASWRDLVRHVGTDDGRSEAEEAWANASAAAGATAERLGRYELRALRLMRDDPDLPHTRHGLLTPEETEAVVARGAGPLRPLPGRRFHELFEERVRRHPDAVAVVHGTTTRTYRELNDDANRIAGALLREGLAPEDVVAVVTGRHPLWPAAVLAVFKAGGCYLPLEPEFPASRIARTLTRSECRWVLSDPDVASLDEALNGRDTIRRMTVGDLARGDGPTRDPGVAVAGDQLAYVYFTSGSTGEPKGAMCEHDGFLNHLYAKIEDLGVQEGDTVGQTAPQCFDISLWQLVSPFLVGGRVLLVEQEAVLDVARFVDLVNRHRVQVLQLVPTYLELVLAEAARGRAALPHLRVMAVTGEALKKELVRRWFEQFPGVPLVNCYGLTEVSDDSHHGVMHTVPDHRSVPLGDTIRNCRVYVMDEQLHLVPDGAPGEIVIAGVCVGRGYVNDPDRTAAVYHQDPLRPAERLYRSGDFGRRLPSGELEYLGRRDAQVKISGFRIEIGEIEDRLLQVPGVRDGAVVVAGTDDAPQLVAYYTGEDAPDGAGTAHALGTALPHYMVPHRLHRVRELPLSGNGKIDKKALTARARDNAHARGSAGTGAPRLDTPAERRVAAVWARLLRVPEDRIGRDSRFTDLGGTSLTAIRLAIELDRRVTVAELRDTPTVADVAALLDGKSAPARATAPAGPAPATTPARPAEGPAPLPLLDCRAADPEPDPAARATAHRAPALAALAASGAVMLRGVGARTPADVARVAAALGIEPLTEREGFAPRTALAPGVYSGSHWPAEDPMCMHHELSHAATVPGTLLFACLTAPDSGGRTTVADSQQVLAALPSGLTARFAEHGWLLRRAYHDVGLSWPEAFGSTDRASVDAYCAEAAVEPTWLADGSLLTRQRRAAVVPHPRTGAPCWFNQIAFLNGLTLEPAIREYLTDVYGPGGLPFDTAAGDGGPVTAGTVEEINAVYDRFTVGEPWQQGDVLLVDNIRTAHAREPYEGAREIAVVLGDPVRLPGHVLPLSDGGPS | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp01086 | Amino acid adenylation domain-containing protein | MSEARLLRRPVSAAQSGIWVAQHLHADSPLYNCGGYYEIAGPVDAEIFAEAVRRGVQETEALRSRFAQEERDTDSGPEVTLHQLVEPAEPHPLRFVDLRAASDPEAAAHRWMNARMARPFDLTRGPVSEQALLTLADDLHWYFHGYHHAVLDGFGQSVYATRVAALYSALLAGEEPSPTGFATLDRVVADEAAYAGSRRHTRDRAHWREVFTDLPEPVSLGRASGSTHSLRRHVRTLPTPLAERLPGAAARLGVQWPALALAATAAFFHRMTGGTDFTFSIPLAGRSGRTSLTTPSAMVNVLPLRVRLTSDIRFTELAAQVSRSLADVVRHQRFRGEELIHELGLSGAGQARLGPTVNIMAFAGEPLFGTTPAVTHPLSTGPVNDLKINFYGTADSRTGIRVELDGHHELYGADELAAHCDRLVRVLEWVADSDDESRVSEVEVLEEAEREQILSGWQGASRPVRGASLPQLIAEQAERTPDAVAVECGDRVLTYGELDAWSARTAGWLQGQGVGRGTFVAVKLPRSVELIVALLAVTKTGAAYVPVDPEYPAERVAHILSDATPALVIDDTAMLKQETGKPFDGVRIDPHDPVYVIYTSGSTGRPKGVVVEHASVGAYLERAREVYPDASGTALLHSSVAFDLTVTALYTPLVSGGRVILTDLDEHAATTGQPTFMKVTPSHLGLLEALPDEISPSGTLITGGEALLGEALASWRATHPDVTVINAYGPTEATVNCTDFHIQPGEPVPSGPVPIGRPFWNTRAYVLDHRLRPVPPGVTGELYVAGIVLARGYHNRPDLTAERFTADPYGPPGTRMYRTGDTARWTHTGQLTYTGRTDDQIKLRGFRIELGEIQAVLMTHPHITQAAVIVREDQPGDQRLTAYTVNTVGTDTTTDDLAAHTAAHLPAYMIPSHFITLDQLPLTPNGKLDRNALPTPEYNQHTSEGRAPRTPHEQALCTLFADVLGTDTVTIDDDFFHLGGHSLLATTLISRIRTTIGAELPIRQLFETPTVAGISATLDQQPARAAVRRPGVTAGPRPGRIPVSYAQQRLRFLSLLEDGSTAYNAPGALRLTGALDQEALRQALADVVTRHESLRTVFAEDESGFTQVILEPYEVALGLDVVAVDEERLAARLAEAARYSFDLAAEPPLRATLFEVGDDEYVLLLLLHHIAGDGSSMRPLARDLAAAYAARVRGATPEWAPLPVQYADYSLWQRDILGTEDDPTSEITRQLDYWTHTLTGLPDQLELPYDRPRSEVVTQHGGQVSLRIPAELHGQLHELARTTRSSLFMVFQAGLAALLTRLGAGTDIPLGSPIAGRTDAAVEELVGFFANTLVLRTDTSGDPTFAELVERVRARSLEAYQHQDLPFERLVEAVNPERSLTRHPLFQVCLTLHNTDPRATVAEEARLPGLAVELERLPIEDTKFDLNWELTEHVDGLGRPAGVTVDLEFSAELFDRGTARSVADRFVRLLSATARDVEVPIGEIDVLAPGERTEILDEWSDATRPPVAAALSGSSLPRTADDTRAYVLDDTLVPVPPGVVGQLYVTGSGPAGDAAEQERWLPCPYGRAGWMYRTGTSARWSADGELRLVEVPGRTPVGPADVWPARSRGPRSPREQILCTVFAELLGVASVGIDDDFFDRGGHSLSAVRLLSRIRAVLGVELSIRRLFENPTVAGVVEALDEASGARRPVTAVARPARIPLSYAQQRLWFLNHLEGPSATYNIPVALGLKGALDRAALRLALTDVVARHESLRTLFAEDSEGARQIVLPAAHATPELIEVDVAPGELPGRIRAAASHPFDLATELPVRAWLFSAHDGERVLVLVVHHIAGDGWSMGPLARDLSLAYTARARGDAPAWTPLPVQYADYTLWQREVLGSEDDPDSEISRQLAHWKTALADLPEELELPVDRPRPARQSHRGGRVPFEVSAGLHARLAAFARETGTSLFMVAQAALAALLTRLGAGTDIPIGSPVAGRTDAAVEDLVGFFVNTLVLRTDTSNDPTFAELVGRVRETNLGAYGHQDVPFERLVEVLSPVRSLARHPLFQVLLGFDNNQEALEILRLPGLTVDVHAPETGRAKFDLAFFFDERYGPHGEPEGLGGAVEYNSDLFDRSTAQEFAERLLRVLEGAVADPERPIGRLEVMSPAERDRVVDEWNRTAHDVPPLPVPTLFERQVAAEPRATAVLGEDVTLSYAELNSRANRLARLLAASGVGAEDVVAIALPRSADLVVALVAALKTGAAYLTLDVSAPEQRLRAVLTDCGPRVVVTDLATRPLLGDGIALDVVLDAPETVRELAAGADADLTDADRVRPLDLRHPAYVVYTSGSTGTPKGVVMPMSSLVNLLAWHTGTYCGGVGTLTAQFLAVSFDFAVQEILQALVVGKTLVIPEEHVRRDAYELAQWIARYSINELFAPTLVIDAVLAAAADTGERLDSLTDLFQGGEQFRLSHELREFCASGWRRMAHNIYGPAETHAATTATLPGDIDEWPTAASIGQPLWNASVYVLDAGLRPVPPGVRGELYIGGAQLARGYLGRPDRTAERFVASPFGRPGARLYRTGDVVRWNHCGELEFLGRADHQVKIGGFRVEPGEVEAVLADHPSVETAVVVTREESAGPTRLVAYVVPEGQDADPALGRTLRAHLEQQLPHYMVPSFVVPLDELPLTANGKLDRRALPAPGSDTVAAEPRTEREKVLCGLVADVLGLAEVGVDDGFFDLGGDSIMSIQLVSRARRAGLQLSVRDVFEHRTVAALAEIVTETDTTVTEEPGAGIGDVPLTPIKRWLLARTDDLDAFnMSAVLRVPADVDADALTGAVQALLDHHDALRARLTPAPQRRLEVREPGSVDAGALVRRVDASGADGADLHALVREAGAAARDRLHLGEGRVVQAVWFDRGRDSAGMLLLIIHHLVVDGVSWRILIPDLAEAYEAVSAGRKPALQPVGTSLRRWSQRLTEEAVKPAWVADAAWWQDVLRSAGPPPGRRPLDPARDRQATAGRLTVTLPTEVTEAVLTRVPAAFHAEVNDVLLTAFALAWARWRPGGPELLLDLEGHGREEHLVEGADLSRTVGWFTNLYPVRLDTGGVDLARAFAGGSAAGSAAKRIKEQLRSVPDKGMGYGLVRHLNPATAAGFDGHAAPHVAFNYLGRFTAADCDRAADWTPVTGFDAVAGDPPQLPLAHPLELNSRTEDGPEGSELVAFWTWAEEILDEDEVRELAELWFQALRALVTHSENPHAGGLTPSDVSLSSIGQDEIEAFEEELDDLFDDFDDEPHDFETEEEASK | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp01091 | Amino acid adenylation domain-containing protein | MPGRVVEMINAQVRRHPRAPALVAPDGSLDYAELDRRSAYLAGHLTRQGVRPGDVVLIQASRGVALGVALLAVLRSGGAFCVVDPQYPADRIQHMWRRSHARFALIESGLRAPDVPDGPAVLPLRQWATPGSAHRAPAPHRAEPGSEDPAYLVFTSGSTGGPKAVLMPHRCLDNLIEWTLASTSSEPLRTLLFAPLGFDVFVQEVFTAWCSGGCLYTPSDAERVDLQCVWELCREREIQRVFLPPVALRRLADLTVEFGILPGALREVAVAGEALHITPAIRELFGRLPAARLHNHYGPAETHVAVAHTLTGPPRSWPDLPPIGRPLPGMTAQVVPRAEGGELWLTGVGLAHGYVHDPRQTQERFRSILVEGRTVRAYRTGDLVRERTDGALEYLGRADGQLKIRGYRVEPGDIEAALLRHPAVRECAVVAWTSLGSEERRLVAHVAAVPGGAPDAAELRAHVAGLLPDYMVPHHVVLATELPLSPNGKIDRRRLPPPGDADDSAGTLPEPEPGDVRSAVADIWSTVLGVADIPPDRHFMDLGGTSLSAALVVTRLHQRFQVQVSVQEFLYDPRVDAIAALITERAAA | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp01096 | Amino acid adenylation domain-containing protein | MSGHRTQQTYTRIPRWTMPGSDEQGAAEHREALPAPLTRALEERAADTGAELPAVLLAAHARVLATVVAEPDLLIGLVPAAGRAESPLGLTVTDSSWADLVGLASTAPAAAPRAEGRPEVVFDLSGLTPTDTAPAGRADPDGTAVGLGEGVVLRVAVVAGSAGLSLRLVYDRAHLDESYARRLAGYHLRALELLAADTSAPHHGRSLLSEEEIDTHLYGLAGPRVDLTDRTFVDHFEDRVREVPDAVAAVHGPVRWTYRELDGRANRVAHALLDAGVRTEDVVAVVMDRTLDWIAAALGVFKAGGVYLPVRPDFPADRVAAQFSRSECAFVLTEPGSATLARKAGELTGRAPTVLSVPEIQASGVSDAAPRVPIAPGQAAYIYFTSGSTGAPKGAMCEHAGMVNHLHMKLDDMEMTNGTAEVVTQTASQCFDISLWQFAAPLMVGGSVRVVDTDALLDVAGFLDEIVTGGVTVVQIVPSYLEVLLTHLEQHPRPLGALRTVSVTGEALKYELVQRWFALYPEIKLVNAYGATEVSDDTMHEVLDRVPDRDFVTVGRSLRNVNTYVLDQDLALVPLGSPGEIAFSGVCVGRGYINDEERTREAFVPDPFRDGTRMYRTGDFGRWLPEGRIEYLGRRDEQVKIRGFRIEIGEIENKLLALTGVREAAVVIDGTDDGQRNLVAFFSGGDGGARPDAEPTTERARDFLAGLLPEYMVPTYFHRLDRLPLTENGKVDKKALIRLAGTLGHGGAAYAAPSTPAEQRLAMLWAQVLGVPLERIGRDDNFFELGGTSLAAVRLLVQLDRALSLKDLVAHPVLADLGRALDERVRGGERAAAENLLQPLANATDPHRILVCFPYAGGNAVNFRSLAAELERDGIAVLGVELPGHDFAGGDDPMADVPEIARRVRDEIAARVTTPVLLWGHCAGAAPALETARLLQEAGRPAERVFVGALLLEDVGALRAEMAEAAEADNKSLLSRLRADNAYVELDELKPERADVVGRAYRHDVLTANSHLIRIREDAGSHRIDAPVDVVVARDDASTARFAADHGDWKAVSDRVTLHELDQGGHYFIGTRAADTAALVRACCPKPTHRD | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp01103 | Aminoacyl-tRNA hydrolase | MDGMSGPHVIRGSVLLPEAELVWRFSRSSGPGGQHVNTTDTAVELRFDLARTGALPEVWKRQALERLAGRLTDGIVTVRASEHRSQWRNREAAAVRLAALLAEATAPPPRPRRPTRIPRGINERRLREKKQRSQTKRGRSPKDWD | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7µM |
| dbacp01108 | Aminopeptidase N | MSCMSVLTRDEAQTRSRLLDVHHYAIALDLTRGDETFDSRTAIRFTVRGDTDATDTFVEVKPAELRSVTLDGQPLDPAALDGNRLPLRGLAPGEHELRVDAAMRYSRTGEGMHRFTDPADGETYLYTQMFLDDVQRVFAAFDQPDLKAVFDLAVTAPEGWTVLANGTTEHTGDGHWKAATTPLISTYLVAVAAGPWHSVRTEHRGLPFGIHCRRSLAPHLDTDADELFEITRACFDRYHEKFTEPYPFDSYDQAFVPEFNAGAMENPGLVTFRDEFVFRSAVTDTQRQTRAMVIAHEMAHMWFGDLVTLRWWDDIWLNESFAEYMGYQTTAEATRFADTWTDFGVSRKAWGYDADQRPSTHPVAPEHVEDTASALLNFDGISYAKGASALRQLVHWLGEKDFLAGINIHFERHKYANASLADFIDSLAAATDRDVHAWADAWLRTTGVDTLTPRVTGDNGGRALEVGRKGERPHRVAVGLYDRDLNDEGRLTLRERLDLDLPQDDPRPIGKLPALVVLNDGDLSYAKVRFDAESFRTIREGLSGLPDPLTRAVVWNALRDAVRDGELPARAYLDIARAHLPRETDLALVDGVLAFAAGQVADRYVAPEQRPAALTTLAELCRDLIRRTEDGDHPGLRLIAVRHRIATAAHPDTIAAWLADGTVPGGPELDPELRWRILTRLAVLGATDEAAIAAELERDPSATGQEGAARCRAALPDAEAKSRAWEAMFATDDLSNYLFTAMAQGFWQPEQADLVREYVPRYYAEAVAVAARRGPAIADAAGRWAFPGHAVDADTLRLGEQCLADAEPLPALRRKLTDQLDDLARALRVREAGAR | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp01113 | Aminopeptidase N | MPGTNLTREEARQRATLLTVDSYEIDLDLTGAQEGGTYRSVTTVRFEVAETGGESFIDLVAPAVHEVTLNGDALDPGEVFQDSRIALAELLPGRNILRVVADCAYTNTGEGLHRFVDPVDDQAYLYTQFEVPDARRVFASFEQPDLKATFQFTVKAPEGWTVISNSPTPEPRENVWVFEPTPRISSYVTALIVGPYHSVHSVYEKNGQSVPLGIYCRPSLAEHLDSDAIFAVTRQGFDWFQEKFDYAYPFKKYDQLFVPEFNAGAMENAGAVTIRDQYVFRSKVTDAAYEVRAATILHELAHMWFGDLVTMEWWNDLWLNESFATYAEAACQAAAPGSKWPHSWTTFANQMKTWAYRQDQLPSTHPIMADISDLDDVLVNFDGITYAKGASVLKQLVAYVGEDAFFQGVQAYFKRHAFGNTRLSDLLGALEETSGRDLKTWSKAWLETAGINVLRPEIETDADGVITSFAIRQEAPALPAGAKGEPTLRPHRIAIGGYDLDADGKLVRGDRVELDVDGELTAVPQLVGKVRPAVLLLNDDDLSYAKVRLDEQSLAVVTEHLGDFAESLPRALCWASAWDMTRDAELATRDYLSLVLSGIGKESDIGVVQSLHRQVKLAVDQYAAPTSREALLTRWTEATLAHLRAAEAGSDHQLAWARAFAATARTPEQLDLLDALLDGTQTIEGLAVDTELRWTFVQRLAAVGRFGGSEIAAEYERDRTAAGERHAATARAARPTEAAKAEAWESVVDSDKLPNAVQEAVIAGFVQTDQRELLAGYTERYFEALKGVWESRSHEMAQQIAVGLYPALQVSRETLDRTDAWLASAGPTAALRRLVSESRAGIERALQAQAADEAAGA | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp01118 | Aminopeptidase N | MRTPRLLASAAALTALAACGGDGAVGGGPGGPGAGDPYFPEAGNGGYDVGHYDLKLDYDPGTGRLAGLATITARATRDLSAFNLDLKGLNVEKVAVGGRDARSHRAGQELTVRPADALDAGETFRVTVRYSGRPVTVTDPDASEEGWLRTADGAVGLGQPTGSMAWFPGSHHPSDKAAYDLAVTVPEGLGAVSVGELRGERTRAGRTTFTWHAAEPVSSHVVTVAVGRWETDRSRTGDGLPVYTAVDPQQADASREVLARIPEIMDWARKNFGPYPFSSTGAIVDRAGDAGYALETQNRPYFPGAPDTVLLVHELTHQWFGNSVSPKTWRDMWLNEGFATYAEWLWQEDHGGDSAQQTFDALYDGTYYPDEAANDAVWSFPPADPPDAAHISASPVYQRGAMVLHQIRRAVGDDAFRALLRGWAAAHRHGNADTADFTAYVEKSAPDEDFTEIWRTWLHGEGRPRRS | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp01123 | Aminopeptidase N | MLHTPHLPAPRPRAHSRRRLRAAALLASAVSVCLVAASAPPTPLGVGDRLYPHLGNPGYDVAAYDLAFTYSGSNSEPLEAVTTIDARATADLDRINLDFAHGKVDSVEVDGEPADFAPAGADLVVTPQDALDEGERMRITVRHSSDPVYAEDRPGGWVRTTDGLAMANQADVAHLVFPCNDHPSDKARFTFHVTAPDGLTAVANGLPTGVERAGGSTTWTYRTQHPMATELAQVSIGRSTVLHRTGPHGLPVRDVVPTEHRAALEPWLEKTPEQIAWMEKKAGRYPFETYGLLMADATTGFELETQTLTLFERELFTEPAYPKWYVESIMVHELAHQWFGNSVTPATWSDLWLNEGHATWYEALYAEETADRPMAERMKAAYGASDRWREAGGPPAAPKPPKSGSKTGIFRANVYDGSALVLYALRQEIGRTAFEGLERAWTATHRDGTATTADFVRLASETAGRDLGGFFQAWLYGEKTPPMPGHPDWKPVAEKEPVKASRKPQGE | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp01128 | Aminopeptidase N | MPLRLGAFVHRRFIVPGALGAATLMLAIPASAAAHSPGAPGIGDPYYPAYGNGGYDVSHYDLRLKYQPDTDRLEGTATILARTTEDLSRFDLDFLLDVGEVRVNGAKASFTTSGEQELEITPAKPLDKDTPLTVVVRYSGVPSSKQAFGFTSWHRTPDGGIAANEPEAAAWWFPSNDHPLDKATYDVSVQVPDGTQAISNGTLQSTSSRLGWTRWNWRSAQPQATYLATLAIGRFDLTTGTTEGGIPVVNAYSEDLGPNGGAARASVERTGEVADWLSGYFGPYPYDALGGYVPNTDTGFALETQTRPFYSPRQFANGSNVSVVVHELAHQWYGDLVSLRGWKDIWINEGFARYAQWLWSEHEGEGTAQELADYTYASYPADDPFWTVKPGDPGPENQFDTAVYDRGALAVQALRNEIGDDAFFTVLKGWPAKYAHGNASVADFQRYAEEVSGKPLAALFDTWLFQPSKPDAAAARAQSLAKPAGTPAQPRSWRKIAATNDVHDHDHGHRH | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp01133 | Aminopeptidase N | MSRDEARERAALLSVDGYEVSLDVRSALGEARGEAPDEAQGGGPRTFRSVTTIRFRCNEPGASSFADLIAPSVTAVSLNGRDLDPSEVFDGSRIALEDLAAENELIVDAQCAYSRTGEGLHRFVDPEDGEVYLYTQYEPADSRRVFANFEQPDLKAPFRFEVRAPEEWTVWSNGAGERADGVWRFAETKPISTYITCVVAGPYHYVTDTYERTFEDGTRLEIPLGALCRKGLAPHFDAGDVFLITKQGLDFFHDRFDYPYPFGKYDQAFVPEYNLGAMENPGLVTFREEYIFRGKVTRASYEGRANTILHEMAHMWFGDLVTMEWWDDLWLKESFADFMGAFANVGATRFKDAWITFANRRKAWAYRADQLPSTHPITADIRDLEDAKLNFDGITYAKGASVLKQLVAYAGQDAFLEGARRYFKRHAYGNTRLGDLLSVLEETSGRDMTAWARSWLQTAGVNSLTPQVLLSTAGTVDELAVVQEAVESHPELRPHRVAVGLYRRTAEGALERYARAEVDVEGPRTVVAELAGAEAPELVLVNDDDLTYCKTRFDATSLATLREHLGALTDPLARALCWSALWnMTRDALLPARDFAALVLRFAGRESDIGVLQMLHAWAGSALVHYAAPDWRETGGRLLGEGAVRELRDAAPGGEQQLAWARFLASVASGEEELSLLRGLLDGTEKIDGLAVDQELRWAFLAPLAAHGAADEGVLAAELARDDTASGKRHQVRCLASRPSAEVKARAWAQVVESDALSNALVEATIAGFAQASQRELLAPYAERYFAVIERVWAERSIQIGMDVVRGLFPSLRDSPETLDATDAWLSAHEDAAPALRRLVLEARDDLARALRGQACDAAAAAR | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp01138 | AMP-ligase | MADLHARLEQLASDRPHDTALVLGRRDGSGRAITFARLVAGCREAADAFERAGVRRGHKAVTMTGDPYHLFTTVHGLLAVGAVPVLVDPGLPRADLRQCLDEVAPEVFVGQPLAHLGRTALGWARGHVRTAVVTGAAVPGLRRRLPVPGARRGWAPAGPPPVRDPLPPTPDDGLALIAFTSGSTGVPKGAEYHHSTLLGQAETLARLVGTDGTLFAGFLPVVLLGPVLGHTTVAPAVNHRAPARTPSARLVRPLLENRTEVVVGSPAVLGLLAEHCARRRLVLSCVDRVISFGAPLRAGLADALHAVLRPDAEVLSAYGATECLPVSAVSTTDACAPGAGTCVGRPLGGVAARILDAGPDGVGEIAVTGANVSPAYHARPEITAATKTATDRGVQHRTGDMGLIDGEGRIWFHGRRSHRVIGTDYVLTTEDVEAAADTLPGVRRTALVGVGAPGRQRAVLCVELTARGPGRGAAVTAVRELLDRRPEGRHVAAVLVHPGFPTDIRHNSKINRDRLADWATRRLRRPR | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7µM |
| dbacp01146 | Ansalvamide A | NA | Marine fungus, Wilt of banana | Apoptosis inducing | Not specified | HCT-116 | Colon cancer | IC50 : 9.8 µg/mL |
| dbacp01184 | Apo E | LRVRLASHLRKLRKRLLRDADDLQKRLAVY | Apoprotein E | Cell membrane disintegration | MTT/MTS assay | COLO-201 | Colon cancer | 65 % Cytotoxity at 40 µg/ml |
| dbacp01202 | ATP-binding cassette domain-containing protein | MPESATTATPGPAAEGPREDTPLLEVRGVTKAFGSGRRRLTALDGVDIEVGRGTTLGLVGESGCGKSTLARVLLGLERPDAGTVRFDGTDPFALRGKELLAWRRRVQMVFQDPFASLNARMSAADLIGEPWRTHRDVVPGAGAREKRIRELLDLVGLRAGDAHRYPNEFSGGQRQRIGIARALALDPDLVVCDEPVSALDLSVQAQVLNVLSDLRTRLGVTYVFISHDLSVVRHISDRVTVMYLGKVVEHGATDEVFETPRHPYTAALMSAAPALHPGGGSRREEIQLRGEVPSPFDIPSGCRFRTRCPRAEERCASEAPPVAARGTADGGEPHTALCHFPLAAGSSWA | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7µM |
| dbacp01207 | ATP-binding cassette domain-containing protein | MVPVLAADGAAVELADTTLLAPTTFEVGPGERWCVTGGNGTGKTTLLRAFAGTRSLTAGSVSVRGEPVAMTDPRHRRLMASLVEPVPVARDMTLREQVALVAASWYGNSTAAAEGTGRVVERLGLSALGERFPHQVSSGQSQLFSLALTLVRPADVVLLDEPERHLDRHRVDLVAGLLAERAEAGTAFLVATHDPALVAACDGRVELG | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7µM |
| dbacp01221 | ATP-binding protein | MGVVVLAMLGSLAVLAVAGPLWWGHAADRPDPSAVLQGPTGRHPLGTDHLGRDLLARLLASTWPSLLPAVAATLLGAAAGITLGALTAVVGGRVRRLLGAFVNLLLAFPALLIAMFFAALFGAGARGAVFALAVACAPGFARLTQTLAAGVAGTDFMAAARVLGLRRHRLLLRHVLPHVAEPLLLNVTVAVGSALVALSGLSFLGLGAQSPSYDWGLLLSQGLERVYTEPLPAVAPGIAIVYAGVAFQLLGEVLAKTATRHAVPRHAEEPAPPPAPAGRRPASPDHVLEVEDLRVALPAGDRTIRPVRGVSLALRRGEMVGLVGESGSGKSLTALALADLLPDGARATWNAHWFLGADVGSLTRGERHRQLATGMAMVFQNPASAFNPALRIETQLTEAVRAHHGTPRDQAVEQALVQLRRVALPGERRLLRSRPFQLSGGQRQRVAIAAASMLRPDLVIADEPTTALDVTVQRQIMDLLRRLRRDDATAILFISHDIALVADTCDRVLVMYGGTIVESLPARRLADGARHPYTRMLVASVLDLTADRDGTPPTVEGPPPDAAGTDPGCPFLDRCPQRLDRCAVEGPVPTLLAPGHEVACWRPLPLAAPPGQPETEEAET | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp01229 | ATP-grasp ribosomal peptide maturase | MTVLILTSEEDVTADMVVVHLNASSVPVVRLDPADLTESVALSGEFVHGSFRGHLSAGERLVSIGGLRSVWLRRPGGPAARAAEPSAWLTEESGQALYGMLRGSGARWMNQPDAAHRARYKPWQLRLAQQCGLPVPATLITTFPRAAREFAERYPDLVVKPVSGAHPQDPPLAVPTSRVPPEADFSAVAHGPTLLQRRVAKRADIRLTAVGDELLAARKATAHPDPDEVDVRFAASAEPWRPVEVPPRVAESVRSYLRAAELAYGALDFAEDGDGTWWFLECNQSGQFGFVEVDTGQPIARTIAEWLARPGPGDPMPSGPPGATAVG | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp01234 | ATP-grasp ribosomal peptide maturase | MDDPTTDLVIDELHGRGVPVVRFDSGDFPATLSIAATLTSNGIGGTLTTPTRTADLSRVRSLYYRRPSGFAFPHLDDQTARFAVTQARYGIGGVLASLPGCRYVNHPHRIGDAEFKPSGLAVAAACGFRLPPTVITSDPDTARAFVKAHGPVLYKPLSTPLYRIDGVSCTVEVREATADEIDDSVTGTVHLFQQRIDKTGDVRVTVMGDHVFCVRIDSDLLDWRTDYARLRYGVVQPPPGVLESLHAYLDHFRLVFGAFDFAVDRRGRWWFLECNPSGQWAWLEPETGLPMVAAMADLLERKTT | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp01254 | Aurein 3.1 | GLFDIVKKIAGHIAGSI | Southern bell frog, Australia | Cell membrane disruption | Not specified | Colon tumor cell line | Colon cancer | LC50 : 10 µM |
| dbacp01263 | Aurein 3.1 | GLFDIVKKIAGHIAGSI | Southern bell frog, Australia | Cell membrane disruption | Not specified | Colon tumor cell line | Colon cancer | LC50 : 10 µM |
| dbacp01273 | Aurein 3.2 | GLFDIVKKIAGHIASSI | Southern bell frog, Australia | Cell membrane disruption | Not specified | Colon tumor cell line | Colon cancer | LC50 : 10-100 µM |
| dbacp01283 | Aurein 3.3 | GLFDIVKKIAGHIVSSI | Southern bell frog, Australia | Cell membrane disruption | Not specified | Colon tumor cell line | Colon cancer | LC50 : 10 µM |
| dbacp01294 | Aurein-1.3 | GLFDIIKKIAESF | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | HCT-15 | Colon cancer | IC50 : 4-5 μM |
| dbacp01313 | Aurein-2.5 | MAFLKKSLFLVLFLGLVSLSICEKEKRQNEEDEDENEAANHEEGSEEKRGLFDIVKKVVGAFGSLGKRNDLE | Green and golden bell frog | Not specified | Not specified | Not found | Colon cancer | Not found |
| dbacp01322 | Aurein-2.5 | GLFDIVKKVVGAFGSL | Green and golden bell frog | Not specified | Not specified | Not found | Colon cancer | Not found |
| dbacp01331 | Aurein-2.5 | GLFDIVKKVVGAFGSL | Green and golden bell frog | Cell membrane disintegration | One-dose and five-dose assay | HCT-116 | Colon cancer | IC50 : 4-5 μM |
| dbacp01340 | Aurein-2.5 | MAFLKKSLFLVLFLGLVSLSICEKEKRQNEEDEDENEAANHEEGSEEKRGLFDIVKKVVGAFGSLGKRNDLE | Green and golden bell frog | Membrane disruption | Not specified | Human tumour cell lines | Colon cancer | LC50 : 10-5 - 10-4 M |
| dbacp01349 | Aurein-2.7 | GLFDIAKKVIGVIGSL | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | HT29 | Colon cancer | IC50 : 4-5 μM |
| dbacp01360 | Aurein-3.1 [Cleaved into: Aurein-3.1.1; Aurein-3.1.2] | GLFDIVKKIAGHIAGSI | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | COLO 205 | Colon cancer | IC50 : 4-5 μM |
| dbacp01373 | Aurein-3.2 | GLFDIVKKIAGHIASSI | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | HCC-2998 | Colon cancer | IC50 : 4-5 μM |
| dbacp01385 | Aurein-3.3 [Cleaved into: Aurein-3.3.1] | GLFDIVKKIAGHIVSSI | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | KM12 | Colon cancer | IC50 : 4 - 5 μM |
| dbacp01408 | Aurein1.2 | GLFDIIKKIAESF | Southern bell frog | Cell membrane disruption | Not specified | Colon tumor cell line | Colon cancer | LC50 : 10 µM |
| dbacp01417 | Aurein2.5 | GLFDIVKKVVGAFGSL | Southern bell frog | Cell membrane disruption | Not specified | Colon tumor cell line | Colon cancer | LC50 : 10-100 µM |
| dbacp01426 | Aurein2.6 | GLFDIAKKVIGVIGSL | Southern bell frog | Cell membrane disruption | Not specified | Colon tumor cell line | Colon cancer | LC50 : 10-100 µM |
| dbacp01596 | BF-30 | KFFRKLKKSVKKRAKEFFKKPRVIGVSIPF | Banded krait | Cytoplasmic membrane permeabilization and DNAspecified-binding | Lactate dehydrogenase release assay, DNA retardation assay, Real-time PCR, Western blot, wound healing assay, and chick embryo chorioallantoic membrane assay | B16F10 | Human Colon cancer | IC50 : 7.3 μM |
| dbacp02039 | Buforin IIb | RAGLQFPVGRLLRRLLRRLLR | Histone H2A | Inducing mitochondria-dependent apoptosis | MTT/MTS assay | COLO-205 | Colon cancer | IC50 : 11.2 µg/ml |
| dbacp02040 | Buforin IIb | RAGLQFPVGRLLRRLLRRLLR | Histone H2A | Inducing mitochondria-dependent apoptosis | MTT/MTS assay | HCT-116 | Colon cancer | IC50 : 14.6 µg/ml |
| dbacp02041 | Buforin IIb | RAGLQFPVGRLLRRLLRRLLR | Histone H2A | Inducing mitochondria-dependent apoptosis | MTT/MTS assay | HCT-15 | Colon cancer | IC50 : 13.2 µg/ml |
| dbacp02042 | Buforin IIb | RAGLQFPVGRLLRRLLRRLLR | Histone H2A | Inducing mitochondria-dependent apoptosis | MTT/MTS assay | HT-29 | Colon cancer | IC50 : 17.6 µg/ml |
| dbacp02043 | Buforin IIb | RAGLQFPVGRLLRRLLRRLLR | Histone H2A | Inducing mitochondria-dependent apoptosis | MTT/MTS assay | KM12 | Colon cancer | IC50 : 12 µg/ml |
| dbacp02044 | Buforin IIb | RAGLQFPVGRLLRRLLRRLLR | Histone H2A | Inducing mitochondria-dependent apoptosis | MTT/MTS assay | SW-620 | Colon cancer | IC50 : 12.7 µg/ml |
| dbacp02300 | Carrier domain-containing protein | MTRPGPAVRDGRPAPDAAGPATAPATYAQERAWLASRLAHDPPTYCAVDEFPLHAAVTANDLVHALYVLMDRHEPLRTVLRTVDGRLRQEVHPRPEPRIELTDLRAHDHAAQAEERRSLRARLARTPFDPHRAPQWRAAVLNLGEGAWSVVFAAHHTVYDTASGFNVHAELTELCAAAEEGREARLPRLPLGYGAYARRERERARTGGADAAAAHWRTRLRGLPPVHTVPLDRPRPPARTFRGAEVRAALPVGVTAALTGAARHHGTRPVMLFLAAWTALLHHHSGAADLAVGLPVAGRDDPATRAMVGTFVnMRVLRADLSGDPDGTELVRRTTAAVRAGEKFDIPFQSLVELLAAPRLPGVPPLYQLAFNHTPADGLGPPVSSCEEDLLLDVAGSGLRLVYDAALFDRSTADLLLADYLRLLAALLDAPGTRLSALLTGPAPRGTPRPAPTAPRARTAPRDAAEERVAAVWRTLLGTDGGTVDVHEDFFTAGGHSLQALRLLARLAPARGSGPTLRTFFADPTVAGLATALKSTPDGRTAWR | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp02305 | Caseinphosphopeptides | PPPEE | Bovine milk | Regulation of immune response; Apoptosis inducing | MTT/MTS assay | AZ-97 | Colon cancer | Inhibition at 24-28g/l |
| dbacp02359 | Cecropin B | KWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKAL | Silkmoth | Pore formation at the cytoplasmic membrane | MTT/MTS assay | HRT-18 | Colon cancer | IC50 : 25.5 µM |
| dbacp02360 | Cecropin B | KWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKAL | Silkmoth | Pore formation at the cytoplasmic membrane | MTT/MTS assay | DLD-1 | Colon cancer | IC50 : >100 µM |
| dbacp02363 | Cecropin B | KWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKAL | Silkmoth | Pore formation at the cytoplasmic membrane | MTT/MTS assay | HCLO | Colon cancer | IC50 : 33.5 µM |
| dbacp02365 | Cecropin B | KWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKAL | Silkmoth | Pore formation at the cytoplasmic membrane | MTT/MTS assay | MAC15A | Colon cancer | IC50 : 37 µM |
| dbacp02367 | Cecropin B | KWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKAL | Silkmoth | Pore formation at the cytoplasmic membrane | MTT/MTS assay | HT-29 | Colon cancer | IC50 : >100 µM |
| dbacp02373 | Cecropin P1 | SWLSKTAKKLENSAKKRISEGIAIAIQGGPR | Small Intestine of Pig | Pore formation at the cytoplasmic membrane | MTT/MTS assay | HRT-18 | Colon cancer | IC50 : >100 µM |
| dbacp02374 | Cecropin P1 | SWLSKTAKKLENSAKKRISEGIAIAIQGGPR | Small Intestine of Pig | Pore formation at the cytoplasmic membrane | MTT/MTS assay | DLD-1 | Colon cancer | IC50 : >100 µM |
| dbacp02444 | Chaperone protein DnaJ | MATDYYAVLGVRRDASQDEIKKAFRRLARELHPDVNPDPKTQERFKEINAAYEVLSDPQKKQVYDLGGDPLSQAAGGGAGGFGAGGFGNFSDIMDAFFGTASQRGPRSRTRRGQDAMIRIEVELDEAAFGTTKDIQVDTAVVCNTCNGEGAAPGTSAQTCDMCRGRGEVSQVTRSFLGQVMTSRPCPQCQGFGTVVPTPCPECAGDGRIRSRRTLTVKIPAGVDNGTRIQLAGEGEVGPGGGPAGDLYVEIHELPHSTFQRRGDDLHCTVTIPMTAAALGTKVPLETLDGLEEVDIRPGTQSGQSIPKPGRGITHLRGGGRGDLIVHVEVTTPTKLDPEQERLLRELAQQRGEERPTGQFQPGQQGLFSRLKDAFNGR | Beras-beras | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp02449 | Chaperone protein DnaJ | MSTKDFIEKDYYKVLGVPKDATEAEIKKAYRKLARENHPDANKGNARAEERFKEISEANDILGDPKKRKEYDEARSLFGNGGFRPGPGAGGGGGTFNFDLGDLFGGGPQGGGGQGGAGGFGGGLGDVFGGLFNRTGGPGTGTGPRTQPRRGQDIESEVTLSFTEAIEGATVPLRMSSQAPCKACSGTGDKNGTPRVCPTCVGTGQVARGSGGGFSLTDPCPDCKGRGLIAEDPCDVCKGSGRAKSSRTMQVRIPAGVSDGQRIRLRGKGTPGERGGPAGDLYVVVHVKDHPVFGRRGDNLTVTVPVTYTEAALGGEIRVPTLGGPPVTLKLPAGTPNGRTLRARGKGAVRKDGTRGDLLVTVEVSVPKDLTGKARDALEAYREATADEDPRAELFQAAKGA | Beras-beras | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp02454 | Chaperone protein DnaK | MARAVGIDLGTTNSVVSVLEGGEPTVITNAEGARTTPSVVAFAKNGEVLVGEVAKRQAVTNVDRTIRSVKRHMGTDWSVNLDGKDFNPQQISAFVLQKLKRDAESYLGEKVADAVITVPAYFNDAERQATKEAGEIAGLNVLRIVNEPTAAALAYGLDKDEQVILVFDLGGGTFDVSLLEIGDGVVEVKATNGDNNLGGDDWDQRVVDYLVKQFQSGHGVDLGKDKMALQRLREAAEKAKIELSSSTETNINLPYITASAEGPLHLDEKLTRAQFQQLTADLLERCKTPFHNVIKDAGIQLSEIDHVVLVGGSTRMPAVAELVKDLTGGKDANKGVNPDEVVAIGAALQAGVLKGEVKDVLLLDVTPLSLGIETKGGIMTKLIERNTTIPTKRSEIFTTAEDNQPSVQIQVYQGEREIAAYNKKLGMFELTGLPPAPRGVPQIEVAFDIDANGIMHVTAKDLGTGKEQKMTVTGGSSLPKDEVDRMRQEAEKYAEEDHARREAAESRNQGEQLVYQTEKFLKDNEDKVPGEIKTEVEESVAELKEKLKGEDTAEIRTATEKVAAVSQKLGQAMYADAQAAGGEAPGAGAGAGAAAGDKADDDVVDAEIVDDERKDGAA | Beras-beras | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp02490 | Citropin 1.1 | GLFDVIKKVASVIGGL | Amphibian skin secretions | Penetration and disruption of the membranes | Sulforhodamine B assay | Colon tumor cell line | Colon cancer | IC50 : 5 M |
| dbacp02501 | Citropin 1.1D | glfdvikkvasviggl | Amphibian skin secretions | Penetration and disruption of the membranes | Sulforhodamine B assay | Colon tumor cell line | Colon cancer | IC50 : 5 M |
| dbacp02537 | CoA ligase | MEPAPQAPTQPVIDARRPEAGPRWETIGELIKDAALLHGDKEFLRCGDKTLSFSETDTRTDRLAQALIAQGVKPGDRVAVMMDNVADWPLSWFAAIKAGAITVPVNTRFGATDLAHVLKDSQAVLVLASPGCVPLARDVSGSIGNPCAVRTLRELEAGFGDRPVDGPGLSAHADDTVNFQYTSGTTGFPKACMLSHDYWLRTAWMIAVHSGLRPDDVVLTAQAFSYMDPQWKAVMCLMGGVPLVVLPRFSASGFWHSVRQHRATLTYVLGSMPMLLYKQPPHSGDRDHAMRLVLCSGIPRDLHHAFEDRWGAAWREVYGSTESGLDLIMPPGEEATVGSGAMGYPPSGKEVLVADERQRPVQPGQIGEILVRGRPMMKGYWNNPDSTERAFRGGWYHTGDLGRAEAAGSVVHAGRLKDMIRRGGENIAAAEVESVLEAHPAVLAAALAGIPDELFGELPKAFLQLRPGYRPTTATARSVLAHTRRHLAKFKVPAYVEFVDSFPMTPSARIQKRQLLRPGDDQRTGAFDAAADAWA | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7µM |
| dbacp02568 | Creatininase family protein | MKTKGRAGMDASLVPADTSADVRERGSGVSRQVAVLPVGSYEQHGDHLPLATDTLVACAVAREIAAGYPVHLLPPVTIGCSHEHADWPGTVSISAVTLHAVVRDIAESLRRSGVGALVVVNGHGGNYVLGNVVQEASARGERMALFPAGEDWEAARQRAGVRTSLLTDMHAGEIETSILLHAHPASVRPGYETADFVADDRRHLLSLGMSAYTDSGVIGRPSLASAEKGKELLASLADSFGTYFSFLTAADGAEGTSAQGARGRS | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp02596 | Cyclic [W(RW)4 ]-Dox | WRWRWRWRW | Not found | Inhibition of the cell proliferation | MTT/MTS assay | HCT-116 | Colon cancer | 50-67% inhibition of cell proliferation at 1 µM |
| dbacp02603 | Cysteine hydrolase | MGKTALIVIDMINTYDHEDADSLIPSVESVLPRATGLLERARRRGVPVIYVNDNFGEWRSHHGEILDKALSGPHSRLVEPLRPDDSSLFVVKARHSVFFETPLTYLLHQQGIDRLVLCGQVTEQCVLYSALDAHIRHLQVIVPRDAVAHIHADLADAALRMMERnMGARVCDSGELWT | Not found | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp02614 | D-aminoacylase | MEELVIRDADVVDGSGADSYRADVVVDGGRIVSIVKEAAAAGCQRPKARRELDAEGLVLAPGFIDMHAHSDLALLRDPDHSAKAAQGVTLEVVGQDGLSYAPVDDRTLGEVRRAIAGWNGPGDDVDFDWRSVGEYLDRLDRGIAVNAAYLIPQGTVRALAVGWDDREATPAELERMRRLVAEGMEQGAVGMSSGLTYTPGMYAKDAELTELCRVVAEYGGYYCPHHRSYGAGALEAYEEMVELTREAGCPLHLAHATMNFGVNRGRAPELLTLLDEALDGGADITLDTYPYTPGCTTLAALLPSWASEGGPEQILKRLADDDTAERIRHHMEELGSDGSHGVPMEWETIEISGTGDPALGEYVGRTVQESARLRGESPWTVVRQLLLADRLAPTILQHVGHEENVRAIMRHRVHTGGSDGILQGAKPHPRAYGTFPHYLGHYVRELGVLPLEECVAHLTSRPAARLRLPDRGLVREGYRADLVLFDRATVAAGSTYEEPRRLPTGIPYVLVDGRFVMEEGRRTDVLAGRSVRRGSR | Not found | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp02746 | DI | LTFEHYWAQLTS | E3 ubiquitin-protein ligase | Cell cycle arrest or apoptosis of cells | Immunoprecipitation assay | HCT-116-p53+/+ | Colon cancer | IC50 : 0.29 µM |
| dbacp02747 | DI | LTFEHYWAQLTS | E3 ubiquitin-protein ligase | Cell cycle arrest or apoptosis of cells | Immunoprecipitation assay | HCT-116-p53+/+ | Colon cancer | IC50 : 1.6 µM |
| dbacp02753 | Diacylglycerol O-acyltransferase | MHAPHLGTDGGPPTPVPMGTADLAYHLAMRGEPLPAGFLFAFSGPVPTLASVRARVAERAHRIPALRYRIDREGRAFSRVEGIDVERHVHEAWLPGDDDGSGAGRLMLSHPPGGDDRPPWDVWLVHGPGGEHSLCYRTDHTLQDGIGAAHTARALLDDDPVGGPPGYHGGRPTARGLASAAGALAASFRHSDKPAFDVPLSGRTGLCQTVVPVARLRAVGRAHGATVNDVFLAALAHAVGTWHRKNTGAAHPPLPVAVPMSVRAPGEECVPGNRIVVARVLLPCDAPSPRHALSRVVARSDGMRTGRLRESLRLMQTAGPRGIGARVGTRVVNGRAVAGPVSSVNFGTALVHRGNAAHRSVVWSGLGAGIRCLVTLTSQHDTACLAVIHDEALTTADELPDLWLASLLDLEQP | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp02762 | Dipeptide ABC transporter ATP-binding protein | MSDNTKTTTAVADTFPQQRDGDTAPLLKVSGLSKYFPIKGGFPIKRTVGHVKAVDGVDFEVFPGESLGLVGESGCGKSTTGRLLTRLYEPTQGTIEYRGKDITRANRRELAPIRSEIQMIFQDPYASLNPRQTVGTIISGPMEINGINPPGGREKRVRELLEIVGLNPEHYNRFPHEFSGGQRQRIGVARAVALQPKLIVADEPVSALDVSIQAQVVNLLQEVQREMGIAFVFIAHDLAIVRHFSQRVAVMYLGKVVEIADRDSLYNRPRHPYTHALLSAVPEADLDAEKRERIRLEGDVPSPISPPSGCRFRTRCWKAQDKCATEEPPLVQISGNREGHLTACHFPEEGTTEARAEDVVMDPGLKALEANTDA | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp02767 | Dipeptide ABC transporter ATP-binding protein | MPETTEPLLEVRGLVKHYPLTSGILFKKQVGAVKAVDGVDFELARGETLGIVGESGCGKSTVAKMLVNLERPTAGEIRYRGEDITRLSGRALKSVRRNIQMVFQDPYTSLNPRMTVGDIIGEAYDIHPEVAPKGDRRGRVQDLLDVVGLNPEYINRYPHQFSGGQRQRIGIARGLALRPEIIVADEPVSALDVSVQAQVINLLARLQSEFDLSYIFIAHDLSIVRHISDRVGVMYLGRIVETGRDAEIYDHPTHPYTQALLSAVPVPDPQAREHRERIILAGDVPSPTNIPSGCRFRTRCWKARERCALEVPALAVPAEFRSVSGPAAHDSACHFAEEKQVVPPEEPGEGPHRPSGDRFGK | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp02772 | Dipeptide ABC transporter ATP-binding protein | MASGIPAQSDGTQEKSGGTATLTKDAAPGETLLKVTGLQKHFPIKKGLLQRQVGAVRAVDGIDFEVRSGETLGVVGESGCGKSTMGRLITRLLEPTAGTVEFQGKDITHLGVGGMRPMRRDVQMIFQDPYSSLNPRHTIGTIVSAPFKLQGVEPEGGVKKEVQRLLSVVGLNPEHYNRYPHEFSGGQRQRIGIARALALSPKLVVADEPVSALDVSIQAQVVNLLDDLQQELGLTYVIIAHDLSVVRHVSDRIAVMYLGKIMELADRDLLYKSPMHPYTKALMSAVPIPDPARRGAKSERILLKGDVPSPIAPPSGCRFHTRCWKATQVCTTTEPPLKELRPGQQVACHHPENFEDQAPQDVVLLSAAKEAAELVSEDALAQSAATSAAVAAEVAETDADADSGAGADADSGAGADVDSGAGTEEPPAQEK | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp02832 | Elongation factor P | MASTNDLKNGLVLKLEGGQLWSVVEFQHVKPGKGPAFVRTKLKNVLSGKTVDKTFNAGVKVETATVDKRDMQFSYMDGDYFVFMDMQTYDQLHIERKVVGDAAHFLIEGFEATVAQHEGEVLFVELPAAVELTIKETEPGVQGDRSTGGTKPAILETGHQISVPLFITTGEKIKVDTRTSDYLGRVNS | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp02962 | FK-16 | FKRIVQRIKDFLRNLV | Not found | Inducing apoptosis | MTT assay | LoVo, HCT116 | Colon cancer | Not found |
| dbacp02964 | Folate-binding protein | MKSPLLSLPGAVPAEGVDEGVAAHYGDLFREQRALADGTGFVDLSHRGVVAVTGDDRLSWLHLLLTQHVSDLPAGEATEALVLSANGHIEHALYLVDDGTTVWAHVEPGTQEELIAYLESMKFFYRVEVADRTADTAVVHLPAGSITGVPEGVAVRETPYGRDVFLPREELEAFAAGAGPAAGLLAHEALRVEQHRPRLGFETDHRTIPHELGWIGTAVHLQKGCYRGQETVARVHNLGKPPRRLVFLHLDGSEVHLPPNGAEIRLADDGPDGRKIGFVTTSVRHHELGPVALALVKRNVPVDARLMAEDTAAAQETVVEP | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7µM |
| dbacp02974 | GA-K3 | FLGWLFKWAKK | Undecapeptide analogues derived from Brevinin-1EMa | Cell membrane disruption | MTT/MTS assay | HCT-116 | Colon cancer | IC50 : 27.00 µM |
| dbacp02981 | GA-K3 | FLGWLFKWAKK | Brevinin-1EMa | Cell membrane disruption | MTT/MTS assay | HCT-116 | Colon cancer | IC50 : 27.00 µM |
| dbacp02988 | GA-K4 | FLKWLFKWAKK | Undecapeptide analogues derived from Brevinin-1EMa | Cell membrane disruption | MTT/MTS assay | HCT-116 | Colon cancer | IC50 : 14.80 µM |
| dbacp02995 | GA-K4 | FLKWLFKWAKK | Brevinin-1EMa | Cell membrane disruption | MTT/MTS assay | HCT-116 | Colon cancer | IC50 : 14.8 µM |
| dbacp03002 | GA-W3 | FLGWLFKWAWK | Undecapeptide analogues derived from Brevinin-1EMa | Cell membrane disruption | MTT/MTS assay | HCT-116 | Colon cancer | IC50 : 24.63 µM |
| dbacp03009 | GA-W3 | FLGWLFKWAWK | Brevinin-1EMa | Cell membrane disruption | MTT/MTS assay | HCT-116 | Colon cancer | IC50 : 24.63 µM |
| dbacp03016 | GA-W4 | FLWWLFKWAWK | Undecapeptide analogues derived from Brevinin-1EMa | Cell membrane disruption | MTT/MTS assay | HCT-116 | Colon cancer | IC50 : 14.80 µM |
| dbacp03023 | GA-W4 | FLWWLFKWAWK | Brevinin-1EMa | Cell membrane disruption | MTT/MTS assay | HCT-116 | Colon cancer | IC50 : 14.80 µM |
| dbacp03029 | Gageostatin A | ELLVDLL | Bacillus subtilis | Perturbation of the cell membrane | Sulforhodamine B (SBR) assay | HCT15 | Colon cancer | GI50 : 4.6–19.6 μg/mL |
| dbacp03047 | Gamma-glutamyl-hercynylcysteine sulfoxide hydrolase | MCRHLAYVGPAEPLGGLLVAPPHALYRQSWAPRHQRHGTVNADGFGVGWYAEGDPVPARYRRAGPIWADQSFADLARVVRAGALLAAVRDATLAGADAEAAAAPFAAGAWLFSHNGAVGGWPGSLAPVAAALPPEELLSLEARNDSALVWALVLSRLRAGDDEGRALAETVLEVAAAAPASRLNLLLSNGTTVTATTWGDTLWYLTRPGAGGTVVASEPYDDDPGWQQVPDRTLLTATRTDVLLTPLKDPGEPAPADAVATEKEPRT | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp03063 | GlcNAc-PI de-N-acetylase | MTDRPLTLMAVHAHPDDEATSTGGVLARYAAEGIRTVLVTCTDGGCGDGPGGVKPGDPGHDPAAVTAMRRQELEASCGALKISDLEMLDYADSGMMGWPSNEAPGAFWQTPVADAAARLAELMRHYRPDVVVTYDENGFYGHPDHIQAHRVTMAALELTDLSPKVYWTTMPHSGVRRFGEIMSEFQEGAPEPDPAEAAATAELGLPDDEVTTWVDATGFSGQKFDALAAHASQGENIFFLKMGREAFGELMGTETFLRVRDTTGAPLPENDLFAGLR | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp03069 | Glutathione hydrolase proenzyme | MRRPVARNLTVLAVSAAVVVSLGAAAPPTHPSGPAGPDRPAAPKAPVAVGYGGAVSSVDQDASAAGIEVLRKGGNAVDAAVATAAALGVTEPYSAGVGGGGYFVYYDARSRTVRTIDGRETAPLTAGEDLFTEDGEPLAFADAVSSGLAVGTPGTPATWQRALDRWGSRRLSSVLEPAERLARHGFTVDETFRSQTADNEERFRYFPDTAELFLPGGELPAVGSTFKNPDLARTYRELAREGVGALYHGALGKDIVDTVNAPPVDPDSGWNARPGDLSAKDLAAYEAKVQAPTRTSYRGLNVYSIAPSSSGGTTVGEALNILERTDLSEASKARYLHRFIEASRIAFADRGRWVGDPAFEDVPADELLSQRYADSRECLISDDAALTGPLAPGDPRHPAACAAGGTAAPTTYEGENTTHLTVADKWGNVVAYTLTIEQTGGSGITVPGRGFLLNNELTDFSFAPANPAVHDPNLPGPGKRPRSSIAPTIVLDRHHKPVVAVGSPGGATIITTVLQTLTGFVDRGLPLVDAIAAPRASQRNAAQTELEPGLYDSALRAELEALGHSFKENPEIGAATGVQRLPGGKWLAAAEKERRGGGSAMVVEPVRQR | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp03086 | Glycoside hydrolase family 92 protein | MQYRVRHRWGPAVVMTTAFALAVGSQGAAVALPNAPAKTDREFTSSFEDGDPAPDWVSTVDTGADGGKRSSGVDGGFSTGIPGNVTEHVTRVRASAENTNGGEVKENLADNEPGTKWLTFAPTGWVEFDLDAPTKIVKYALTSANDHSERDPRDWTLKGSADGESWQTLDTRSGETFGEPFTTKTYDLAEAAEFQHFRLEFTKNNGAGDALQLGDVQFSTGDAETPAPEDMLAFVDEGPTSSPTAKANAGFTGTHALRYAGRHTADGRAYSYNKVFDVDVKVDRRTELSYKIFPAMADRDLDYDATNVSVDLAFTDGTYLSDLEATDQHGFPLTPRGQGDAKILYVNQWNSVESGIGSVAAGKTVDRILVAYDSPKGPAKFRGWLDDVEIKRAEPERPEAHLSDYALTTRGTNSSGSFSRGNNFPATAVPHGFNFWTPVTNAGTTSWLYDYASGNNDDNLPTLQAFGASHEPSPWMGDRQTFQVMPSAASGTPDTSRDARELAFRHENETARPYYYGVRFENGLKAEMAPTDHAAMMRFTYPGDDASVIFDNVEDKGGLTLDKENGTFSGYSDVKSGGSAGATRLFVYGEFDSKVTGGEDTGGVKGHLRFDAGRDRAVTMRIATSLLGVDQAKDNLRQELPKRASFEKVKRDAQKQWDTILGKVEVEGATRDQLTTLYSSLYRLYLYPNSGHEKVDGKYKYASPFSKAVKENTPTETGAKVVDGKVYVNNGFWDTYRTTWPAYSFLTPSKAGELVDGFVQHYKDGGWTSRWSSPGYADLMTGTSSDVAFADAYVKGVDFDAKAAYDAALKNATVVPPSSGVGRKGMETSPFLGYTGTETHEGLSWALEGYLNDYGIAKMGEKLYKETGEKRYKDESAYFLNRAQDYVNLFDSKAGFFQGKDTKGNWRVDSEKYDPRVWGYDYTETNGWGYAFTAPQDSRGLANLYGGRDGLGDKLDEYLSTPETASPDLKGSYGGVIHEMTEARDVRMGMYGHSNQVAHHALYMYDAAGQPYKTQKNIREVLQRLYTGSEIGQGYHGDEDNGEQSAWFLFSSLGFYPLVMGSGEYAVGSPLFTKATVHLENGRKLVVKAPKNSTKNVYVQGLKVNGKRWTSTSLPHSLISKGGVLEFDMGAKPSSWGTGENAAPPSITKDDEVPTPRADAITGEGALFDNTSATDATVTSVDLPVADKGAKALQYTLTSSADHTGAPAGWKLQGSADGKTWRTLDRRSGESFAWDRQTRAFSVKSPGTYAKYRLVLDGEHTLSEVELLS | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp03091 | Glycoside hydrolase family 92 protein | MRAPRRLRLCVAGVVAASALLTAPAAQAVPTTDQHLTDLVNPFIGTENEGNTYPGAAVPFGMVQFSPDTGHSTGYDHSDTHIRGFSLVHLSGVGCGLGGDLPVLPTTGDVTETDYTKYAAPFSHDDEEASPGYYRVGLGSGVDAELTATERTGVQRYTFPSTDKANVLLNAGQSLHKNVSTKVEVLDSRTVRTAITGSGFCQDTKPYTVYTVTRFDRPFASYGTWDDGTVTAGAKSGGDGAYVRFDTTEDRTVEATTALSYVDARGAARNLRAEGGHSFDSVRRGAERTWEKRLDDVKVRGGDDTLRRTFYSSLYRSFLAPNVGSDVDGRYTGWDRKVHRAKGFTYYQNWSLWDTYRTQSQLLALLAPREARDMAVSVIKIDEESGWLPKWGYGTVETNIMTGDPVTPFLTNAYQQGLLHGWEERAYRALKKNADGVPPTDSPAVGREANREYLADGFAPYVKGRPHAKPGDSDYDHGASATLEYALSDAMLSRMARDLGHDRDAKRYAERAQSYRNVFDASTGFFRARDAEGAFTGPADPAQSEGFHEGTSWQYQWMVPQDLPGMIDLIGGTDAANERLDSFFAYDQLLADPAKTAREVWVNGPYDYYNADKYNPQNEPDLIAPYTYLSTGQPWKTTDVVHAALTLFTDTPTGMTGNDDLGTMSAWNVLSSIGIFPIQPGYDTWGLSTPVFDRVDLALDRRYYPRGALTITAPGTSDTDRYVQSARTDGAEYARTWLTTDALRSVRSLAFTVGPQPSGWGTSAEAVPPPLT | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp03096 | Glycosyltransferase | MASRTRRHGAARSARGGFRRRLPLRLLLPLLVLVALAAMLMLRGYVHSEILADHRVQPPAATDKVPEKILEGGPVIDVRGGRTEGLSVPDHRLVLTFDDGPDPTWTPRVLDVLKKHDAHAVFFVTGTMASRYPDLVKRMVDEGHEVGLHTFNHPDLSFQSTKRIDWELSQNQLAITGAAGVRTSLFRPPYSSFADAMDNKSWPVTEYIGSRGYITVVNNTDSEDWKKPGVREIIRRATPHGGKGAIVLMHDSGGDRHQTVQALDEFLPGLKEKGYEFDNLTEALEMPSAMSPVTGAELWKGKAWVFLVQASEKITDVLVVGLAVIGTLVIGRFGLMLLLSGVHARRVRRKRFSWGRTVTEPVTVLVPAYNEAKCIENTVRSLVASDHPVEVIVIDDGSTDGTARIVEGLGLPGVRVIRQLNAGKPAALNRGLANARHDIIVMMDGDTVFEPSTVRELVQPFGDPKVGAVAGNAKVGNKDSLIGAWQHIEYVMGFNLDRRMYDVLGCMPTIPGAVGAFRRSALEPIGGMSDDTLAEDTDVTMALHRAGWRVVYAENARAWTEAPETVQQLWSQRYRWSYGTMQAIWKHRRAVIEKGHSGRFGRVGLPFVSLFMVLAPLLAPLIDVFLLYGIVFGPTEKTVVAWLGVLAIQAVCAAYAFRLDRERMTHLISLPLQQILYRQLMYVVLLQSWITALTGGRLRWQKLRRTGVVEAPGGSVPRQRSRSSDDRRPVA | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp03101 | Glycosyltransferase | MTTPTTPTAPPSPPARGRRRGPSRIGRAASRAAALQRPRVLLALLLLLALTCVMLLDGYLRAEVGGDERVRTGASASDVPDDVLDGGPILTFPGGQATTVSVPDKTIVLTFDDGPDPTWTPQVLDILDEYDVPGTFFLVGSMISRHPGIVRDLVEQGNEVGVHTFTHVDLSYQSEARVTREIEQTQLALAGAAGITTTLFRAPYSSETNAIDDYSWPVYQNLGEDGYTSVFIDTDSDDWKRPGVSKIVEWATPEDDEGASVLFHDAGGERSQTIAALPKYIEKMKAKGYTFTTVSGAMADQQSPQQEADQQSQQQQQESQQPGGGRQPEQSGGGLQAAHHKATGATLYEGKALVAAVAVAEWTVPALSVGLVIVGVAVMGRFAMMLVLARRHHRQRNRRRFSWGPPVTGPVSVVVPAYNEKECIEATLRSLARSTHPVEIIVVDDGSTDGTAEIAESLGLPGVRVVRQANAGKPAALNNGVRHARYDIVVMMDGDTVFEPDTVRHLVQPFADPAVGAVAGNAKVGNRRTLIGAWQHIEYVMGFNLDRRMYDLLRCMPTIPGAIGAFRREAVLQAGGMSDDTLAEDTDITIALHRAGWRVVYEEHARAWTEAPGSLGQLWSQRYRWSYGTMQALWKHRRSLTDKGPSGRFGRVGMPLVVLFQVVTPVFAPLIDVFTVYSMVFVDFRAALLAWLAVLGVQLVCAAYAFRLDREKYRYLLMMPLQQLAYRQMMYLVLIHSCVTALTGGRLRWQKLKRTGEVGTPAGNG | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp03107 | GNAT family N-acetyltransferase | MVDVVLKLSVRDLVHADLASCGWAGSDHHLDGVAEQLVRARIGEVDYLAVCAATNIPVAKGGVDYQVKEGVGTLWQLAVHPALQSCGIGTFLVEAAELRIRRRGLRQAELGVEENNPRARALYERLGYVAYDRQPDAWDEQAPDGSLRRYETMCTLMRKELA | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp03112 | GNAT family N-acetyltransferase | MALADCERVSRIRVRGWQSAYAGLVPQPYLDAMDTAEDAERRRATFARAAEGVVNLVAEDDDGRVVGWAAHGPYRDGELRTADAELYALYVDTGRFGAGVGRALLGEAVRRCGAAGHPRMLLWVLRGNARARRFYERSGFLADGAEESFEVRGVAVPEVRYARPLPG | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp03117 | GNAT family N-acetyltransferase | MPGDLLLRSAGPADLDAVLAFWKAAAEGTSISDDREGVERLVARDPEALLLAEAGGDLVGTVIAGFDGWRCHLYRLAVHPDHRRRGIGSALLAAAEERFVRLGGRRGDAMVLRRNERAQHAWRAAGYAPEEQWRRWVKPLAE | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp03154 | GPR15LG | MRLLVLSSLLCILLLCFSIFSTEGKRRPAKAWSGRRTRLCCHRVPSPNSTNLKGHHVRLCKPCKLEPEPRLWVVPGALPQV | Human | Inducing G1 arrest | Not specified | Not found | Colon cancer | Not found |
| dbacp03190 | HAL-1 | GMWSKILGHLIR | Sweat bees and their analogs | Cell membrane damage | MTT/MTS assay | SW | Colon cancer | IC50 : 44 ± 8 µM |
| dbacp03193 | HAL-1/10 | GMWKKILGKLIR | Sweat bees and their analogs | Cell membrane damage | MTT/MTS assay | SW | Colon cancer | IC50 : > 60 µM |
| dbacp03196 | HAL-1/12 | GKWSKILGHLIR | Sweat bees and their analogs | Cell membrane damage | MTT/MTS assay | SW | Colon cancer | IC50 : > 100 µM |
| dbacp03199 | HAL-1/15 | GMWSKLLGHLLR | Sweat bees and their analogs | Cell membrane damage | MTT/MTS assay | SW | Colon cancer | IC50 : > 40 µM |
| dbacp03202 | HAL-1/17 | KMWSKILGHLIR | Sweat bees and their analogs | Cell membrane damage | MTT/MTS assay | SW | Colon cancer | IC50 : > 100 µM |
| dbacp03205 | HAL-1/18 | GMWSKILKHLIR | Sweat bees and their analogs | Cell membrane damage | MTT/MTS assay | SW | Colon cancer | IC50 : 18 ± 2 µM |
| dbacp03208 | HAL-1/19 | GKWKKILGHLIR | Sweat bees and their analogs | Cell membrane damage | MTT/MTS assay | SW | Colon cancer | IC50 : > 100 µM |
| dbacp03211 | HAL-1/20 | GKWSKILGKLIR | Sweat bees and their analogs | Cell membrane damage | MTT/MTS assay | SW | Colon cancer | IC50 : > 40 µM |
| dbacp03214 | HAL-1/21 | GKWKKILGKLIR | Sweat bees and their analogs | Cell membrane damage | MTT/MTS assay | SW | Colon cancer | IC50 : > 100 µM |
| dbacp03217 | HAL-1/22 | gmwskilghlir | Sweat bees and their analogs | Cell membrane damage | MTT/MTS assay | SW | Colon cancer | IC50 : > 40 µM |
| dbacp03220 | HAL-1/29 | GMWSKILGHLIR | Sweat bees and their analogs | Cell membrane damage | MTT/MTS assay | SW | Colon cancer | Not found |
| dbacp03223 | HAL-1/4 | GMWSKILGHLKR | Sweat bees and their analogs | Cell membrane damage | MTT/MTS assay | SW | Colon cancer | Not found |
| dbacp03226 | HAL-1/5 | GMWKKILGHLIR | Sweat bees and their analogs | Cell membrane damage | MTT/MTS assay | SW | Colon cancer | IC50 : 44 ± 5 µM |
| dbacp03229 | HAL-1/6 | GMWSKILGHLIK | Sweat bees and their analogs | Cell membrane damage | MTT/MTS assay | SW | Colon cancer | IC50 : > 100 µM |
| dbacp03232 | HAL-1/9 | GMWSKILGKLIR | Sweat bees and their analogs | Cell membrane damage | MTT/MTS assay | SW | Colon cancer | IC50 : > 50 µM |
| dbacp03235 | HAL-2 | GKWMSLLKHILK | Sweat bees and their analogs | Cell membrane damage | MTT/MTS assay | SW | Colon cancer | IC50 : 35 ± 3 µM |
| dbacp03238 | HAL-2/1 | GKWKSLLKHILK | Sweat bees and their analogs | Cell membrane damage | MTT/MTS assay | SW | Colon cancer | IC50 : > 100 µM |
| dbacp03241 | HAL-2/11 | GKWLSLLKHILK | Sweat bees and their analogs | Cell membrane damage | MTT/MTS assay | SW | Colon cancer | IC50 : 40 µM |
| dbacp03244 | HAL-2/13 | GKWMTLLKHILK | Sweat bees and their analogs | Cell membrane damage | MTT/MTS assay | SW | Colon cancer | IC50 : > 60 µM |
| dbacp03247 | HAL-2/18 | GKWMSLLKHIWK | Sweat bees and their analogs | Cell membrane damage | MTT/MTS assay | SW | Colon cancer | IC50 : > 40 µM |
| dbacp03250 | HAL-2/19 | GKWMSLLKHWLK | Sweat bees and their analogs | Cell membrane damage | MTT/MTS assay | SW | Colon cancer | IC50 : > 40 µM |
| dbacp03253 | HAL-2/2 | GKWMKLLKHILK | Sweat bees and their analogs | Cell membrane damage | MTT/MTS assay | SW | Colon cancer | IC50 : 35 ± 5 µM |
| dbacp03256 | HAL-2/20 | GKWMSLWKHILK | Sweat bees and their analogs | Cell membrane damage | MTT/MTS assay | SW | Colon cancer | IC50 : > 40 µM |
| dbacp03259 | HAL-2/22 | gkwmsllkhilk | Sweat bees and their analogs | Cell membrane damage | MTT/MTS assay | SW | Colon cancer | IC50 : > 100 µM |
| dbacp03262 | HAL-2/24 | GKFMSLLKHILK | Sweat bees and their analogs | Cell membrane damage | MTT/MTS assay | SW | Colon cancer | IC50 : > 40 µM |
| dbacp03265 | HAL-2/4 | GKWMSLLKKILK | Sweat bees and their analogs | Cell membrane damage | MTT/MTS assay | SW | Colon cancer | IC50 : 38 ± 6 µM |
| dbacp03268 | HAL-2/6 | GKWMSFLKHILK | Sweat bees and their analogs | Cell membrane damage | MTT/MTS assay | SW | Colon cancer | IC50 : > 40 µM |
| dbacp03271 | HAL-2/8 | GKWMSLLKHILK | Sweat bees and their analogs | Cell membrane damage | MTT/MTS assay | SW | Colon cancer | IC50 : > 40 µM |
| dbacp03345 | Hydrolase | MPDSQPQPPHSPSPSGPADPGSLLLCGARLTDGRTVDVRLCRGRIEAVGTAGSLSPPRAPGPGTRVDLAGYLLLPAPAEPHVHGDTALTADAPGPASYEPQDVEGRATEAALLQLGHGATALRAHVRVGDVAGLGALTAVLRARRTLRGLVEVTAVAMPRVLTGVAGADGLAVLRDAVKMGADVVGGCPDLDPDPAGYVEAVLEVAAEHGCPVDLHTDAGDPARLARLAAMAGGLRPGVALGPCDGLARLPAEMASRAAEQLSAAGVTVVCLPQGACGAVDHHDGMAPVRLLRAAGVRVAAGSGALRDVSNPVGRGDPLEAAYLLASRHGLRPEDAYAAVSSAARAALGLPEVRVEAGFPAELLAVRGDGLAGALSLAYSRVVVHRGRVVARTNAVREYGDATAGADLGLPRQGRGKRGRE | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7µM |
| dbacp03354 | Hymenochirin-1B | KLSPETKDNLKKVLKGAIKGAIVAKMV | Zaire dwarf clawed frog | Membrane disruption and cell lysis | Cytotoxicity assay, Cell TiterGlo Luminescent Cell viability assay | HT-29 | Colon cancer | LC50 : 9.7 ± 0.2 μM |
| dbacp03530 | KW5 | KAAKKAAKAAKKAAKAAKKAA | Synthetic peptide | Through interactions with the plasma membrane | MTT/MTS assay | HT-29 | Colon cancer | IC50 : 55 ± 14 µM |
| dbacp03535 | L-amino oxidase (CP-LAAO) (LAO) (EC 1.4.3.2) | MNVFFMFSLLFLAALGSCADDRNPLEECFRETDYEEFLEIARXXXXTSNPKHVVRVGAGMSGLSAAYVLAGAGHQVTVLEASERPGGRXXXXXXXXEGWYANLGPMRXXXXXXXXXXXXXKFGLNLNEFSQENDNAWYFIKXXXXXXXXXXDPGLLKYPVKPSEAGKSAGQLYEESLGKXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXFDEIVDGMDKLPTSMYQAIXXXXXXXXXXXXXXXXXXKVTVTYQTPAKXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXIFLTCTKKFWEDDGIHGGKSTTDLPSRXXXXXXXXXXXXXXVIIAYGIGDDANFFQALDFKDCADIVFNDLSLIHQLPKEEIPSFCYPSMIQKXXXXXXXXXXITTFFTPYQFQHFSEAXXXXXXXIYFAGEYTAQAHGWIDSTIK | Mangrove pit viper | Cytotoxic; Anti-proliferative; Apoptosis | Not specified | SW480 | Colon cancer | EC50 : 29.43 ± 0.48 |
| dbacp03536 | L-amino oxidase (CP-LAAO) (LAO) (EC 1.4.3.2) | MNVFFMFSLLFLAALGSCADDRNPLEECFRETDYEEFLEIARXXXXTSNPKHVVRVGAGMSGLSAAYVLAGAGHQVTVLEASERPGGRXXXXXXXXEGWYANLGPMRXXXXXXXXXXXXXKFGLNLNEFSQENDNAWYFIKXXXXXXXXXXDPGLLKYPVKPSEAGKSAGQLYEESLGKXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXFDEIVDGMDKLPTSMYQAIXXXXXXXXXXXXXXXXXXKVTVTYQTPAKXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXIFLTCTKKFWEDDGIHGGKSTTDLPSRXXXXXXXXXXXXXXVIIAYGIGDDANFFQALDFKDCADIVFNDLSLIHQLPKEEIPSFCYPSMIQKXXXXXXXXXXITTFFTPYQFQHFSEAXXXXXXXIYFAGEYTAQAHGWIDSTIK | Mangrove pit viper | Cytotoxic; Anti-proliferative; Apoptosis | Not specified | SW620 | Colon cancer | EC50 : 23.19 ± 1.57 |
| dbacp03537 | L-amino oxidase (CP-LAAO) (LAO) (EC 1.4.3.2) | MNVFFMFSLLFLAALGSCADDRNPLEECFRETDYEEFLEIARXXXXTSNPKHVVRVGAGMSGLSAAYVLAGAGHQVTVLEASERPGGRXXXXXXXXEGWYANLGPMRXXXXXXXXXXXXXKFGLNLNEFSQENDNAWYFIKXXXXXXXXXXDPGLLKYPVKPSEAGKSAGQLYEESLGKXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXFDEIVDGMDKLPTSMYQAIXXXXXXXXXXXXXXXXXXKVTVTYQTPAKXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXIFLTCTKKFWEDDGIHGGKSTTDLPSRXXXXXXXXXXXXXXVIIAYGIGDDANFFQALDFKDCADIVFNDLSLIHQLPKEEIPSFCYPSMIQKXXXXXXXXXXITTFFTPYQFQHFSEAXXXXXXXIYFAGEYTAQAHGWIDSTIK | Mangrove pit viper | Cytotoxic; Anti-proliferative; Apoptosis | Not specified | CCD-18co | Colon cancer | EC50 : 15.99 ± 1.20 |
| dbacp03551 | L1 | PEWFKCRRWQWRMKKLGA | Lactoferrin | Cell membrane disintegration | MTT/MTS assay | HT-29 | Colon cancer | IC50 : > 404 µM |
| dbacp03554 | L10 | PAARKAFRWAWRMLKKAA | Lactoferrin | Cell membrane disintegration | MTT/MTS assay | HT-29 | Colon cancer | IC50 : 35 µM |
| dbacp03557 | L11 | PAARKAARWAWRMLKKGA | Lactoferrin | Cell membrane disintegration | MTT/MTS assay | HT-29 | Colon cancer | IC50 : 248 µM |
| dbacp03560 | L12 | PAWRKAFRWAKRMLKKAA | Lactoferrin | Cell membrane disintegration | MTT/MTS assay | HT-29 | Colon cancer | IC50 : 25 µM |
| dbacp03563 | L13 | PAWRKAFRKAWRMLKKAA | Lactoferrin | Cell membrane disintegration | MTT/MTS assay | HT-29 | Colon cancer | IC50 : 29 µM |
| dbacp03566 | L14 | PAWRKARRWAWRMKKLAA | Lactoferrin | Cell membrane disintegration | MTT/MTS assay | HT-29 | Colon cancer | IC50 : 423 µM |
| dbacp03569 | L15 | PAWRKARRWARRMKKLAA | Lactoferrin | Cell membrane disintegration | MTT/MTS assay | HT-29 | Colon cancer | IC50 : 178 µM |
| dbacp03588 | L2 | PAWFKARRWAWRMKKLAA | Lactoferrin | Cell membrane disintegration | MTT/MTS assay | HT-29 | Colon cancer | IC50 : >440 µM |
| dbacp03599 | L3 | PAWRKAFRWAWRMKKLAA | Lactoferrin | Cell membrane disintegration | MTT/MTS assay | HT-29 | Colon cancer | IC50 : 141 µM |
| dbacp03606 | L4 | PAWFKARRWAWRMLKKAA | Lactoferrin | Cell membrane disintegration | MTT/MTS assay | HT-29 | Colon cancer | IC50 : 57 µM |
| dbacp03609 | L5 | PAWRKAFRWAWRMLKKAA | Lactoferrin | Cell membrane disintegration | MTT/MTS assay | HT-29 | Colon cancer | IC50 : 14 µM |
| dbacp03612 | L6 | PAWRKAFRWAARMLKKAA | Lactoferrin | Cell membrane disintegration | MTT/MTS assay | HT-29 | Colon cancer | IC50 : 15 µM |
| dbacp03631 | L7 | PAWRKAFRAAWRMLKKAA | Lactoferrin | Cell membrane disintegration | MTT/MTS assay | HT-29 | Colon cancer | IC50 : 16 µM |
| dbacp03634 | L8 | PAWAKAFRAAARMKLKAA | Lactoferrin | Cell membrane disintegration | MTT/MTS assay | HT-29 | Colon cancer | IC50 : 180 µM |
| dbacp03637 | L9 | PAWRKAARWAWRMLKKAA | Lactoferrin | Cell membrane disintegration | MTT/MTS assay | HT-29 | Colon cancer | IC50 : 52 µM |
| dbacp03648 | Lan-7 | fA*YwKA*T | Analogue of TT-232 | Tubulin depolymerization | Sulforhodamine B assay | HCT-116 | Colon cancer | IC50 : 29.97 ± 1.19 µM |
| dbacp03659 | Lanthionine synthetase C family protein | MTAPEATHVAVGEVEDVAADGLRWLLGAARETPGGGLAWPAGPSDDALHPMLYSGTAGTVPVLLEAWRHFGDDSYADAALRAARELAARVDDLDDDSLYFGRTGLALVLRTLQEELGDTAAGAAADRALALVRSRFDGTRWGSLFELMGGNAGIGLGALLTGDPELAVLALEPYLRTAERTANGVHWAHRPDTDARMHHLSHGTLGIAVALARVGAATGRTDLLDLGLTAVRDVVARDEAGPEGFLVRHSTPQFRPDVIDPVSYGWCHGPAGDAQVFRALRYVTSDPAWTALADRCWHTVTHSGLPRRLRPGFWDNNGRCCGTAGVLALACDRIAEQGDDQDTRDFAGVLVTDLVARAVRDADGARWSNFDHRSTPGDLEPQTGWAMGGAGIVRELLRFVRVARGGSPRYAFTWPDQPPVPA | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7µM |
| dbacp03671 | Large ribosomal subunit protein uL2 | MGIRKYKPTTPGRRGSSVADFVEVTRSTPEKSLVRPLHSKGGRNNAGRVTVRHQGGGHKRAYRVIDFRRHDKDGVPAKVAHIEYDPNRTARIALLHYADGEKRYILAPRNLQQGDRVENGPGADIKPGNNLALRNIPVGTTIHAIELRPGGGAKFARSAGASVQLLAKEGSMAHLRMPSGEIRLVDQRCRATVGEVGNAEQSNINWGKAGRKRWLGVRPTVRGVVMNPVDHPHGGGEGRTSGGRHPVSPWGQKEGRTRSPKKASNKYIVRRRKTNKKR | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7µM |
| dbacp03691 | Lasso peptide biosynthesis B2 protein | MRLESADPPPWPLRPPAVLAAAVARVLTRLPPARLRRVLTFASRGAGPASAAQALRARNAVVHVSLACAGPRCLQRSVAAALLCRLGGTWPQWCTGVVTEPFGAHAWVAVDGEPVGEADAHARAFHVIMSVPPRR | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp03696 | Lasso peptide biosynthesis PqqD family chaperone | MSFALKPGVSLADTEHGTVLLDERSGRYWMLNRTGAVVLRSLLDGESPQEAARTLLRRYPDAADGAGGHVESLLDALRTAKVIVP | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp03701 | Lasso RiPP family leader peptide-containing protein | MAKEDVYEVPALIEVGDFAELTQLTSQGYWIDSPWGAWWL | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp03721 | LFB | GLFSVVKGVLKGVGKNVSGSLLDQLKCKISGGC | The Fujian Large Headed Frog | Cell Apoptosis | MTT assay | H460 | Colon cancer | IC50 : 3.47 μM |
| dbacp03725 | LFB | GLFSVVKGVLKGVGKNVSGSLLDQLKCKISGGC | The Fujian Large Headed Frog, China, Asia | Cell Apoptosis | MTT assay | H460 | Colon cancer | IC50 : 3.47 μM |
| dbacp03729 | LfcinB | FKCRRWQWRMKK | Bovine milk | Regulation of immune response; Apoptosis | MTT/MTS assay | AZ-97 | Colon cancer | Inhibition at 0.1g/l |
| dbacp03730 | LfcinB | FKCRRWQWRMKK | Bovine lactoferrin (Lf-B) | Cell membrane disintegration; Regulation of immune response; Apoptosis | MTT/MTS assay | HT-29 | Colon cancer | IC50 : > 160 µM |
| dbacp03734 | LfcinB | FKCRRWQWRMKK | Bovine lactoferrin (Lf-B) | Cell membrane disintegration; Regulation of immune response; Apoptosis | MTT/MTS assay | HT-29 | Colon cancer | IC50 : 148 ± 8 µM |
| dbacp04105 | linear (RW)4-Dox | RWRWRWRW | Doxorubicin (Dox) is a well-known anthracycline which has been conjugated to a CPP | Inhibition of the cell proliferation | MTT/MTS assay | HCT-116 | Colon cancer | 21-61% anti-proliferative activity at 1 µM |
| dbacp04108 | Lipid II isoglutaminyl synthase | MSDNQLRIVWIYPDLLSTYGDQGNALVVERRARQRGLDVARLDVRSDQPIPTSGDIYLIGGGEDRPQRLAAERLRRDGGLNRAVENGAIVFSVCAGYQILGHEFINDLGQREPGLGLLDVVSTRGEGDRCVGDVLGDIDPRLGLPPLTGFENHQGVTHVGPHARALAQVRFGNGNGTGDGTEGAYNDTVFGTYMHGPVLARNPQIADLLLKLALDVNALPPTDDRWYEALRSERIAAAQQPA | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp04113 | Lipid II isoglutaminyl synthase | MAGNSDPLTPRAKIAVTAGKAVARASRAAGRGSGSVIGGRVALKLDPDLLARLAGHLDVTLVSATNGKTTTTRLIAEALKAAGPVVSNALGAnMPAGITSALASGAEARYGVIEVDEKYLVGVAQATDPKCIALLNLSRDQLDRAAETRMLAENWREGLAGSKAVIVANADDPLVVWAASSSPNVIWVAAGQMWKDDAWSCPSCGGVMQRPGDDWFCGECGFRRPTPSWALSGDHVLDPHGSAWPIHLQLPGRANKANAASSAAVTAVFGVPPQVALERMYQVQAVAGRYDVVQFQGRDLRLLLAKNPAGWLETFSLIDPPPAPVILSVNARGADGTDTSWLWDVDYTRLTGHPICVVGDRKLDLAVRLEVANQQFQVCEDLDQAVQLCPPGRIEVIANYTAFQDLRRRVGN | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp04118 | Lipoprotein | MHRRRRSALLLTAAIATAAPLLTACGNDAHPGAAAVVGDQRITVSQLENRVDEVREAQRAAVPDDGQYQQVVARSGALTRDTLHGMVLDRVLHSAAAEAHVSVSRKEVQAMRGDLEDQAGGAEQLETVWLQQYGVAPGRLDDNLRVQLEAQKLAESLGTDTSRPEFWQALSKASDKLDIDLNPRYGAWDVQKAGRVDSETPWVREVAEAEPSQQTA | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp04124 | Lipoprotein signal peptidase | MAEAERIIGTPDTPDAAGDGQELPDAEQEQAPERPRGRRRVAVLFVVAVFAYLLDLVSKMIVVAKLEHHEPIEIIGDWLRFAAIRNAGAAFGFGEAFTIIFTVIAAAVIVVIARLARKLYSVPWAIALGLLLGGALGNLTDRIFRAPGVFEGAVVDFIAPKHFAVFNLADSAIVCGGILIVLLSFRGLDPDGTVHKD | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7µM |
| dbacp04181 | LL-III | VNWKKILGKIIKVVK | Lasioglossin III and its analogs | Cell membrane damage | MTT/MTS assay | SW | Colon cancer | IC50 : 18 ±4 µM |
| dbacp04184 | LL-III/1 | VNWKKILAKIIKVVK | Lasioglossin III and its analogs | Cell membrane damage | MTT/MTS assay | SW | Colon cancer | IC50 : 12 ± 3 µM |
| dbacp04187 | LL-III/10 | KNWKKILGKIIKVVK | Lasioglossin III and its analogs | Cell membrane damage | MTT/MTS assay | SW | Colon cancer | Not found |
| dbacp04190 | LL-III/11 | VNWKKIILGKIIKVVK | Lasioglossin III and its analogs | Cell membrane damage | MTT/MTS assay | SW | Colon cancer | IC50 : 48 µM |
| dbacp04193 | LL-III/12 | vnwkkilgkiikvvk | Lasioglossin III and its analogs | Cell membrane damage | MTT/MTS assay | SW | Colon cancer | IC50 : 20 µM |
| dbacp04196 | LL-III/15 | VNFKKLLGKLLKVVK | Lasioglossin III and its analogs | Cell membrane damage | MTT/MTS assay | SW | Colon cancer | IC50 : 42 µM |
| dbacp04199 | LL-III/16 | VN-NAl-KKLLGKLLKVVK | Lasioglossin III and its analogs | Cell membrane damage | MTT/MTS assay | SW | Colon cancer | Not found |
| dbacp04202 | LL-III/17 | VNWRRILGRIIRVVR | Lasioglossin III and its analogs | Cell membrane damage | MTT/MTS assay | SW | Colon cancer | Not found |
| dbacp04205 | LL-III/18 | KNWKKILKKIIKVVK | Lasioglossin III and its analogs | Cell membrane damage | MTT/MTS assay | SW | Colon cancer | Not found |
| dbacp04208 | LL-III/19 | VNWKK-Aib-LGK-Aib-IK-Aib-VK | Lasioglossin III and its analogs | Cell membrane damage | MTT/MTS assay | SW | Colon cancer | IC50 : 28 µM |
| dbacp04211 | LL-III/2 | NVWKKILGKIIKVVK | Lasioglossin III and its analogs | Cell membrane damage | MTT/MTS assay | SW | Colon cancer | IC50 : 11 µM |
| dbacp04214 | LL-III/22 | KNWKK-Aib-LKK-Aib-IK-Aib-VK | Lasioglossin III and its analogs | Cell membrane damage | MTT/MTS assay | SW | Colon cancer | IC50 : > 100 µM |
| dbacp04217 | LL-III/23 | VNWKKLLGKLLKVVK | Lasioglossin III and its analogs | Cell membrane damage | MTT/MTS assay | SW | Colon cancer | IC50 : 15 µM |
| dbacp04220 | LL-III/24 | VNWOOILGOIIOVVO | Lasioglossin III and its analogs | Cell membrane damage | MTT/MTS assay | SW | Colon cancer | IC50 : 20 µM |
| dbacp04223 | LL-III/25 | vnwkkllgkllkvvk | Lasioglossin III and its analogs | Cell membrane damage | MTT/MTS assay | SW | Colon cancer | IC50 : 20 µM |
| dbacp04226 | LL-III/26 | VYWKKILGKIIKVVK | Lasioglossin III and its analogs | Cell membrane damage | MTT/MTS assay | SW | Colon cancer | IC50 : 30 µM |
| dbacp04229 | LL-III/27 | VNWKKVLGKVVKVVK | Lasioglossin III and its analogs | Cell membrane damage | MTT/MTS assay | SW | Colon cancer | IC50 : > 100 µM |
| dbacp04232 | LL-III/3 | VNWKKILKKIIKVVK | Lasioglossin III and its analogs | Cell membrane damage | MTT/MTS assay | SW | Colon cancer | IC50 : > 40 µM |
| dbacp04235 | LL-III/34 | NKWKKILGKIIKVVK | Lasioglossin III and its analogs | Cell membrane damage | MTT/MTS assay | SW | Colon cancer | IC50 : 37 µM |
| dbacp04238 | LL-III/36 | VNWKKILAKIIKVVK | Lasioglossin III and its analogs | Cell membrane damage | MTT/MTS assay | SW | Colon cancer | Not found |
| dbacp04240 | LL-III/37 | VNWKKILGKIIKVVK | Lasioglossin III and its analogs | Cell membrane damage | MTT/MTS assay | SW | Colon cancer | IC50 : 5 ± 1 µM |
| dbacp04241 | LL-III/37 | VNWKKILGKIIKVVK | Lasioglossin III and its analogs | Cell membrane damage | MTT/MTS assay | SW | Colon cancer | IC50 : 13 µM |
| dbacp04244 | LL-III/4 | VNWKKILGKIKKVVK | Lasioglossin III and its analogs | Cell membrane damage | MTT/MTS assay | SW | Colon cancer | IC50 : > 40 µM |
| dbacp04247 | LL-III/6 | VNWKKILPKIIKVVK | Lasioglossin III and its analogs | Cell membrane damage | MTT/MTS assay | SW | Colon cancer | Not found |
| dbacp04250 | LL-III/8 | VNWKKILGKIIKVVK | Lasioglossin III and its analogs | Cell membrane damage | MTT/MTS assay | SW | Colon cancer | Not found |
| dbacp04253 | LL-III/9 | VNWKKILGKIIKVVK | Lasioglossin III and its analogs | Cell membrane damage | MTT/MTS assay | SW | Colon cancer | IC50 : 25 ± 5 µM |
| dbacp04258 | Lon protease | MAAESAAFTPLTLPVLPLDDEVVLPGMVVPLDLSDAEVRAAVEAAQAAARSEPGKPRVLLVPRIDGNHAATGVLGTVEQVGRLADGDPGALIRGRGRVRIGAGTTGPGAALWVEGTRVDETLPEPLPGQVSELVTEYKALATAWLRKRGAWQVVDRVQAIDDVSALADNSGYSPFLTTEQKVELLETTDPVARLKLATQQLRDHLAEQDVAETIAKDVQEGVDKQQREFLLRRQLEAVRKELREINGEQEGEESDDYRARVEAADLPEKVREAALKEVDKLERSSDQSPEGSWIRTWLDTVLEMPWSERTEDAYDIQGAQGVLDAEHAGLQDVKERITEYLAVRKRRGDRGLGVVGGRRGGAVLALVGPPGVGKTSLGESVAHAMGRKFVRVALGGVRDEAEIRGHRRTYVGALPGRIVRAIKEAGSMNPVVLLDEIDKVGSDFRGDPAAALLEVLDPAQNHTFRDHYLEVELDLSDVVFLATANVLEAIPEALLDRMELVRLDGYTEDEKVVIARDHLLPRQLERAGLDAGEVTVDESALRKLAGEYTREAGVRTLERSIARLLRKVAAQHELGERELPFTVTDADLRALIGRPHHVPESAQDPAERRTSVPGVATGLAVTGAGGDVLYVEASLADPETGAAGLTLTGQLGDVMKESAQIALSFLRSHGAELELPVGDLKDRGAHIHFPAGAVPKDGPSAGVTMTTALASLLSGRLVRTDVAMTGEVSLTGRVLPIGGVKQKLLAAHRAGITTVIIPKRNEPDLDDVPAEVLDRLDVHAVNDVRQVLELALAPATSGAQPEVPVAA | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp04263 | Long-chain fatty acid--CoA ligase | MTGPRYADKPWLDLLTDAQKAPLHPDDSLVHALRRAAAEAPDRALIAYFDGRLTYREVDRLSDSVAGHLTARGLERGDRVAVLLQNSPHFVLAVLGAWKAGAVVVPVNPMYKSGEVGHVLRDGEVAALVCSDRAWESYLRETAARSPVRIVLTACELDFQTRRDTRVLAFERLPRAAGTDDLAEVARAGHRAPEGRDPGPDDTALISYTSGTSGTPKGATNTHRNIMYNAERQRTGLLLPDAPVYFALAPLFHITGMVCEFGACLNSAGTLVLAYRFEAGVVLDAFAEHRPHYTVGPSTAFMALAAHPSVTREHFASFANISSGGAPLPPALVEKFRAGLGPYVRNGYGLTECTAPCASVPPHLEAPVDPASGTLAVGVPGPETVVRIVDDQGAEVPFGEQGEIVVSGPQVVPGYWRRPDATAETFPGGELRTGDIGFMDTQGWLYVVDRKKDMINASGFKVWPREVEDVLYTHPAVREAAVVGVPDGYRGETVKAYISLRPGADTDPDALAAYCGERLAAYKYPRQVEILPDLPKTASGKILRRELRSRTHQDTAVNGQ | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp04268 | Long-chain fatty acid--CoA ligase | MATLSVAAVLAENARRRPDKEALVEGDLRLTFGEVWRRARAQAGALVGLGVRPGDRVALMAPNTADFPQAYYAIAAAGAVVVPVHLLLSAAEVEHVLRDSGATLLLCHPAQARTGAAAAREAGVRTLTLGEEFGGLAADAEPLTSYVTRDADDPAVVFYTSGTTGVPKGAVLSHFNLVMNATVNAFDANDIRPDDVALGALPLFHAFGQTVSLNSTWRAGATLVLLPRFDAGRAIELMVREKVNTFHGVPTMFVALAAAAADAGALPGLRVCVSGGASLPVAVLERFEEAFGARIYEGYGLSETSPAAAVNQPAFGARPGTIGHPLWGVDVEIARSETEDAVELLPPGELGEVVVRGHNVFSGYLGRPEATAEALVDGWFRTGDLGTKDGDGFLRIVDRKKDVIIRGGYNVYPREVEEVLARHPGIAQVAVIGLPDDLHGEEVCAVVVPAQGSAPDAREVTEWSKEHLGRHKYPRRVEFADALPLGPSMKVLKRELRARYADRPVTVTG | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp04273 | Long-chain fatty acid--CoA ligase | MTVALHDLLPATLRRTWAVEGTCPDLDLYSLYRARQIADPHRTAVLDGKGKLCYTALDRKARCLAAGLSGLGIHAGDVVGVQLPNGRDAVVADLALAALGAVALPFPVGRGGREAASLLRRSEAVAVIATAEHRGNHHAADLLALTGELPALRTVVAAGPAGAAPQGAVPLSALTRTDPKTFAPARPDPDTAARILVSSGSESEPKMVAYSHNALAGGRGNFLGSLIPDGRPPRCLFLVPLASAFGSNGTPVTLARHGGTLVLLDHFTPEAALEALAEHEPTHVLGVPTMIRMMLDRIAEGGHRTFTPPTAMVVGGSPLDEATATEARLAFGCPVVNLYGSADGVNCHTGLTHGSPDGDGRPGIAAGQPDPRVADIRIAVPGTRELREVSGGTVGEIVARGPMTPLCYVAAPELDTRYRTEDGWVRTGDLGLIDDDGTLRVVGRLKDVVIRGGANISPAEVEVELAAHPAVRDVVCVGVPDPLMGERLAACVVPRDEATPTLEELCAHLDTRGLERRKHPERLLVLSELPLTPAGKPDRAVLRERCTPQAERQQQPLASAG | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp04278 | Long-chain-fatty-acid--CoA ligase | MKTSTALRPQSARVHHPEPGTLVHTARFHAARQPEATAVICEGRTVTYADLHRESNRMAHALRAAGLGEGDRVAYLGKESEHYYEALFACAKTGTVLVPVNWRLTAPEVSHILQDSGTRLLFLEDEFAPIVEGMPTEPPETVVPVNSIHSWRAQHPDDETEFEATPDTPVAQLYTSGTTGLPKGVVLAHRSFFAIRDGLASEGLDWIDWRAGDLALIGIPGFHVGGLWWATQNFNAGTTVVAMRAFAARQAVDLIRDLGITTACVVPAMLRMMLNEPGVSAQDFSTLRKTVYGGSPISEALLEESLTVLDCEFAQIYGLTETGNTAVCLPPAAHVPGGPLMQAAGRPYPGVRAKVIDHRGRELPPGAVGEVCLHTPARMVEYWGLPEKTAETLVDGWVHTGDAGYVDREGYVFIRDRIKDAILVAGENVYPAEIENVLEHHPGVGEAVVVGVPDARWGEKVHAFVVPAAGERPSPRDLHTFLVPRLAAFKLPASYEFTDRIPRNPSGKILRRELRDRFWNDSARKVN | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp04296 | LTX-302 | WKKW-Dip-KKWK | Synthetic peptide | Cell membrane disintegration | MTT/MTS assay | HT-29 | Colon cancer | IC50 : 75 ± 5 µM |
| dbacp04299 | LTX-315 | KKWWKKW-Dip-K | Synthetic peptide | Cell membrane disintegration | MTT/MTS assay | HT-29 | Colon cancer | IC50 : 38 ± 3 µM |
| dbacp04305 | LTX-318 | OOW-Dip-OOWWO | Synthetic peptide | Cell membrane disintegration | MTT/MTS assay | HT-29 | Colon cancer | IC50 : 248 ± 5 µM |
| dbacp04367 | M1 family peptidase | MTNRPDRPLRPSRRRTRRGRAALGAGLALAGTAYGMGTALGQPVPGPATAPADDGVRAYDVAGYDVRVTYDPEASRLEGDAEVAVRATADLARFDLDLALTARSVDIDGKPARSFSRSGDGSVTVVPEEAIEEGRTFTVRVRYDGDPGRSNPSWARGEDGGVITVLAPVGTWFPGNGDPDDTADFRLAATVPDGWTVVSGGRDRPVRRHGGRSTFDWRSTKPLPAKDALFGVGKWDVERTRLADGTPLTTVYAAGRKAEFEKYADQQRGIMSFLSSEFGPYPNDTLVSYFLDSVSEEVPNLAVQGGVIFPNAENEAYFDATVVAHELTHQWYGSLVREKEQRNLCLSECFASYAQWMWPEFSAGEDLDAKYRQEIEEHRTDDGFWQQRLSEGRGVYDKGPVMLHALRRQIGEAAFAEVLREWPARYGGTAPEWAELEKLVQEVSGQNLKGFFDAWVRGDRAPDDAYLRSRS | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp04372 | M28 family peptidase | MPRSPLSGRALTAGAVAVATLMAGGSAAGAASAAEWPAAVADAPDIPVANVKAHLTQLQSIATANGGNRAHGRPGYQASLDYVRAELDAAGFTTSLQEFTASGSTGYNLIADWPGGDADQVVMSGAHLDSVTSGPGINDNGSGSSAVLETALAVARSGYQPTKHLRFAWWGAEELGLVGSSHYVDSLGSADREKISGYLNFDMIGSPNPGYFVYDDDPTIEKTFKDYFAGLGITTEIETEGDGRSDHAPFKNAGVPVGGLFSGADYRKTSAQAAEWGGTVGEPFDPCYHSSCDTTANVDDTALDRNSDAIAYAVWELSQ | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp04377 | MAC1 | GFGMALKLLKKVL | Wallabies and their analogs | Cell membrane damage | MTT/MTS assay | SW | Colon cancer | IC50 : 23 ± 4 µM |
| dbacp04380 | MAC1/1 | gfgmalkllkkvl | Wallabies and their analogs | Cell membrane damage | MTT/MTS assay | SW | Colon cancer | IC50 : 19 ± 2 µM |
| dbacp04383 | MAC1/10 | GFKMALKLLKKVL | Wallabies and their analogs | Cell membrane damage | MTT/MTS assay | SW | Colon cancer | Not found |
| dbacp04386 | MAC1/16 | GFGMALKLLKKVL-NH2 | Wallabies and their analogs | Cell membrane damage | MTT/MTS assay | SW | Colon cancer | IC50 : > 100 µM |
| dbacp04389 | MAC1/19 | GFGMALKLLKKVL-NH2 | Wallabies and their analogs | Cell membrane damage | MTT/MTS assay | SW | Colon cancer | IC50 : 68 ± 2 µM |
| dbacp04392 | MAC1/2 | AFGMALKLLKKVL | Wallabies and their analogs | Cell membrane damage | MTT/MTS assay | SW | Colon cancer | IC50 : 16 µM |
| dbacp04395 | MAC1/20 | GFGMALOLLOOVL | Wallabies and their analogs | Cell membrane damage | MTT/MTS assay | SW | Colon cancer | IC50 : 35 ± 4 µM |
| dbacp04398 | MAC1/21 | GFGMALRLLRRVL | Wallabies and their analogs | Cell membrane damage | MTT/MTS assay | SW | Colon cancer | IC50 : 17 ± 2 µM |
| dbacp04401 | MAC1/24 | GFGMALKL-(AC6C)-KKVL | Wallabies and their analogs | Cell membrane damage | MTT/MTS assay | SW | Colon cancer | IC50 : 16 ± 1 µM |
| dbacp04404 | MAC1/25 | GFGMALK-(AC6C)-LKKVL | Wallabies and their analogs | Cell membrane damage | MTT/MTS assay | SW | Colon cancer | IC50 : 14 ± 1 µM |
| dbacp04407 | MAC1/26 | GFGMA-(AC6C)-KLLKKVL | Wallabies and their analogs | Cell membrane damage | MTT/MTS assay | SW | Colon cancer | IC50 : 18 ± 1 µM |
| dbacp04410 | MAC1/3 | LFGMALKLLKKVL | Wallabies and their analogs | Cell membrane damage | MTT/MTS assay | SW | Colon cancer | IC50 : 11 ± 1 µM |
| dbacp04413 | MAC1/4 | GFGMALKLLKKVL-NH2 | Wallabies and their analogs | Cell membrane damage | MTT/MTS assay | SW | Colon cancer | IC50 : 49 ± 9 µM |
| dbacp04416 | MAC1/6 | GFGMALKLLKKVL-NH2 | Wallabies and their analogs | Cell membrane damage | MTT/MTS assay | SW | Colon cancer | IC50 : 29 ± 3 µM |
| dbacp04419 | MAC1/9 | GFKMALKLLKKVL-NH2 | Wallabies and their analogs | Cell membrane damage | MTT/MTS assay | SW | Colon cancer | IC50 : 13 ± 3 µM |
| dbacp04422 | MAC2 | GTGLPMSERRKIMLMMR | Wallabies and their analogs | Cell membrane damage | MTT/MTS assay | SW | Colon cancer | IC50 : > 100 µM |
| dbacp04446 | Maculatin 1.3 | GLLGLLGSVVSHVVPAIVGHF | Fringed Tree Frog, Australia | Disruption of cancer membrane integrity | Not specified | Not specified | Colon cancer | MIC : 1 – 100 µg/ml |
| dbacp04456 | Maculatin 1.4 | GLLGLLGSVVSHVLPAITQHL | Fringed Tree Frog, Australia | Disruption of cancer cell membrane integrity | Not specified | Not specified | Colon cancer | MIC : 1 – 100 µg/ml |
| dbacp04465 | Maculatin 1.4 | GLLGLLGSVVSHVLPAITQHL | Fringed Tree Frog, Australia | Disruption of cancer cell membrane integrity | Not specified | Not specified | Colon cancer | IC50 : 10−5 - 10−6 M |
| dbacp04490 | Magainin 2 | GIGKFLHSAKKFGKAFVGEIMNS | African clawed frog | Dissipate ion gradients; Induce osmotic lysis; Membrane damage | Trypan blue assay | Daudi | Colon cancer | IC50 : >150 µg/ml |
| dbacp04667 | MFS transporter | MASSLTKDSVSPGTPGSEKTFFGHPRGLATLFMTEMWERFSYYGMRALLPLYLVAPGGLGLSAGTATAIYSVYLSLVYLLTMPGGWFGDRVWGPRKTVAVAGGVIMLGHLTLALPYAGTFYAGLGLVAIGSGLLKANISTMVGQLYDGPDDPRRDGGFTVFYMGINLGAFFAPLTIGTIGESVNWHLGFALAALGMGLGVVQFLLGSRHLAPHSSTVPKPLSAEEKTSTLRKAAFWAALAVVFYAIVGFSGHYTLNWILVPLTLLGVIIPVLVLTSIKRDKSLDRAEQSKMSAYIWFFVAAAVFWMIYDQGGSTLSLFADSSAKNSVFGWGFPVSWYQSVNPVLIMALAPVFATLWLALARRGREPSTIVKFAFGLVLVGASFFLFLAPLGIAEGGHKAAALWLVAIYFVQTCGELLLSPVGLSVTTKMAPVKYASQMMGVWFLAVTAGDATTGLLSLAGVDLNKTGIVAAEATLAVVAGLAIWMYRRRVKELMGDVR | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp04672 | MFS transporter | MKNAQPDGPPPSGDDAAFFGQPRGLLTLSGLEVWERFSFLGMQAILVLYFADTVANGGLGMAAGTAASVSAAYGTLVYLVSVAGGWLADRILGSYRAVLWGGILIACGHYAMAVPAGATTWIGLGLISAGTGLLKPNAATMVGKLYRTDDERRDAGFAVYYMAINIGAFAGPLVTGWLSDHQGWHWGFSAAAVGMTLGLAQYVLGRRHLAGRRHAAEFALAPDAMRRAVRLIASGVVAAAVVATVLALAGWLTMSRFVDLLTLISVLAPVAYFAVMFASPRVTSQERGRLKPYVVIFLASTVFNYILFQAYSTMMLLASTDAETTLLGFDFPASWYASALGAFEVALAPVVAALWVRMGRRQPHASNKIAIGVVLGGLSFLLMVLPTSGDSGGHLMSAWWIVGSYLLLGLGDIVLETSGMSATTKLAPTAFSSQTMSLWFLSLALANGIQAQTVKLYDHVSQPAYFGVNGAIAVAAGLAVMAAAPYLRRTMHPVH | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp04685 | MIP | PRFWEYWLRLME | E3 ubiquitin-protein ligase | Cell cycle arrest or apoptosis of cells | Immunoprecipitation assay | HCT-116-p53+/+ | Colon cancer | IC50 : 0.01 µM |
| dbacp04686 | MIP | PRFWEYWLRLME | E3 ubiquitin-protein ligase | Cell cycle arrest or apoptosis of cells | Immunoprecipitation assay | HCT-116-p53+/+ | Colon cancer | IC50 : 0.12 µM |
| dbacp04687 | MIP(F3A) | PRAWEYWLRLME | E3 ubiquitin-protein ligase | Cell cycle arrest or apoptosis of cells | Immunoprecipitation assay | HCT-116-p53+/+ | Colon cancer | IC50 : 0.57 µM |
| dbacp04688 | MIP(L10A) | PRFWEYWLRAME | E3 ubiquitin-protein ligase | Cell cycle arrest or apoptosis of cells | Immunoprecipitation assay | HCT-116-p53+/+ | Colon cancer | IC50 : 1.14 µM |
| dbacp04689 | MIP(M11A) | PRFWEYWLRLAE | E3 ubiquitin-protein ligase | Cell cycle arrest or apoptosis of cells | Immunoprecipitation assay | HCT-116-p53+/+ | Colon cancer | IC50 : 0.4 µM |
| dbacp04690 | MIP(R9A) | PRFWEYWLALME | E3 ubiquitin-protein ligase | Cell cycle arrest or apoptosis of cells | Immunoprecipitation assay | HCT-116-p53+/+ | Colon cancer | IC50 : 0.02 µM |
| dbacp04691 | MIP(W7A) | PRFWEYALRLME | E3 ubiquitin-protein ligase | Cell cycle arrest or apoptosis of cells | Immunoprecipitation assay | HCT-116-p53+/+ | Colon cancer | IC50 : >100 µM |
| dbacp04692 | MIP(Y6A) | PRFWEAWLRLME | E3 ubiquitin-protein ligase | Cell cycle arrest or apoptosis of cells | Immunoprecipitation assay | HCT-116-p53+/+ | Colon cancer | IC50 : >100 µM |
| dbacp04717 | Multivalent DR5 binding peptides, TRAILmim/DR5 (1m) | WDCLDNRIGRRQCVKL | Not found | Inducing apoptosis | Not specified | HCT 116 | Colon cancer | Kd (Binding constants of TRAIL mimics): 129 ± 3.68 nMol/L |
| dbacp04718 | Multivalent DR5 binding peptides, TRAILmim/DR5 (2m) | WDCLDNRIGKRQCVRL | Not found | Inducing apoptosis | Not specified | HCT 116 | Colon cancer | Kd (Binding constants of TRAIL mimics): 664 ± 18 nMol/L |
| dbacp04719 | Multivalent DR5 binding peptides, TRAILmim/DR5 (3m) | WDCLDNKIGRRQCVRL | Not found | Inducing apoptosis | Not specified | HCT 116 | Colon cancer | Kd (Binding constants of TRAIL mimics): 226 ± 5.64 nMol/L |
| dbacp04721 | Mycothiol acetyltransferase | MTSDDTVHPGRPRSIETLAELAPEQTEAVLALLAEAARNDGQYAVSEQGRLQLRGPAREGVAHLLLTADGGELVGYAQLEGVDPIEPPAAELVVHPSHRGRGHGRALGSALLAASGKRLRVWAHGGHSAARHLAQVLGLTLFRELRQMRRPLAGLDLPEPRLPEGVTVRAFAPGQDDAAWLAVNAAAFAHHPEQGSLTQRDLDDRKAEGWFDPAGFFLAERDGRLIGFHWTKVHAEEGLGEVYVLGIRPDAQGGGLGKALTTIGLRHLAGQGLPTAMLYVDADNEAAVAVYERLGFTVHETDLMYRTET | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp04726 | Mycothiol S-conjugate amidase | MTDQLRLMAVHAHPDDESSKGAATMAKYVSEGVDVLVVTCTGGERGSILNPKLQGDPYIEEHIHEVRKKEMDEAREILGVRQEWLGFVDSGLPEGDPLPPLPEGCFALEDVDKAAGELVRKIRSFRPQVITTYDENGGYPHPDHIMTHKITMVAFEGAADTEKYPEAEYGAAYQPSKVYYNQGFNRPRTEALHHALLDRGLESPYADWLKRWAEFERKERTLTTHVPCADFFEIRDKALIAHATQIDPDGGWFRVPLELQKEVWPTEEYELAKSLVETSLPEDDLFAGVRDNA | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp04755 | N-acetyltransferase | MLSLALRDGVRLRALEVWHAQEFAAHLDRAREHIRPWVGAAFVTDDVAGARATLRRYGESGAADGARLYGIWRDGVLVGGVMYVHFSEALGSCEIGCWLEPSAEGQGLVTAACGALLDWAFTARGLHRAEWHCRADNARSSAVAERLGMSLEGVRREAWPYEGRRYDKQLWAVLAPEYAHPGG | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp04760 | N-acetyltransferase | MLHAGQFEQALTVTQVTERRMTSTFPNISINTERLVLRPLDEDDVPALAAMMNDEQVAAWTHVPQPFTEKDAGVWIGDHAPAERTAGRGLDLAVTEFLTQRLVGVVRLTRTDWHVRSTELSYIVAPWARGEGYASEAALATAQWLFGDQKFERVELRTAADNTASQQVAQKIGCISEGVLRGACIARARTDDGVWTDVRTDFIVWSLLPEDLEGTTGQPVGSDGFTAFTDWN | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp04765 | N-acetyltransferase | MPSMPYLTRPVIAEGTLSRTPQPALPTGDGLLLRPWRADDAPAVHAAFQDPAMHQWHARAADSEDEVRGWITEWQRAWEGERGVQWAVADASDDRLLGRVALREVVLGDGVAEVAYWTTAAARGRGVAARATRALAHWALDGIGFQRLELLHAVANEASCRVAHKSGFALEGTKRSALLHPDGWHDMHLHARVRGD | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp04770 | N-acetyltransferase | MAPTPAHRTHATGVPDPSRAEPRGHGLHLRSWDADSDSDAEAWLRGFLDPEFQRWNTPLNLWTDVAGARESLRARARDAADGRSVSFRVTDGGSGTTLGHIGVNEISRQMKVARVGYWVLPAARGRGVAGRALLLASRWAFAELGLHRLELGHAMGHEASCRIAERCGYRAEGTLREAMFESGRHDAFRDVHLHARLATDTEPAPPDTR | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp04775 | N-acetyltransferase | MEPVTLTTDRLVLRTVGSQDTEAVYAAAQDPDIQRWTTIPSPYLLEHARNFAEQAVPDGWANDSMFTFGLFLPDGDLAGMLGVTMISLGVGEIGFWGTKEHRGHGYVTEAAVAVSRWAFTERAVDRLEWRAEVGNTASRAVARRAGYTMEGTLRSAINNNGVRRDCWIASLLPSDLTLPSTSPYLPAP | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp04780 | N-acetyltransferase | MNSPSWPAELRDGGIVLRPIRLRDQRAWREVNRRNRDWLRPWEATIPPPGPGGPITSRPTYRQMVRHLRSEAHAGRMLPFVIEYQGRLVGQLTVAGITWGSMCSGHVGYWVDEAVAGRGVMPTSVALAVDHCFRTVGLHRVEVCIRPENAPSRRVVEKLGFREEGLRPRYLHIDGAWRDHLVFALTADEVPEGLLRRWHRSRNRSTPNAGN | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp04785 | N-acetyltransferase | MGGVTGGELGAEQVQAAVAGSVALLATAADRDWEAARAGRLEWSCRYTAEHVAGDLITYAGQLAGRATTAYVPFEITLDEGTGNGGVLRVIETTGALLAATLRTTPREVRAFHPYPYRSANREGFAAMGVAEVLLHTHDIAEGLGLSYEPPAGLCADVLTRLFPHVRPGGDAWRTLLWATGRGELPGRAPVTEWRWRNNLVVPAERLTLQGVTPAAATDLAAGGDGGFAWVDGGPLEGTRFSAGMVLKAYEAGTHRPEWGVFVLVRRADGRAVGGIGFHGAPDEDGRVEIGYDLAEAARGNGYATEGLRALSAWALDRDEVTSVFATTEPHNAASQAVIARAGFRRAAVVEEHGGESGQYAYELRR | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp04794 | N29D | PDEDAINDALNKVCSTGRRQRSICKQLLKK | Synthetic peptide | Apoptotic inducing | Cell viability assay | SW-480 | Colon cancer | > 100% cell viability at 5 µM |
| dbacp04795 | N29D | PDEDAINDALNKVCSTGRRQRSICKQLLKK | Synthetic peptide | Apoptotic inducing | Cell viability assay | SW-480 | Colon cancer | 60% cell viability at 50 µM |
| dbacp04800 | N29D | PDEDAINDALNKVCSTGRRQRSICKQLLKK | Synthetic peptide | Apoptotic inducing | Cell viability assay | SW-480 | Colon cancer | > 100% cell viability at 5 µM |
| dbacp04801 | N29D | PDEDAINDALNKVCSTGRRQRSICKQLLKK | Synthetic peptide | Apoptotic inducing | Cell viability assay | SW-480 | Colon cancer | 60% cell viability at 50 µM |
| dbacp04806 | N29N | PDEDAINNALNKVCSTGRRQRSICKQLLKK | Synthetic peptide | Apoptotic inducing | Cell viability assay | SW-480 | Colon cancer | 100% cell viability at 5 µM |
| dbacp04807 | N29N | PDEDAINNALNKVCSTGRRQRSICKQLLKK | Synthetic peptide | Apoptotic inducing | Cell viability assay | SW-480 | Colon cancer | 40% cell viability at 50 µM |
| dbacp04812 | N29N | PDEDAINNALNKVCSTGRRQRSICKQLLKK | Synthetic peptide | Apoptotic inducing | Cell viability assay | SW-480 | Colon cancer | 100% cell viability at 5 µM |
| dbacp04813 | N29N | PDEDAINNALNKVCSTGRRQRSICKQLLKK | Synthetic peptide | Apoptotic inducing | Cell viability assay | SW-480 | Colon cancer | 40% cell viability at 50 µM |
| dbacp04818 | N29N | PDEDAINNALNKVCSTGRRQRSICKQLLKK | Synthetic peptide | Apoptotic inducing | Cell viability assay | SW-480 | Colon cancer | MIC : 5 µM |
| dbacp04827 | neo-N-methylSansalvamide A | NA | Marine fungus | Apoptosis induction | Not specified | HCT15 | Colon cancer | 0.85 ± 0.63 nM/L |
| dbacp04833 | Nickel ABC transporter permease | MSAPRSRAGRLARPDARLRRLPVTSRIALGVLLVVVLGAVFAPLLTQDPLATGIPARAPGADHWFGTDRAGRDVFARVVHGARYSLVIGLGATLAALVLGSALGALAATSRRLADESVMRTLDVVMSFPPIALAAVLVAVFGPSVPVIIFTIAFVYSPSLARVVRANVLEQYGEDYVAAERVVGARRGHIVVRHVAINCAAPVLVFATVMVADSIIFEASLSFIGAGVQDPDPSWGSVLAYGRQILLSGGWWATLFPGLCVLVTVLALNVLSEGMTDAAASPDTSRTGGTDSDATAATAPAAERADGAEVDAALAELASRLRATEPAVPPLAADAADLLVVRDLSIRFPDRYGDTRVVDGISFTVREGETLGLVGESGCGKSVTSLAVMGLLARNAEAAGEIRYRGRDLLKLTPKERRALMGPEIAMVYQDAMSSLNPSVLIGTQLKWLTSRGGTRTPAELLELVGLSPERTLRGYPHELSGGQRQRVLIAMALSRGPRLLIADEPTTALDVTVQAQVVELLVRLRDELGFAMVLVSHDLALVGDLAHRVAVMYAGQVAETGETRALLTDPAHHYSRGLLGSVVSLESGAERLHQIRGVVPAPKAFGAGCRFASRCAAATELCATTPPPATDREAGLDHLFACHHPASALRPPSADRPAAGKTPASGDGPASGGPSATSLERAR | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7µM |
| dbacp04838 | Nickel-type superoxide dismutase maturation protease | MMPEQLSQETERARGALPFGPAEVTGPSMVPTLHHGDVLLVHWGARVRPGDVVVLRHPFQQDLLVVKRAAERRRGGWWVLGDNAFAGGDSTDYGVVPEELVLGKVRLRYRPRAGQRSPFTVVRWALSALRPVLADRSASRRLRAR | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7µM |
| dbacp04843 | Nicotinamidase | MRRALIVVDVQNDFCEGGSLAVSGGADVAAAITELIGQAPAGYRHVVATRDHHVAPGGHFADTPDYVHSWPAHCVAGTEGVGFHPNFAPAVASGAIDAVFDKGAYSAAYSGFEGADENGTPLAEWLRSREIDEVDVVGIATDHCVRATALDAAREGFRTQVLLDLTAGVAPETTERALEQLREAGVELSGKPVVQ | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7µM |
| dbacp04890 | Non-ribosomal peptide synthetase | MPVSAAPQHHHYCPHRAATRSVDGPRGHDRRPSPHGGVHVIPASYAQRRLWLVDRLEGPSALYTVPLVLHLTGRPDVTALRAALHDVVARHEALRTRFPQVDGEPVQEIVPVGELDDLLTEDEVRADELEHEIGRTARHVFDLAAGIPFHARLLTVDDRTSALVVALHHIAADGWSAAPLWRDLSAAYAARLTGAEPDLAPLPVQYADYTLWQRELLGDADDPGSLLAEQLAHWRAALAGAPEELALPTDRPRPAASAHDGGVVRLDVPAGLHARLADLARDENATMFMVWHAALAVLLSKLGAGEDIPVGSPFAGRDEADLEDLVGFFVNTLVLRTDVSGDPAFTEVVRRVRGTAVDAMNHQDVPFERLVEDLAPARSLTRHPLFQVNLTLHNTPRLPVDLPGLTAVAEFAAPPLAKYDLDVQVQEHADAQGRPAGQRVELHYSADLFDRTTAEAIAGRLLRVLSQVAHTPELPLHAVDVLSPAEHQALTAAAGSAAAPPPGDTVPDLFAARAAAHPDAAAVTHGATTLTYAELDAESNRLARHLVARGAGPETRVAVSLERTPGLVTALLAVMKAGAAYLPADPAHPAARTGALLADAAPVLLLTTADTAAHAAAAPELRRVLLDDPQTRTAVAARDAGPLTQDERRTPLRPGHPAYVIHTSGSTGAPKGVVVGHAQVTALLRSAADRYGFGTDDVWTWFHSYAFDFSVWELWGALLTGGRLVVVDHDTSRSPDDFHDLLVREGVTVLSQTPSAFQQLDQADARRDAAALGARLRLLVFGGEALDPARLTDWHDRHGTDGPRPVnMYGITETTVHVTHLDLDPGTAAAPGTHGGSPVGRPLDHTRVHVLDDALRPVPPGVPGEMYVTGSGVARGYLNRPATTAARFVACPFEPGTRMYRTGDRARRAADGTLTYLGRTDDQVKLRGFRIEPGEVEAALLDHAPIGRAAVVLRTDTPGDRRLVGYVVPRDPAAATGEAGAELARRAREHAAALLPAHMVPSVCVPLARLPLTANGKLDRAALPAPDREGAAGGRGPATAREEILCTAFAEVLDLPSVGADDDFFALGGHSMLAVRLLDHLRTRGVRVDMRTLFTAPTPARLAAAAGPEPVRVPEGTVPPGATRLTPEMVPLAGLTEDELRTVTDALPDGAAGVADVYPLGPLQEGLFFHHRLNAGTGTAGGSGDGDPYVVRYVLGFDTPRLLDSFLAALAQVIDRHDVLRTSLAWTGLPHPVQVVHRHAELPVTETDLGDGPDPVARLLAHGDEPLDLRRAPLMDARTATEPGTGRRLLAVRMHHITQDHTTLDLVLREATAVLAGRGGTLPAPRPYREFVGRALLTTPAEEHLAHFGRLLGDVTEPTAPFGVWEVRGGGTDVTERRTVLGEPVAARLRAQARRTGVSAATVLHVVWSRVLAAVSGRDDVVFGTLLLGRMQAGDGAGDVPGMFINTLPVRARTAGTDVAQAVHAMHHQLAELMVHEHASLAVAQRAGGVRPPAPLFTAVLNYRHNPEGGPGTVLPPGTELLAFRERTNYPLLVSVDDDGGALAFDVQAATPIDPDLVTRLLHATTERVVDALEQAPDTPLADVDVLPAAERHRVLTEWNDTGRPDTARTLADVLADRATATPHAPALTHDHDGVPEQLDYAELFARANRLARHLIGQGVGPEDRVVLLMDRSPDLVVALLAVVGAGAAYVPVDPDQPAVRVAHLCVDAAPAAVLTGRAHAASVPRSAPAPIVVDDPEVRSAVAAHAPDPIGQDERTCPLRPSHPAYVIYTSGSTGIPKGVVVPHSGAVNLLAFRWPGLTADSSLLQFASIGFDVATWEIMTAFAAGARLVVAPAARLLPGAGLEDVVERHAVTHLQLPPTVLGMVADDHRLASVRTLLVAGEALGQALVDRWGAGRWFGNAYGPTEITVIAAADGPLRPGDAPTIGRPLPGVRLYVLDARLRPVPDGVDGDLYVAGAGLARGYLDRPGLSAERFVADPHGAAGTRMYRTGDTVRRTADGRLLYTGRADDQVKIRGFRVEPGEIETRLTEHEGVAHAAVVARDDVPGAPGDTRLVAYVVPSGPGVPAALRDHLAALLPAHLVPSAFVALDRLPLSVNGKLDRAALPVPDPATGTGAARPAGTYDELLCAAMAQVLGVPRVGADDDFFALGGHSLLAVRLVGRIRAVLDVEIPVHAVFEAPTAARLAARLDEWTGAQVRPSVVAGERPGRLPLSYAQRRLWFVDRLEGASALYNIPLVVRLSGRVDVGALGAALGDVVGRHEALRTRFPQVEGEPYQEVVPVAEARVELPVVPVAAGELEARIEEVSGHVFDLAGELPVHAALLTSGEESSVLVLVVHHIAGDGWSLAPLWRDLSAAYGARRAGGTPRFAPLPVQYADYTLWQRDLLGDAADPGSVLAEQVAHWRTALEGVPEELSLPADRPRPSAKTHRGAAVPVRVPAGLHARLAELARSEGVTMFMVWQAAVAVLFSRLGAGEDIPLGGPVAGRTDESLEDLVGCFVNTLVLRTDLSGDPAFTDVLARVRRDTLSALHRQEVPFERLVEELAPPRSMGRHPFFQTVLEVQSTPLLAPELDGVNVAVLPHAVRDAKFDLDLQIAESFDAEGRPTGMAGELVYAADLFDHATAETLTARLLRVLDAVADAPGRPVHTVDVLDDAERRRLVGEWSRRQPAIAGPDVRVFVLDDHLMPVPPGVTGLLYTTCDASADSTVACPFTEEESVMRPTGAQARWDDEGRVHVVPADDAAAPEADTQPSGAPVPRGSGTELREELLRTVFAQVLGVPEVGADDDFFALGGHSLQAVRLVSRIRAVLGVELLVRDLFETPTVAGLAARLDDTAGAQVRPSVVAGERPGRLPLSYAQRRLWFVDRLEGASALYNIPLVVRLSGRVDVGALGAALGDVVGRHEALRTRFPQVEGEPFQEVVPVAEARVELPVVPVAAGELEARIEEVSGHVFDLAGELPVHAALLTSGEESSVLVLVVHHIAGDGWSLAPLWRDVSTAYAARRSGKTPDFPPLPVQYADYALWQQRLFGDEDAAGSRLAAQVEHWRATLDGVPHELALPFDRPRPARPGRGGGWADIEVPAELHARMAELARSEGVTMFMVWQAAVAVLLSRLGAGEDIPLGSPVAGRTDESLEDLVGFFLNTLVLRTDLSGDPAFTDVLARVRSTALDALDHQDVPFDRLVEKLAPARYTDRVPFFQVLVAVQnMPQAQVALPGLDVDAGPGKPTTAKVDLDVQVVELHDADGAPSGMAGGLTYATDLFDHSTAESLVARLLRVLDAVTADPARRVSRIDVFDPAERRRLLTESNGARSDTLALTVPELFAVRASRAPKAVALDTGAEPVTYGQLDARSNRLAHHLIDLGVGPETVVAVVMDRSPDVVTTLLAVLKAGGAYLTLDPAQPDSRTAEMIALAGAEVCLADQRYAEAARGRFATVVVADAGDAEWADRPAGTVAGRSLPDQLAYLMFTSGSTGEPKGIGTTHRDIVDLAGDRCWQFPGTARGMFAAPHTFDGSTVEVWVRLLTGGTLIVTPPGRTDAARLRSLVADHGLTHAHLTAGLFRVIAEEDPAAFTGVHDVLTGADVVPREAVRRVLEAVPGIVVRSSYGPTEATVIATQIPLTEPDALGDVVSIGRAMDNTGVYVLDDSLQPVPAGVAGEAYIAGAGLARGYVARPGLTAERFVACPFDVPGARMYRTGDIVRRRADGALEFVSRADDQVKIRGFRVEPGEVEKILAGHPAVAQAVVTVREDTPGDKRLVAHLTAAPGEALPDVREFVAGRLPEYLVPDAVVVLDRLPLTANGKVDRAALPAPEAASTGAARRPPSLREDLLCSVFAQVLGVPRVGVDDDFFALGGHSLLAVRLVSRIRSVLGAEIPVQAVFETSTVAGLAPTVEAAGSTGVLRPALAAGPRPPRLPLSYAQRRLWFVDRLEAAGPLYNVPLALRLTGALDTGALRAAWTDLLTRHESLRTRFLHADGDPYQDIVSLDDFPPYFAVESVGRGELEARIDEAAGHVFDLTAGPPVRATLLDVDGPDTDEAVLVLVTHHIVADGWSMVPLLRDLSTAYTARRAGRAPGWEPLPVQYADHTLWQRGLLGDGDDPDSVLAGQVAHWREALDGSPEELALPTDRPRPAVASREGGWVPMSAPADLHARLTELAVAQGATAFMVWQAALAVLLSRLGAGQDIPIGSPVAGRTDEAADDLIGFFVNTLVLRTDLSGDPTFTEVLGRVRRSALGALGHQDVPFERLVEELAPTRSRARHPLFQILLAVQNVPAATVDLPGLRVEALPTELGRAKFDLDLHVAEAFDDEGRPAGIDGGITYAADLFDRTTVEALLDRLLLVLHAVAADPSRRVHDIALLDSDDRHRVLTEWNRTERAAPAATVPDHFRAQAARTPDAAALVTDGARTTYAELDAASDRLARYLTRHGAGPGRLVAVVMERSPETITALLAVLKTGGAYLPVDVGYPAARIELMLRDAAPALLLTTTDLADRLPGSAGGPDRIVLDDPSVRDAVAAEDATPTATPPHLDSAAYTIYTSGSTGTPKGVVATHRAVDRLVRPADYADLRAGDVVSHLGSVSFDSTTFDIWATLLNGATLAVGPAGSPSVADIRDYLARHRVTVALLPTGLLHQVIDLDVEALRGVRSVLTGGEALSVEHCRTLLDTLPGTRLMNGYGPTESVTYTHTHPVTRADVDSGRAIPLGRPLARTRAYVLDSALRPVPVGVPGELYIAGDGLARGYANRPGLSAERFTACPFEDGGARMYRTGDLVRWRADGVLEFVGRVDDQAKIGGFRVEPGEVEATVSAHPDVAQAVVVVREDTPGDKRLAAYAAPADPAVSGRELADRIRHFVADRLPDHLVPPFVTVLDRLPLTPNGKVDRAGLPVPDPMAAVSVARGPASPYEELLGVVFADVLRLPRVGVDDDFFALGGHSLLAVRLVSRIRAVLGAETSVATVFENPTVSGLARQLTRAGGRARPALVPMPRPPVLPLSYGQSRLWFVDRIEGPNHLYNICLVLRLTGDLDPELLRLALADVVARHESLRTTFPLVDDEPSQHVLAVEEAAVDLPVTAVTEEELAGRLDALAAHPFDLARELPLKTELFSLRPGEWVLSATVHHIAGDGWSMGPLWRDLSQAYLARAAGRAPEWEPLPVQYADHTLWQRDFLGDVDDPDSVLATQVAHWKERLRDAPQELALPVDRPRPAVSDHRAGLVPLNIPAPLHARLAELALGQGVTMFMLLHAAVAVLLSKSGAGRDIVLGSPVAGRTDQALDDLVGYFAGTLVLRTDLSGDPDFLELLDRVRTAGLDAFEHQDVPFERLVEELAPARSMARNPLFQVMLAVQNNQRGTLSLPGVQVREEPAGALTARFDLDFEVRESFDESGAPAGLDGEVVYAAELFDRSTVQTLTARLLRVLETVAADPTLPVTRVDLLDDAERRRVTEEWNDTAGPLPDGTLAGLFDRQAARTPDAVALVHDGAEITYAELDERSGRLARHLIGLGAAPETLVGVALDRSVEQIVALLAVVRTGAAYLPVDPGQPRRRTDLVLTDASPVLVLSTAETTARLGGTEAGTPARWIDLDGPLADGLRDTPAPAAVTDADRGTPLRPHHPAYVMYTSGSTGTPKGVVVPHSGVVNQLAWMQEEYRLEPADRMLQRASFGFDASVWEIFWPLLNGAAVVLSGPGSHADPEYLADLVDRERVTVAQFVPSVLRTFLDGGAAGRCTSLRTVLCLGEALPAAVRDRFRQTLDAELHNLYGPTEASVAVTAWPCDAAQDGASVPIGRPLRNIRAYVLDDGLLPVPPGTAGELYVAGTGLARGYLGRPVLTSERFVACPYGPAGERMYRTGDIVRWTAGGHLEFLDRADDQVKIRGFRVEPGEVEATLATHPEVAQAAVVTREGPGGDPALVGYLVPAAAGDDGADLVARVREYLAERLPEHLVPPVLTPLDTLPLTPNGKLDRAALPAPDYTALATGGRAPATLREQLLCSVFEQVLGVSPVGVDASFFDLGGHSLLAVRLVNRIRVVVGADVPVRAVFEAPTVAGLLAWIAREGRQGTADVLVPMRSTGERPPLFCAHTVLGLGWEYGWLTDAAPGDQPLYALRPRGMDTGTAELPDSLPRMAADYVEQIRTVQPTGPYHLLGWSFGGNVVQEMAAQLQDAGEEVAALVLLDSSPVDGPATAEQRAGFAEQEETVAGALTGEEHEAYLRIVRNNTRILLAHRTRKTTGTLLLVSADSETKAALWRPFVSGEVREHVLDCAHRDMLLNPDVVRRIWDIAADELEPTDTDDTDNDPDRA | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp04895 | Non-ribosomal peptide synthetase | MTKQSGLQDILPLAPLQEGLLFHSVFDEKAPDVYLVQQAIDLEGDLDTAALAAACRTLLRRHANLRAAFRYQGLKRPVQLIPHQVELPWEETDLSRLPEPERSAAADRLLEEDRLRRFDLGRPPLMRFTLMRLGDGRYRFVLTNHHILLDGWSRPMLVRELLALYRTRGDDSALPRVRPFRDYLQWLAGQDRDSAVAAWREVLAGLDGPTLVAPQAGERTPVVPGRLETELADADHAALTRLAREHSLTLNSLVQGAWAVVLSGLTGRDDVVFGTTVSGRPPEVAGIETMVGMFINTLPVRVRLRPDEPFLDAVRRTQDEQTRLQSHQQLGLAEVQRLAGEGELFDTTMVFENYPVDIGAERDEPGGIGGVTVTGTRNRDATHYPLALVAVGRDGLRLRLDHQPDLVPPAAARAVLERLVRVLRGAASEPHRTVGRFELLSAEERGAVLSLGRGTDTGPADTTLPAAFRAQAERTPHADAVRCGTTVLDYAELDVRSDRLARALVAHGVRTETPVGLLMDRSEHLVVALLAVLKAGGAYVPLRQGDPLDRLRQVTALAGVRHVLTDAEHAARAGELGVTAVRADAADAPAGGAELPSGPGHADRLAYVMHTSGSTGMPKGVAVTHRDVVELARDRSFACGAHARVLVHSPHAFDASTYEVWVPLLSGGTAVVAPPGDLDADTLGKVLTEHEVTGLWLTAGLFQLVADEAPHHLAGVREVWTGGDVVQAAAVRRVREACPGTVVVDGYGPTETTTFAVRHRIPANAPVPDTVPIGTPLDNTRLLVLDTALRPVARGVAGELYLAGAGLARGYWRRPDLTAERFVADPHGPAGTRMYRTGDLVRWTPDGTLEYLGRADEQVKIRGFRIELGEIEAVLGLHFEVAQAVVTVHEPRPGDKRLVAHLVAEEGSDPTPASLRDHLAAELPDYMVPSAYVSLDALPLTGNGKIDRRALPVPDLTAADATVESRAPRTPREEILCGLFAELLGMPRVGVDDDFFALGGHSLLATRLVGRIRAVLDAELTVRQLFDAPTVAALSRALDTAGAARPALRPAEPRPERVPASPAQRRLWFLHRFEGPSPTYNIPFALRLSGDLNRSALRAALADLTDRHESLRTVFAEDAEGPRQIVRPAAEARPELTVVPSAPSDGLEAEVARAASYSFDLAAEIPLRAWLFETGEREQVLLLLVHHIAGDGWSVPLLARDLTTAYTARLGQRAPQWRPLPVQYPDYTLWQREALGSEDDPDSPAARQLAYWRDALAGLPEELALPADRPRPATAGGRGGRVLYEVPEELHARIVTVARTCQASPFMVVQAAVAALLTRLGAGEDIPLGTPVAGRTDDALDGLVGFFVNTLVLRADTSGNPAFRDLVARVRETDLAAYAHQDVPFERLVEVLNPKRSPARHPVFQTMLTFNNTDRRPGDGLRLPGLDAESLSADTGTAKFDLLFSFAERHDAEGRPAGLGAGLEFSTDLFDPDTAEALVARLLRLLDAVTAAPDRAIGAVPLLGDEERARALSASLGPARVPVGGSLPERFAVSVARAPHAVAVETAEGVLTYAELNARANRLARLLVERGAGPESLVAVAMHRSAELVTACLAALKAGAGYLPVDPEYPADRIAYMLDDARPASVLTTRDLAGALPTGPAGTPLVVDAPATVARLGSLPDSDLTDTERTSPVGPAHPAYVIYTSGSTGRPKGVTMPVRALANLLDWHERTLPGGPGTRVAQFTAVSFDVSVQEILSALLAGKTLVVCPEDVRRDPERLAGWLGERQVQELYAPNLVIDAVCEAAVAARLDLPHLTDLVQAGEALTPHGAMRAFCAARPGRRLHNHYGPAETHVVTAHRLPADPAGWGPSAPPIGRPVDNTAVRLLDPWLNPVPPGVPGELYIGGDALARGYLGRADRTAERFVADPYGADGARMYRTGDLARLTPDGLLVYLGRADSQVKIRGFRIEPGEIEAALTAHASVAQAAVVVREDRPGDRRLVGYVVAAHQEAPDSARLREHLSGRLPAHMVPAAFVVLEALPLTPNGKLDRTALPVPEYAAGGGSRAPRTPAEHRVCTLFAEVLGVERAGVEDDFFELGGHSFLAARLVARLREEFGQDLPVRTVFDSPTPEGVAAVLTGTADGGPGRSSESLLALRARGTAAPLFCLHPGGGFSWCYAGLVRHLGPDVPVYGIQARGLDGSGPLPSSMAEMTAEYLALIRSVQPSGPYRLAGWSFGGLVAHALATALRAEGEEVSLLALLDAYPPGENADTSEPVEHEVVAHNLRAMGFEFDMAELIADQEGVLRRFREFLQSGDQALAQLEARDILALKDVYVNNVRLMRKFTPEFFDGDVLFVSAERKSADDREGRLNVSLWQPFTGGSVEVCAIDSTHGNLMTDARHMARIGQFLADRL | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp04900 | Non-ribosomal peptide synthetase | MTEQSAVGLPLTPAQESLWFAHQSRPLDAGFLIAEYVDIEGELDLTTLRRAVASVARETEALRTTITDAPDGGTAGQRVHDGMALDVPLVDLSASANGEADAHRAMLQDLATPVDVTRGPVTALVLYRLSTSRHLLYLRTHHLVLDGYGAAAALGRIATTYGLLATGEEVTAEPLPLEPLVADARQYARSAEYAEDGAYWRESLAGAPHAERLTDRTGPPGTEVLRRSVALDPARWRRLREGARQGRVAWPALFVAGTAAYTHRMRGAHDLLLGMPVTGRRSRIARRTPGMTSQIVPLRLRLDPAVPVRDLLRQVTTAMRGALRHQRFPVEELRRELGLGRGDSLVGPAVNVLAFDENLRFGPATGTLHNLSLGPVEDLTLAVHPAPGGAGARVDVLANAALYDGTSAAGHLERILRLTEEFAADPDRPLSALELTGPEERDRVLALGTGPRERSRIPAPRTDAPVDGGVDGRPGPATAPTEHAGSTEHADVPEPTLPEVLARLARETPDAPAVDDGTRGLTFAELDRAVDAAASALRADGAGPGTTVAVALPRSVDTVVAPLAVLRSGAVYLPVDVTYPAERIAHLLADAAPVVLLCAPGGPVAGMAPAGTAVRSLSRSGTTAPGAPFDGPRAEDAAYLFYTSGSTGRPKGVLVEHRSISNLLAHHRRESHASAESAGGRRLRVALTASTSFDASWDPLLWMLGGHHLHIADDTTRRDPEALVAFLRAERIDVIETTPSFLGQLLAAGLTAETPTADGADGAPVHRPTVIALGGEPVGDELWQRLSSQPGLLAYNFYGPTETTVDAVTARVRGTDPVIGRPVRGARAYVLDTALRLLPYGATGELYLAGEGVARGYTGRPGPTADRFLADPFGEPGSRMYRTGDLARWHENGSLEFAGRSDTQIKIRGQRVETGEIEAALAALPGIAQAAVALHADGPAGETLAAYLVPTPDEAGDGVRRDRRRVRDALAASLPAYMVPAAYAATDRLPLTPNGKLDTAALPRATAVSTGPKSPPRTATERAVCAAVADLLGLADVGRDDDFFSLGGHSLLATGLLADLAGRTGVRLPVRALFEAPTVAGLAARVDAGRRSAGPEDPPGGRAVAERPARLPLSAAQHRLWLLEHMGEGGDRYHIPVAVRLDGDLDVPALRAAFSDLLARHESLRTVYPQDAEGPHQVVLPAGGCGVELRTAPVLPDARPEDVPAPRFELAERPPVHAVLVPTAEPAGDGPGSHLLLLTLHHIVTDGWSMGPLVHDLCAAYRARTGGHAPRWQPLPAQYADYALRQRARLGDREDPGSLAARQLAASRAALEGLPPELPLPHDRPRPERATARGGRVPVRLDAADHRALGALAREAGVSPFMVLHGVLATLLHRLGGGDDIVVGTPVAGRDEEEFHDVVGFFVNTLVLRVGVGGDPTFRELLDRVRETDLSAYGRQDLPFEQLVEALAPPRSLSRHPLFQVMLALNNTPAPRLDLPGVHAEPLRSGRTTAKFDLTWDFTETHDAHGRPDGLTGEVEYSAELFDESTVRRFAGHFVRLLRSVLRSPDARLGALGMLTEDQRLAALDTGARDDSAERGDELVHSVCDVLETQAAVTPDRTAVAEGRRTVSFGELATGLRDTARLLAAAGVRPGDRVAVALPRSARQIAAVFGVLRAGAVYVPLDPAHPAARNARILESARPALLLTERERAAALPASRTPTLYLDEAPDAAPAAEALPADGPRGADPAYVLYTSGSTGRPKGVVVEHRALANLLRHHGRHLIEPAERANNGRPLRVALTAAATFDASWDPLLWMVAGHELHLVDDASRHDPEALVRILHERRIDVLETTPSFLEQLRVCGLFAPGRPWPRVVALGGEPVHEKLWRELAELSGVSVWNLYGPTETTVDSVIAPVTAGTGPAIGHAVTGMRARVLDSRLGPTPPGVTGELYLAGAGVARGYDGATGLTADRFLADPYGPAGSRMYRTGDLVRRRPDHSLVFVGRTDSQVKVRGFRVETGEVEAALTAHPAVRRAVVTVRQAEGGGRLVAWAVPETGARPTPAGLRAFLGDRLPAYMTPSHLALVPEIPLTAHGKTDFGRLPDPAPALAEQGERPRTPQEEILCALFAECLGTDSVGRDADFFALGGHSLLATRVVNRVRSAFGAEIPVRALFEDPTPAGLARHLDGAARGRPSLHARADRPAELPLSFAQRRLWFLNRMRPDDASYNLPMAVSLCGRLDVAALHGALGDVVARHESLRTVFREAADRSGTPVQRVLSPGAARPALTVTPSTPDQVAGLLREAARAGFDLGGDLPLRAELLRTGADEHVLLLTVHHIAADGWSMGPLAQDLAAAYAARVAGRAPDWTPLPVQYADYALWQRDLLGGHDDPDSVYARQLAYWRGALADAPTETALPADRPRPDAGSGLGGSVPLPLSGSDGRRLAELARREGASTFMALHAVLAALLDRYGAGDDVVVGSPVAGRTDEALAGLVGFFVNTLALRVRTDGDPDFRALLERARETDLAAYAHQDLPFESLVEHLAPPRSPARHPLFQVMLSLNNAGRPALDLPGLHAEVRGVDTDAAKFDLSFSFSEQSGDGELTGQLEFARDLFDTATAQDLADSFVALLRLVVADPDSPLSRHDPLDASRLAGPLGHGDGPQAAPRHPTVVAGFAATAAAARSSDIAVRCGAQALSFAELARDGARLAHLLRGRGVDADRTVAVLLPRSTGSLTALLGVLAAGGAYAPLDDALPPARVAAVLSDARPAVVLATAATADRIPDGPWQTVLLDSPGTWAELAALPAEFPDGAAPGPRDPAYVVHTSGSTGRPKGVVVEHRSLAQLAEHHRRTLFDPARAATGRHRLRVALTASLSFDAAWDPVLWMLDGHELLVVDNDTRRDPAALVRAVREERVDVLETTPSHAAALLDAGLCAEGSPGHRPAVLALGGEDVPPGLWRRLREVPGLTVWNLYGPTEATVDTLYARLDRGDRPELGEPVAGTSCYVLDRLLRPAAPNTTGELYLSGASLARGYLGRPAETAARFVPDPFGPPGGRMYRTGDLVRRTADGRLEFRGRADGQVKVRGFRVEPGEIVTALEAQPGVRRAAVALRPVGSGAAHGTEQLVAYVVPGDGPGASGGPAAPDRDALRAALAAELPGYMVPAAFVVLDALPLTASGKLDAGALPAPRGEHLAHAAGRAPSGPREDLLCALFAETLDVERCWSDDDFFTLGGHSLLAARLLARVREATGVELGIRELFEAPTPAGLATALTAREAEAGTGTGPGADLACLLPLRSGGSLPPLFCVHPAGGLAWPYAGLLQHVADRPVYGLQTPNLDGTEHFPDSIEAMAAYYVDQLRTVQPHGPYRLLGWSFGGNVVQEIAVRLQEAGEEVALLSIMDAFPVPPADGLEDAGHDVVFRALLTALGVDLSAWDADAPLDAAVVRDALRESGSPLGALEPAAIETMVGNFADQARLMRRHVPRTFRGDVLFFRATEEDPASGLVPSLWDPYVDGALVVHDVPCGHAQMLRPDARAVVGPVLDAALRAT | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp05082 | P5317-28 | QETFSDLWKLLP | E3 ubiquitin-protein ligase | Cell cycle arrest or apoptosis of cells | Immunoprecipitation assay | HCT-116-p53+/+ | Colon cancer | IC50 : 4.7 µM |
| dbacp05083 | P5317-28 | QETFSDLWKLLP | E3 ubiquitin-protein ligase | Cell cycle arrest or apoptosis of cells | Immunoprecipitation assay | HCT-116-p53+/+ | Colon cancer | IC50 : 30 µM |
| dbacp05227 | Penicillin acylase family protein | MPPNNTASTGQQPGTSGRKKGRKGRLLVVVLVLAVVGGLVFGGYWSVSTVRASFPQTKGSITLDGLSGPVDVKRDGYGIPQVYASSEEDLFMAQGYVQAQDRFYEMDVRRHMTAGRLSEMFGKDQVGNDEFLRTLGWHRVAKKEYDEKLSDSAKKYLQAYAKGVNAYLKGKDGADLSLEYAALGFTNDYKPQEWTPVDSVAWLKAMAWDLRGnMQDEVDRALMTSRLGPKQIADLYPAYPYDRNKAIVQEGQYDELTQTFDGSGSSGGDSGTGTGAGTGAGSGTGAGAGTGAGSALEGQLAGLQNVLDDVPTAVGVNGNGIGSNSWVVSGEHTITGKPLLANDPHLSPSLPSVWYQMGLHCRTVSDKCRYDVAGYTFAGMPGVVVGHNQEIAWGLTNSGADVTDLYLEKITGEGYQYDGKVVPFETREETIKVAGGDSKKIVVRETNNGPLLSDRDDELVKTGKKATVETAAPDRGDGYGVALRWTALDAGTTMDAVFAIDRAQNWSEFREAATLFDVPSQNLVYADSEHIGYTLPGKLPVRAEGHDGSVPAPGWDPKFRWTGEYIDQDELPHEYDPERGYIVTANQAVVDEDSYPYTLTTDWGYGTRSQRITSLIEQKIKDGGKISTDDMRQMQLDNSSEMAKLLVPQLLKIDVADKDVREAQKLLEGWDYTQDADSAAAAYFNAVWRNVLKLAFGNKLPKELRVKGQCLWVDPVNTTGPADATNKVYECGQRDADQAQPDGGDRWFEVVRTLLDDPKSDWWSTPKYGTRKGADKNRDDLFKRAMVDARWELTAKLGKDIDSWNWGRLHRLFLKNQTLGTEGPGFLKYALNRGPWKLSGGEAAVNASGWNAAGGYGVIWVPSMRMVVNLGDLDKSRWINLTGASGHAYSAHYTDQTDKWAKGELLPWSFSEKAVDESTSDTLVLKP | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp05232 | Penicillin acylase family protein | MSAETYRDAWGIPHLRADSPEELARAQGRVTARDRAWQLEAERHRAQGTSAAFLGPEALSWDRLARRARLADTARRCFIALEEKDPETAAWVRAYVHGVNEGLALHRGGDGPGDREGPGDREGSHPLDGSPRRDDPRRPPAPEFARAALAPGRWEPWTPLAVWLATHILFAGFPAKLWREHITARLGPDAVALFAADGPGTTGSNGWLLSGERTTTGHALIAGDPHRWIEDPGVYQQVHLSCPEFDVVGLAVPGVPGVAHFGHTGTVAWAITNAMSDYQDLYHERLRRTGAGVEALGPDGTWRRAARHTETIRVAGEGTVEVEVIETDRGPVVAGGPEGLDDGTPAALSLRYPPRVTSDLGFGALLPLLRARTVADVDRALDAWAEPVNVVQAADTGGGLLHRVAGRVPVRAEANGLRPVPAWEPGHEWTGWHTPPRAGLADGAAVMANQRGLATPLGVEFAAPHRADRIAALLAGRRRWSAADLSAIHTDTHLGSAGPLLAHLTALTGLGPEATDLRDRVLAWDRRMDARSTGAAAYAAVRAAVVRRLAAHPVLAPASVAPAYPEVLQPWLALVPRVAYALEHLLRADDLYGIDRAAVVRAALEEVAARPPAGPWGDTHRLTPWRALPDPAAPADAPALSGDHDCVLCTSSVPGLTDRAARGPAARYVWDLADRGNSRWVVPHGASGTPGSSHHRDQQPLWLAGELVPVITDFDRLTLICTHTHTHTSTEETDA | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp05237 | Penicillin acylase family protein | MAAGTSPSAGTTAAEPAEAAANDHCGGQCSDILPPGQNGNATLAQILLNQAFGTQPEHAEDQLGPYANLATGYTGLTNDKINTFFNDASFGVPDGQAASTLRPAGRDDVTIVRDKKTGVPHITGTTRYGTEFGAGYAAAQDRLWLMDLFRHVGRGQLTPFAGGAPANQGLEQQFWRSAPYTEADLEAQIESAAAKAGERGDLALADVDAYLAGVNAYIDASDRGRYFPGEYVLTGHKDAITNAGTIERFQRADLIALASVIGSLFGAGGGGEVDNALSLLAAQEKYGVAEGTEVWESFRQRNDPEAVLTQQDGSFPYLPTPDDPQGRALPDAGSAEAEPLVYDRTGSAAGASATGASTTAAQSATASARRGMSNALVVSGEHTASGHPVAVFGPQTGYFAPQLLMLQELQGPGISARGASFAGLSMYVELGRGQDYAWSATTSGQDIIDTYAVELCQDDYHYLHRGTCTPMEKVERHNAWKPTVADSTAAGSYTMRVWRTAYGPVEYRATVGGKKVAYTTLRSSYLHEADSIIGFQMLNDPDYLDGPERFKGAVQHINYTFNWFYADSEHTAYYNSGDNPVRADGVDAEFPVWARQAYEWRDWDPAANTARYTGASAHPQSADQDYYISWNNKQAEDYPAASWGNGSVHRGNLLDDRVKKLVADGGVTRTALVGAMAEAALADLRAEDVVPGLLKVVESAPVTDPAAKTAVDGLKAWLSAGGLRTETSAGSGKYAHADAIRTLDAWWPLLVKAEFEPGLGTGLYTAFTRNLPVDESPSAAHGPTGAHAGSAFQYGWWSYVDKDIRAVLGQNVKGPLAHPYCGDGDLAACRDTLVTTLKEAAGRTAGQVYPGDENCSAGDQWCADSVIHRTLGGIKHGGIGWQNRPTYQQVVEFTSHR | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp05317 | Peptide 5 | fCYwO-CyLeu-Pen-TKKrPKPfQwFwL-CyLeu-KKLMYPTYLKKfQWAV-Aib-HL | Synthetic peptide of four designed analogs of vasoactive intestinal peptide, bombesin | Not specified | MTT/MTS assay | PTC | Colon cancer | 16.5 % inhibition of cell proliferation at 1 nM |
| dbacp05318 | Peptide 5 | fCYwO-CyLeu-Pen-TKKrPKPfQwFwL-CyLeu-KKLMYPTYLKKfQWAV-Aib-HL | Synthetic peptide of four designed analogs of vasoactive intestinal peptide, bombesin | Not specified | MTT/MTS assay | PTC | Colon cancer | 14.2 % inhibition of cell proliferation at 10 nM |
| dbacp05319 | Peptide 5 | fCYwO-CyLeu-Pen-TKKrPKPfQwFwL-CyLeu-KKLMYPTYLKKfQWAV-Aib-HL | Synthetic peptide of four designed analogs of vasoactive intestinal peptide, bombesin | Not specified | MTT/MTS assay | PTC | Colon cancer | 16.8 % inhibition of cell proliferation at 100 nM |
| dbacp05320 | Peptide 5 | fCYwO-CyLeu-Pen-TKKrPKPfQwFwL-CyLeu-KKLMYPTYLKKfQWAV-Aib-HL | Synthetic peptide of four designed analogs of vasoactive intestinal peptide, bombesin | Not specified | MTT/MTS assay | PTC | Colon cancer | 21.7 % inhibition of cell proliferation at 1 µM |
| dbacp05321 | Peptide 5 | fCYwO-CyLeu-Pen-TKKrPKPfQwFwL-CyLeu-KKLMYPTYLKKfQWAV-Aib-HL | Synthetic peptide of four designed analogs of vasoactive intestinal peptide, bombesin | Not specified | MTT/MTS assay | PTC | Colon cancer | 27.9 % inhibition of cell proliferation at 10 µM |
| dbacp05329 | Peptide 5 | fCYwO-CyLeu-Pen-TKKrPKPfQwFwL-CyLeu-KKLMYPTYLKKfQWAV-Aib-HL | Synthetic peptide of four designed analogs of vasoactive intestinal peptide, bombesin | Not specified | MTT/MTS assay | PTC | Colon cancer | ED50 : >10 µM |
| dbacp05332 | Peptide ABC transporter permease | MPGRITPRRPGPHRRSGRPRATALGAALATVLVPALSACGGDAASASGDATLKWTSTYFPAHWDPVVGGSGAQFRELSLVYASLTRTDESGKAVPDLAESWEYNDEGDRITFHLRPGLKFSDGEPVDGAAVKAAVERAQKQKNSALFGDLTSIESVDAKGLDATVNLNQVDYQIPQLLGQRVLQIASPKAAAAPEKLDQNPVGAGPFTVTQIVPGTKAVLKKNPEYWDADNIHIDNVELTSAPDASTVVSGLQTGVYNFADIAPSQADAAKKAGLDVFVQPGFNASNISLNVNKAPFDNDKVVDAVRHAVNRQEFVDKLTFGYGEATNQPFPKGYVAYDPESEDAYPYDPAKSKKLLAEAGYRSGDIKLDLVIPEEDPQAEIVQSQLAAVGITVDIRIDKNWSTPFFAKDLTFSLYGTTGRDSAAQTLTAHFGPDGPLNLSTPYEPEGFESAIAKVRQTPLDAPEYPQVLQEATRAGLDSKALVFTYSQPNLIAKSKSVSGLPKNPAHLDWTGVTIGGKGAAS | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp05337 | Peptide ABC transporter substrate-binding protein | MKSSVSSTRRAAPGRPRAVGAMLLAGLVFVSSGCAVAGSAGGDAGRADGRTLRVVLTQEPPTLEPCEASLTGTGVVVRSNITEPLVERDPASGELDPLLATGWKQTAPRTWTFDIRSGVTFHNGAPLTAEDAAFSIDRAVNSDLACNVEGYVFGNDDLDVEAVDDHRLTVTTEEPDPILPLRISFVEIVPRTTDTEAKVRVPVGTGPYAVGSWKAGAAISLDRYDGYWGEAPDFARARYVWRSDASVRAAMIDKGEAEIAVALDPTEAGKDTTAAYPNNETTALRLDGREAPLDDLRVRRAVDLAVDREGIVDALLGGLAEPAGQLVPPGVVGHNDEISPTRQNVTEARALVERAAADGVPTGRQITLVARNGMFSGVSETAEALQYQMQQIGLNVKVRMADTATHLQYQLRPLPEDVGPIALLIMHGNQAGDAGFTTSQYLLGDGPQSTFGTEALDRRITEAGALSGEKRQRAFAGLLAEQNEDVVQYAHIAHMSGLLGLSRSIRYEPNSATGDELRLSEVHPAKGAKD | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp05342 | Peptide ABC transporter substrate-binding protein | MSPARTAARRRRALAVGACAAVGVLLSGCAGGVSAPSGSKNEINYALPANFTPNWIVPIGTPGHLNTNNASISQSLWEPLIAYDGSTGEIGWNKDNSLATEAEFAADNKSVTVTLGDRHWSDGEPVTARDVEFWFNLVRENKKSWASYSPGKAPDVWTSFRTLDDRHFTLDFDRAYNRQWMLANELSMIRVMPQHAWDRTSDSGDVSDLDRTPDGAKKVWTYLIDAGKKISRYASDPLWKTVSGPYRLKSFSTSGRVELVENEKYDGGGAAHVKQVNLLSFTTVAAEENALRAGTVDYGYIRASDLGIKKSFTDLGYHVERWSGWAVTYMPYNFNNPEMGAVFRQPYARQAVQMSVDQKTLAKVLYNGTAVPTYGPVPQGQASAFLSGEQKAEPYPFSNSRARALLTDHGWSERDGTMVCTSPGEGAGHCGEGVEEGTEFRMRVLYQSGSTETDnMMSALQSSFEETGIDFDIKTAPVNSVLSQTGQCEEDDPACDWQLSFFGSAGSWYFPAYPSGDALFASGGGSNFGNYSNPEVDELIDRTTTSSSPDAMLDYSKALAEDLPVIWLPEPDYQVSVIRDGLGGFAQDSLANFHPAMWAWTE | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp05347 | Peptide ABC transporter substrate-binding protein | MKILISADMEGATGVTWPADVLPGTPQWERCRSMFTSDVNAAVQGFLDGGADEVLVNEAHWSMRNLLLERLDERTQMLTGRHKALSMVEGVQHGDVDGIAFVGYHAGAGMEGVLAHTYLANQLTGVWLNDVRASEGLLNAHVVAEYGVPVVLVTGDDVACEDALGYAPEARKVAVKDHVSRYAAVCRTPARTAADIRAAAKEATPLAVRHEPVTGGPFTVAMEFDAEHLAAASTVVPGVAQVGERKVAYTHDTMFEAIRTFKAVTTIASAAVEEQYG | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp05352 | Peptide chain release factor 1 | MFEAVEELVAEHADLEKKLADPSVFADQANARRLNKRYAELTPIVATFRSWKQTGDDIGTARELAADDPDFAAEVKELDKQRDELTEKLRMLLVPRDPSDDKDVILEIKAGAGGDESALFAGDLLRMYLRYAERVGWKTEIIDSTESELGGYKDVQVAVKTKGGQGATEPGHGVWARLKYEGGVHRVQRVPATESQGRIHTSAAGVLVTPEAEEIDVEINPNDLRIDVYRSSGPGGQSVNTTDSAVRITHIPTGVVASCQNEKSQLQNKEQAMRILRSRLLAAAQEEAEKEAADARRSQVRTVDRSEKIRTYNFPENRISDHRVGFKAYNLDQVLDGDLDSVIQACVDADSAAKLAAA | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp05357 | Peptide chain release factor 1 | MDLAFLHPLYEHQGPWASVYLDLSRHTEDTPHERELTAAAVARELAEQGADDATCEAVREAVDGLRHASDPHGRALFARAGEVVLDPRLARPPYGGTTADWAPLPHVAPLLDLAGEDPVCVVAYVDRKGADFELRSALGSSDAGGVTGRQWPVHRTSSADWSERHFQLRVENTWEHNAAEIADALAVCQEETGADLLILVGDDRERRSVHERLPKRLQGRVAEASRGAGSRLLDDEVERLRADHVRSRAREDLDRFLAARSPDDEGRAGAAEGVPALVEAAREHRIDELLVIPDAPDTHREVWIGEDADQLAVRRTELKTLGEQNSWSARADDALLRSAVMTGAPAISVTPVLPPETAGKAPVGGLGALLRWK | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp05362 | Peptide chain release factor 2 | MAVVDVSEELKSLSSTMESIEAVLDLERMRADIAVLEEQAAAPSLWDDPEAAQKITSKLSHLQAEVRKAEALRGRIDDLGVLFEMAEEEDDPDTRAEAESELAAVRKALDEMEVRTLLSGEYDAREALVNIRAEAGGVDAADFAEKLQRMYLRWAEQRGYKTEIYETSYAEEAGIKSTTFAVQSPYAYGTLSVEQGTHRLVRISPFDNQGRRQTSFAGVEVLPVVEQTDHIEIDESELRVDVYRSSGPGGQGVNTTDSAVRLTHIPTGIVVSCQNERSQIQNKATAMNVLQAKLLERRRQEEQAKMDALKGDGGNSWGNQMRSYVLHPYQMVKDLRTEHEVGNPESVFNGEIDGFLEAGIRWRKQREK | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp05367 | peptide chain release factor N(5)-glutamine methyltransferase (EC 2.1.1.297) | MPSSPPGPATPAGTPSGDVLARAVATLRGAGCVFAEEEARLLLDAAPAPADLERLVGRRVDGEPLEVVLGWAEFCGLRVRVEAGVFVPRQRTRFLVDAAAELAGRPGAVVVDLCCGTGAIGAAVAARVPGIELSCADVDPAAVRCARLNVGPDARVYEGDLYDALPDALRGRVDVLVVNAPYVPTDEIAMMPPEARDHEPRHALDGGGDGVEVHRRVAAGAPAWLAPGGTLLIETSEEQAPLTARAMKDHGLVPRVSTNDEMYSTIVAGTRAVR | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp05378 | Peptide deformylase | MRHGSIPGAHGRVRPLALLGDPVLHAPCAEVTDFGPELAALVEDLFATMYASRGVGLAANQVGEGVRVFVYDCPDDEDERHLGHVVNPRPVEAGGVVVRGPEGCLSLPGLEAGVERYDEAVVTGVTVTGEPVTVRGTGFFARCLQHECDHLAGRVYPERLSGLRHRRLMRKAARAPWSR | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp05383 | Peptide deformylase | MPSVFVQGRPTASYPPFAPEARRGSVRRVTEVGEEVLHRPCRDVTEFGPDLAALIDDMFRTMYVAEGAGLAANQVGLGLRLFVYDCPDDEGVRHVGHIVNPVLDALAPAARRLLDEGEGCLSVPGAVMAVPRPDRAVVRGLDKDGAPLLVEGTGYFARCLAHETDHVNGHVYLDRLSARERKTALRQSADRREEVFARRSANAAAFA | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp05388 | Peptide deformylase | MAQQDTDQQHTGVLPVDDEGFVVDTEECEQREADWRGRGTSRPITVVGNPVLHKECEDVTDFGEEFQQLVADMFASQRTAEGVGLAANQIGVSKKVFVYDCPDDDGVRHVGVVCNPRLVELPADRRRLDDSNEGCLSVPTAYAALARPDFAEVTGQDEKGNAVRVRGTGYFARCLQHETDHLYGYLYIDRLSKRERKDALRQMAENEPRYPVVAND | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp05393 | Peptide deformylase | MGTPSDRAPLAERVEELLALGGPLPIVAAGEPVLRRAAEPFDGQLAPALLARFVEALRLTMHAAPGVGLAAPQVGVGLRIAVIEDPAPVPEEVRAARGRVPQPFRVLVNPSYEPVGAARAAFFEGCLSVPGWQAVVARHAEVRLRARDEHGRAVDEVFTGWPARIVQHETDHLDGTLYLDRAELRSLASNASMADLWSQPTPERAASALGFELPGRPGPSGSPGLPGSAS | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp05423 | Peptide methionine sulfoxide reductase MsrA | MAAQTQRAVLAGGCFWGMEELIRRLPGVTATRVGYTGGDVPNATYRNHGTHAEAIEILYDPEVTDYRAILEFFFQIHDPSTENRQGNDIGLSYRSAIYYVDDEQKRIAEDTIADVDASGLWPGKVVTEVEPAGPFWEAEPEHQDYLQRYPNGYTCHFPRPGWRLPVRTEG | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp05429 | Peptide transporter permease SapC | MKLTTAVLAAGAAVSLTTAVVGATRLRQNARHQAERNEAFLTRNQLDWLAQMSTNPDLAKLWAPEDMDVEEYMQLLAANRLICILSVRDRLGFVRTGHLPWHAAKLMENDACRRYWQRFGDLRAEEAEGDEQGEHFTRVLDQAAKQHPRAQAAAT | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp05448 | Peptide-binding protein | MAWSEGGFGRLGAAVWSADPWYGGSRSAHVFNRKRRLRRVVAIVSLSSLATGCGLLSPDDPEDDGPIVVGTTSAPSTLDPAASWDGSWELFRNVYQTLLSYPDGATAPEPDAAEQCAFTDSANQVYRCELREGLTFSNGHSLDALAVKHSIDRIKEIDVNGGPAGLLGSLERVQAPSAREVVFHLDKPDATFPFVLATPAMSIVDPSGYPADALREDGEAVGSGPYTLRSYEDGVRAELVRNDRYQGFAERRNNAVTVRYFKDSAGMVEALRDDDIQVTYRGLAADDVIGLQAKDAGDEALRLVEGSGTEISYLVFNPEDPWAGRREVRRAVAQIVDRATLAHEVYQDTVDPLYSMVPKGLTGHTTGFFDDYGDPSVPKARKLLTEAGITERVPLTLWYTSDRYGSETATGFKEIKRQLDASGLFEITLESRPWKTYVTGYQKGEYPVFGRGWSPDFPDAENFIAPFVGEQNALGTPYPAPEITGELLPRSRRESDRADVEREFERAQQIIVDDARLLPLWQGKQYVAVSTEISGVEQAMDPSTIMMVWQLSRKTGW | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp05453 | Peptide-binding protein | MNRKTLVLPAVVGLLAPVLAACGGSDGGSGGGDAIAVGTTDRFTITKDVPAPFDPAYAYDIGAWNIMRHTAQTLMTQPRGDGEPVPEAAQQCGFTDTGNERYACTLRDGLKFSNGDDLTAEDVKYSIDRAVSLEADTEVGKVLLSTVDTVETKGDREVVFHLKTADATFPYKLSTPVASILNKEQYAKDKFRDGFDLDGSGPYEMKSESKNGVLSKIVFTKNPTYKGSVKVNNDKVELVSFEDAESMGNALDKGDIDVMTRAMAPEQVKKLSDSSQGAVKLVEVSGLEIRYLGFNVDAASVEDKAVRQAMAQVINRAELVSRVYGSQAEPLYSMVPAGITGHSNSFFNKYGDPSVAKAKQTLKSAGIDSPIELTLHYTTDHYGAATKLEFEELQRQLNASGLFDIKLDGKPWDIFRPAERRLEYDVFGMGWFPDFPDADSFIAPFLDEDNTLKSPYLNQKIIKDLIPESRSEADRLSAADSLTEIQDITAADVPLIPLWQGKQYVAARDDVTGAAYLLNSSSTLQLWELGRGVSG | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp05458 | Peptide-methionine (R)-S-oxide reductase | MSYDVEKPDEQWRKELAPAEYAVLREAATEPAFTGEYTDTKTEGVYSCRACGAELFTSTTKFESHCGWPSFFDPKDTDAVELIEDRSHGMVRTEVRCARCGSHLGHVFKGEGYPTPTDQRYCINSISLRLEPERG | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp05475 | Peptidyl-prolyl | MAEQLYATLKTNHGDIEVRLLPNHAPKTVRNFVELARGEREWTNPETGEKTTDRLYDGTVFHRVISGFMIQGGDPLGNGTGGPGYQFEDEFHPDLSFNKPYLLAMANAGPGTNGSQFFVTVSPTTWLNRKHTIFGEVAGEAGQKVVDAIAALPTNPRTDRPVNDVVIESVTVETRQG | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7µM |
| dbacp05480 | Peptidyl-prolyl cis-trans isomerase (PPIase) (EC 5.2.1.8) | MSNSKVYFDIDIDGQDAGRIVFELFEDVTPRTAKNFIELSTGEHGFGYAGSSFHRVIPQFMLQGGDFTAGNGTGGKSIYGAKFEDENFKLKHTEPYLLSMANAGPNTNGSQFFITTVVTSWLDGKHVVFGKVVEGTEVVDKIEGYGSSPQGTTSAKITVRASGKL | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp05493 | Phenyloxazoline synthase Mycobactin synthetase protein B | MNIPELLARYADEGVVLWAQDGQLRFRAPQGRLTDTHRAELRTHKQDILRHLEAGRPALRPDPDSRHEPFPLTDIQAAYLIGRTDAYAYGGVGCHAYVELDHPELDVERVTAVWRELVERHDMLRAVVHHDGYQQVLADVPDLHVACDDLTGLPAADAEAELARTRARLSARETPTDQWPLFDVHVSRTAGRAVLHLSFDMLVVDHASLRILLAEFRHRYGGGVLSAAPRITFRDYVLARRAQTGIDGHARDRAYWTERLDTLPPAPELPLAEPWEAAVSASTGTRGAPTDAVTFRRLEVPLSAADRERLTERAARRGLTVSTALLTAYAETVGRWSRTSRFTLNVPTVDRPDLHEDIGRLVGDFTSLELLAVDLDTPAAFAERTGALGQQLLEDLAHPLFTGSEVLAELSRRAGAPVLMPVVFTSALGTGGTAEGVPPEVAHAATRTPQVWLDCQVMHRGDALILSWDVREGALAHGVAEDMFGAWTSLVRLLSAEGEEGDAAWDAPVDIPLPAAQRDRRAAANATGGPLPDALLHEPLLDRARTTPDAIAVRTPETALTYRQLADRAGGVAETLTASGLRPGEPVAVWTDKGWEQVVAVLGTLMAGGAYLPVDTAQPPARRDTILADAGVRTVLTQSWLAETDDLPATVSAVAVDLVPAAPATREPRTAPRRDPDDLAYVIYTSGSTGTPKGVMISHRAALNTVQDINRRYAVTDRDRVLGIAGLGFDLSVYDLFGPLAVGATLVLPRADRRGDPSHWAELVRDFGVTVWNSVPGQLHMLCDWLRSEPPADDGTLRLALISGDWIPVALPDQARALLPGLEIISLGGATEGSIWSIAHPIGEVDTDRPSIPYGTPLTNQTFAVLDRHLRPRPEWVPGELFIGGAGVALGYLGDEARTAERFLTDPRTGQRLYRTGDLGRYLPDGTIEFLGREDAQIKIRGYRVELAEVEAAVQAHPAVAAGAVVVDDSAAGGRRLAAFVETARRDGDRRAAPGARQAREAAADAVREASAAVDGARLADFLAALDEVALDGMTRVLAGSAVFEDGAARTADEVGTALRATPRHRHIVRRWLRALAARDRLTHRDTDDTYSGLVAVSGPDTERRWRLAADLEHEVGWSSELLTVMRTCAERLPELVAGDVGIRDLLFPGAATDAADAAYRDNLAIRHLNRAVVAALREIAASHTGEERLRILEVGGGVGGTTGELVPVLAEYGVDYLFTDPSAFFLNEARERFADHTWVRYQRFDVDQDLRGQHLPPNTFDVVVCANTLHAAADADAAVGRLRELLVPGGQLVFVENTRDENLPLLVSMEFLEVAGRPWTDVREHTGQSFLTHPQWRELLGRHTASDVTSLPEGQDALARTGQEVFLATMKDDRHHVPTGELARTAATRLPEYMLPAVWQVVDTLPRTANGKTDRARLVDWLPRESAPVVVDERPRDELENSLADLWSELLAVEGVTRNDDFFDLGGDSLLVARMVGRLRERVPRAADLEWEVVLRHMLRRPTVAGLAGFLRSLADPKDAPAPGAVRTDPVIHLHGARSDDEPTTVLVHAGTATIMPYRALITEIRRRSPGLAEVVGVEVPDLNGFLAAPPQGLIEQLAADYARALTADGRSRFHVVGYCLGGLIATEVARNLAESGAEVESLTVISSHSPRFRLDDELLAEYSFAVMMGIDPAELGFPDDQYRVAAAADAVLASSPGILPDGGLAALPEEFEDVAGRFRSLAEVPRATRIARMCEAVPASAGSYEPDHMSRLFLAFRQSVFAITRYTAEPYAGDITFLRHDGAYPFPGSKDAVTTYWEELTLGDLDIVDIGGDHYSCLSVEHAPGILKTLGELTRGAITR | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp05498 | Phenyloxazoline synthase mycobactin synthetase protein B | MSDEAVVEARTAEGDAGRRGPHTAPAVRDAVARALDLAPQELDDDRDLFELGLDSLLLMSLVGAWRREGSTVTFQDLTRVPTLAAWTALLARAPHGDAPAAARPAPVPRQADRSVPRQADRATERSAPQQAERSAPRRSVRQADRQQNRQADGAAEPFPLATMQHAYWIGRQDGQPLGGVAAHFYVELDGREVDPARLDAALRALVHRHGMLRAVFDEEGRQRYGATGAPLTVHDLRARTPEEADSALESLRERNTHARGDVAGGEVFRAALCLLPDGRTRLQIDLDMMAGDALSLRVLLSDLRRFYACPDDPPPVLGLDYRRYLAEHDARRRAERERDAVWWRERLHELPRGPRLPTTVDPLTPVGAGDTALTRSRRLHHWLGPDDKAALIKAAGRHGLTPAAALATAFAETVAAWSDSRRFLLNLPLFDREMFSPEVAHLVGDFSSSVLLDADLGAPLPFARQARRLQERLQEGISHGAYGGVEVLRDLARAEGAPVLAPVVYTSAIGLGEIFEQDVQKSFGRPSWIISQGPQVYLDAQVTELDGGLLLNWDVRDGVFEAGVPDAAFDAYRRLITCLRTDPDAWDRPVDGLLAPGVLARRAVAALPPAPVPHRALHTRFFELAETEPDRTAVVRTTGAPLTYGQLADTARRIAALLGDHGVGEGDTVAVTLPKGDGQIGAVLGILAAGAAYAPVGVEQPAVRRRRIHSVAGAAAVLTDRAHADLCADAAAPAPVLLVEDAPAAGPAPVVLPDPGLPAYVLFTSGSTGEPKGVEVPHRAVVNTVEAMAEQLGLGPDDRTLAISALDFDLATWDIFAPLSLGGQVVAVGQEHRRDAHHWAELVRTHGVTLVQCVPALLDLLMAAGEDAAGGEGLGTSPRMVLLGGDWVGLDQPARLRALVPGCRFVALGGMTEAAVHSTVFEVTETDPAWKSVPYGVPLRnMRARVVDGRGRDCPDMVPGELWIGGPGVASGYRADPARTAERFVEYDGERWYRSGDLARYRPDGVLEFLGRADHQVKIGGHRIELGEVESALESDPAVRHAVATVLDTPVRRLAAAVSSRDGAAPEPDAVRDRAAERLPAHMVPERVLVLDALPLTENGKLDRAAVRRALTEAAGHATARASAPEGPVETAVAAEWSDLLAVDRVGRESSFFLLGGDSLVATRMIGRLRAAGFPDARVADLFARPVLRHFCETLRAGTADGREQEPPAPALVPDPDHAHEPFPLTDVQAAYHTGRDPRFALGGVGTWHYTEFDGTDVDLDRLERAWNTLVRRHGMLRAVVEDGHQRVLPDVPPVRIPVREATAADAPEALAELRARLSQQVRDPARWPLFAVEAVRHPDDGDGHGDGDGTVRTRVGVGLDYLVLDALSITTLYAELNALYADPDHQLPPVDVTFRDYLTRLPADPASVDRARAHWQARLAELPPPPALPYDRDPATLDAPVFTRRRLTLSAEDWQAVKRRAARHGLTPSTVLLALYGEILAAWSGTDAVTVTLTLFNRRDVHPHIHRVLGDFTSLSLAGHRREGASWLAAALALQHRQAEDLDHADVPIDWLLREFGRRTGTVDAAAPVVFTSAVGVGDATLARAGTGLPEKVWGISQSPQVCLDNQVTEESGGLVVTWDAVEELFAEGVLDAMFDAHARLLRHLVTGDWEAPLPDPLPAAQHDRRAAVASGAALEPVAPRLLHEAFFAHAAGRADRTALVTTAGEELSYGALAERALRTAAALADAGVGPGDLVAVTLPKGPDQIAAVLGVVAAGAAYVPLGLEQPAARLARVRAAARFRVVVGEWPDTGDGTAPRALSFARTQRSEPWRSPRETSPEALAYVIFTSGSTGRPKGVEISHAAAWNTVADISARHGIGAGDRVLALSALDFDLSVYDLFGLLAAGGSLLLPTEDQRREPARWPDLVDRYGVTVWNTVPALLDLLLDADEQGTGGLRGLRTALVSGDWIGLDLPGRLRARTARPCAFVAMGGATEAAIWSNTLTVTDVDPRWASIPYGRPLTGQHYRVVDRDGRDCPDWAPGELWIGGAGLARGYLAEPERTAEKFVVRDGRRWYRTGDLGRFRGDGLLEFLGRLDTQLKIAGHRVEAGEIEAALEAHPAVARAAVVAVGERTAKRLVAFAVPLATPATATEPPTADDLLGHLADRVPAYAVPSRIALLPALPLTANGKVDRKALTDTAGPAPVPAGAEPPRGGTETALAELWREHLPEPVRDRNANFFTLGGGSLAALRLLTAIERRLGAAVPVRRFFAAPTVAALAADITRTLAAHGTAYETGEL | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp05551 | Phylloseptin-PHa | FLSLIPAAISAVSALANHF | Northern orange-legged leaf frog | Disruption of the membrane | MTT assay, Lactate dehydrogenase (LDH) assay | HCT116 | Human colon cancer | LD50 : < 5 µM |
| dbacp05599 | Polysaccharide deacetylase | MSSEGFGLPKESWRWPETAWRGHVDAVRAGRRLVPDRWPGGARVAVALSFDSDHETIPLRDGETSPGRLAQGEYGARAGAPRILRLLERYGVPATFFMPAVSALLHPEEARAYTRDGHELAVHGWIHERnMLLDREEERELTARALDTLTTVTGQRPVGIRTPSWDFSDSTLDIMLELGFAYDSSLMADDEPYEIVAGGRSTGLVEIPVDWIRDDAPYFTMDRYGSVRPHSRPRGVGEIWRDEFDAAYHDGGVFQLTLHPHVIGHRSRLVVLRELLDHIASHQDVWFATHAQLADAARSMLPASGPDRP | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp05604 | Polysaccharide deacetylase | MITLVRRAAALCVLGAALTACGTTAAEVAPRPAPSAPAPSSSASRTPTPTLAPGPGGLTPVFEHGPRTDGTNHGEQDGTRDGKLIALTFDADMTADQGPRAASGERFDNPQLIAALRELKVPATVFMTGRWAEEYPDEARSIGRDRKFEIANHSYSHYAYTDDCYGLPTVAEDDMRADLERAYTAFEKAGVPNPMPYFRFPGGCYDKAALKELSATGVTAVQWDVVSGDAFATDADAVTRQVLDGARPGSVVVMHCTRSAAPVTEEVVRAVVPELRSRGYRFVKVSDLVGAANGRA | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp05609 | Polysaccharide deacetylase family protein | MPVLMYHAVAAGPNDATRALSVTPQAFAEQMAAVADRGRTPIGTAELAAAWRSGRPLPRRPVLITFDDGYAGVHRHALPVLARHGFPATLFVSTGWLRGPHDTGGAPDTMLDWAQVRELAAAGVEIGGHSHTHPQLDQVGEERLRHELIHSKEIVADQLGVVPASFAYPYGYSDRRVRRAVRETGYAQALAVGNGLARRAQGPYALRRVTVRRSTGTEEFARLVEGRAIARTFALDRALTKGYAVLRRTRQARRKVLGAGA | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp05614 | Polysaccharide deacetylase family protein | MYHSVGDRSDDPYRITVTPDRLEAQLRWLRRRGLRGVPVAELLAARAGGDGGDLVGLTFDDGYADFVEHALPCLRRWGCGATLFVLPGRLAGDNAWDPLGPRKPLLSADGIRHAAAEGVEIGSHGLTHVDLTTADDAVLTAETAGSRALLAELTGTPVTGFCYPYGTVDARAADAVRAAGYTYACAIDPGPLTGPYALPRVHVGQRDTSVRLLLKTRLHRLRRRASAGV | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp05619 | Polysaccharide deacetylase family protein | MDDPPAWIAEFTVTPKEFAAHLDAIVGSGRTPVTIGVLADHLAGRAPLPPRPVLLTFDDGFADLPGPTAEALAERSLPATAYLTTGAIVPGGRSLLPPAPMMTLAAVAGLERSGMEIGSHTVTHAQLDTLPGTDLAYELRTSKAVLEDALGHPVRHLAYPHGYNSAKVRSWSARAGYETATAVRHALSSERDERYRIARLIVRRGHTVADVESWLAGGGVRTAPYRDGPKTVAWRWYRRGRAMVRGPEFAG | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp05624 | PPL-C | VSVSHFQKVWVV | Not found | Not specified | Not specified | CT26 | Colon cancer | MIC : 11 mg/kg |
| dbacp05628 | Prepilin peptidase | MGPGLGVDLDLLVVLVAALWGAGAGALLPRAVYRFAAPSGEAWRERCPGEHPVRGWLGRARCAQCTGERQAYGPGAGLLAAVTAVVCVALAGATGARPEVAVWLLLAPVGVLLAAVDLRVRRLPDPLTLPLAGAALVLLGLTALVPEHAGEWTTALLGSLALGAGYLVLFLINPAGMGFGDVKLALGAGAVLGWYGWPTLILGTFAGFLLGAFYGGVLLVTRRAGRKTAIPFGPFLIAGAFLGLLVGAFTA | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp05635 | Proline iminopeptidase | MGLYPEIEPYDHGMLDVGDGNHVYWETCGNPHGKPAVVLHGGPGSRATPGHRRYFDPAAYRIVLLDQRGAGRSRPRASAHDTDMGVNTTAHLMADLERLRAHLGIERWLVWGVSFGSFLGLRYAQTHPGVVTELVLTGVATGSNREVDLLTRGLGKLFPEAYEQLLAGLPPDEREGNHAAAYHRLLESPDAAVRERAARAWTDWETATIPAPPRSVARYEDPAFRLGFARTVTHYWGNDHFLGDGNDEGVVLRDAPLLKGVPGTLVQGSLDFGNLLGTVWRLHHAWPDSELVLVDEAGHDAGAVGDEVLVAATDRYARGAA | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp05640 | Proteasome accessory factor PafA2 | MGIETEYGISVPGHPNANAMLTSSQIVNAYAAAMHRARRARWDFEEENPLRDARGFDLARETADSSQLTDEDIGLANVILTNGARLYVDHAHPEYSAPEVTNPRDAVLWDKAGERIMAEAAERAAQLPGAQPIHLYKNNTDNKGASYGTHENYLMKRETAFSDIVRHLTPFFVSRQVFTGAGRVGIGQDGHEHGFQLSQRADYFEVEVGLETTLKRPIINTRDEPHADAEKWRRLHVIIGDANLSEISTYLKLGTTALVLSMIEDGFIAVDLAVDQPVRTLHQVSHDPSLKHLVTLRSGRTLTAVQLQMEYYELARKYVEERYGADADDQTKDVLGRWEDTLNRLENDPMSLAGELDWVAKRELMEGYRRRDNLDWDAPRLHLVDLQYADVRPTKGLYNRLVDRGRIKRLLDENEVERARTKPPEDTRAYFRGRCLEQYADDVAAASWDSVIFDLPGRDSLQRVPTLEPLRGTRNHVKELLDRCRTADDLVRVLSGG | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp05645 | Proteasome subunit beta | MEANTRSTGRLPAAFLTPGSSSFMDFLGEHQPEILPGNRQLPPVQGAIEAPHGTTIVAVTFPGGVVLAGDRRATMGnMIAQRDVEKVFPADEYSAVGIAGTAGLAVEMVKLFQLELEHFEKVEGAQLSLEGKANRLSTMIRSNLGMAMQGLAVVPLFAGYDVDRGRGRIFSYDVTGGRSEELNFATTGSGSIFARGAMKKLFHDELTEEQATTLVVQALYDAADDDSATGGPDVARRIYPIITVITEDGFRRLGEDECSALARSVLERRLEQPDGPRAALL | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp05655 | Protein GPR15LG | MRLLALSGLLCMLLLCFCIFSSEGRRHPAKSLKLRRCCHLSPRSKLTTWKGNHTRPCRLCRNKLPVKSWVVPGALPQI | Mouse | Not specified | Not specified | Not found | Colon cancer | Not found |
| dbacp05656 | Protein GPR15LG | MRFLALTSLLCILLLCLSFFSAEGRRHPRNPAKPGKIRICCPRLPGPDLMPQKGHHMRICRPCKFKQKPQLWVVPGALPQV | Pig | Not specified | Not specified | Not found | Colon cancer | Not found |
| dbacp05761 | PUMA BH3 | LRRMADDLN | BH3-only, Direct activators (PUMA, Bid) | Inducing apoptosis | Not specified | MDA-MB-231 | Colon cancer | Not found |
| dbacp05762 | PUMA BH4 | LRRMADDLN | BH3-only, Direct activators (PUMA, Bid) | Inducing apoptosis | Not specified | HCT116p53–/– | Colon cancer | Not found |
| dbacp05763 | PUMA BH5 | LRRMADDLN | BH3-only, Direct activators (PUMA, Bid) | Inducing apoptosis | Not specified | HCT116p53+/+ | Colon cancer | Not found |
| dbacp05764 | PUMA BH6 | LRRMADDLN | BH3-only, Direct activators (PUMA, Bid) | Inducing apoptosis | Not specified | GLC-82 | Colon cancer | Not found |
| dbacp05765 | PUMA BH7 | LRRMADDLN | BH3-only, Direct activators (PUMA, Bid) | Inducing apoptosis | Not specified | SGC-7901 | Colon cancer | Not found |
| dbacp05766 | PUMA BH8 | LRRMADDLN | BH3-only, Direct activators (PUMA, Bid) | Inducing apoptosis | Not specified | HEK293 | Colon cancer | Not found |
| dbacp05767 | PUMA BH9 | LRRMADDLN | BH3-only, Direct activators (PUMA, Bid) | Inducing apoptosis | Not specified | 2BS | Colon cancer | Not found |
| dbacp05770 | Putative ATP-grasp-modified RiPP | MFAHSDRLPSGTPLPNGISTPTPWGLRRMAPYPALAPSYARVELDPATQTGRYFDASGAVLEMPGHGTSTGTRPATNTGNSSDGAGPGGNGGGDQDSGNDTDQ | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp05930 | Release factor glutamine methyltransferase | MNLLLAEVAQAAQRLADAGVPSPRTDAEELAAHLHGVKRGELHAVPDADFDARYWEVVARREAREPLQHITGRAYFRYLELQVGPGVFVPRPETESVVGWAIDAVRAMDVVEPCIVDLCSGSGAIALALAQEVPRSRVHAVELSEDALVWTRKnMEGSRVDLRQGDALTAFPDLDGQVDLVVSNPPYIPLTEWEYVAPEARDHDPQLALFSGEDGLDLIRGLERTAHRLLRPGGVVVVEHADTQGGQVPWIFADERGWADAADHPDLNNRPRFATARKALP | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp05936 | Retro | LGGIVSAVKKIVDFLG | Amphibian skin secretions | Penetration and disruption of the membranes | Sulforhodamine B assay | Colon tumor cell line | Colon cancer | IC50 : >10 µM |
| dbacp05977 | rRNA methyltransferase | MNRPVPVPPLADVLRAALAELVDGLPPRQAGRAVERLIGHYRGDTPTDAPILRDRADVVAYAAYRMPATFAAVRSALDAFADAVPGWAPGSHVDVGGGTGAATWAVGDTWAGPRQVTVLDWAEPALALGREIAAAHPALRDVRWQRSRIGAALTVEDTDLVTVSYVLNELTSADRAALVDAAASAARAVVIVEAGTPDGYARVIEARDRLVAAGFHVAAPCPHSAACPIVPGTDWCHFAARVSRSSLHRQVKGGSLAYEDEKFSYVAATRLPVSPAPSRVVRHPLIRKGQVLLDLCEPDEQLRRRTVTKRHGDLYKAARDAVWGDAWPDAANPPTE | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp06015 | S9 family peptidase | MGEPVRTLSYGSWPSPVDAALAAAHDGRPDEVGFVGDEVWWTAPRPAEGGRRTLVRRHADGTEEAVLPAPWNVRSRVIEYGGRSWAAVTTDAGPLVVFVNFADQRLYSFAPGGDAPRPLTPLSAVGGGLRWIEPDPRPEHGEVWCVLEEFTGEGPTDLRRVLAAVPLDGSAADDRDAVRELTAERHRFVTGPRVSPDGSRAAWLAWDHPRMPWDGTELIVADIGPEGTFRDARAVAGGPEESIAQADWAPDGSLLYASDRTGWWNLYRDGRPLHAREEEFGGPLWKLGQRWFAPLDSGLIAVLHGRGAAVLGVLDPETGEVVDAAGPWTEFAPALAAHGERIAGVGAGAHSGFEVVELDARTGRARVIGAPYEDATDPAYYPPSRIRTFTGPGGRDIHAHLHPPHHPGCRAPDGELPPYVVWAHGGPTSRSPLVLDLEIAYFTSRGIGVAEVNYGGSSGYGREYRNRLRGQWGVVDVEDCAAVALALAEEGTADPRRLAVRGGSAGGWTTAASLATTDVYACGAISYPVLDLAGWGAGETHDFESQYLESLIGPRAEVPDRYTERSPAEHAESVTAPFLLLQGLDDVICPPAQCERFLARMAGRGVPHAYLTFEGEGHGFRRAETMVRALEAELSLYAQVFGFTPPGVAALELTR | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp06022 | San A-amide | NA | Marine fungus, Wilt of banana | Apoptosis induction | Not specified | HCT-116 | Colon cancer | MIC : 0.98 µg/mL |
| dbacp06037 | Sec-independent protein translocase protein TatA | MFGRLGAPEIILILVVIILLFGAKKLPDMARSLGKSARILKSEAKAMKGENKSDDSAPADPPNPEQSAAQRTIQASPGDVTSSRPVAEPTDTTKR | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp06042 | Sec-independent protein translocase protein TatA | MLRNGLEPWHLLIVAIVFLVLFGSKKLPDMARSLGKSARILKSEAAAMKSDGGPAAERASGGGPAAPAPAATQPSGSAPAGDRDRARDR | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp06048 | Sec-independent protein translocase protein TatB | MFNDIGALELVTLVVLAVLVFGPDKLPKVIQDVTRTIRKIREFSDSAKQDIRDELGPEFKDFEFEDLNPKTFIRKQLDNDELGLKELRSGFDLKKEMAEVTDAVHGRDTEASSASSAAASSSGGRIDMSKKADLSKRPEKAEKPAADDRPPFDVDAT | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp06054 | Sec-independent protein translocase protein TatC | MLKPARSKEKDPEGRMPLAEHLRELRNRLAKALLAIVVVTVVAAFFYRDIINFLTDPILESVGCEKSFEELAEAKAGSEPCAQITINGLLGPFTLALKVSLTAGIVLASPVWLYQLWAFVAPGLHRSEKKYAYAFVATGAPLFLVGAYFAYAVLPTSAKVLIEFTPSDVDNLLPLDELLDLVTRMVVVFGLSFELPLLLVMLNLTGVLSGKRMLGWWRAMIMGITLFAAIATPSTDPLTMLMLAGPIWVLYFAAVTIALLNDRRKSRREALEPDDDEASDLDLTPEDVGEVEPVTTARALPEQATRDRVNGYDDVT | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp06077 | Shiva-1 | MPRWRLFRRIDRVGKQIKQGILRAGPAIALVGDARAVG | African clawed frog | Pore formation at the cytoplasmic membrane | MTT/MTS assay | HRT-18 | Colon cancer | IC50 : 49.3 µM |
| dbacp06078 | Shiva-1 | MPRWRLFRRIDRVGKQIKQGILRAGPAIALVGDARAVG | African clawed frog | Pore formation at the cytoplasmic membrane | MTT/MTS assay | DLD-1 | Colon cancer | IC50 : >100 µM |
| dbacp06093 | Signal peptidase I | MDIETQPTERDRSSRSSGSEQPSDPAGPEERSRSALAGRIADWVPGGRITVTLLVLLLFLLLVSTFVLKPFQIPSGSMERGLRIGDRVLVNKLAYRFDGRPQRGDVVVFDGTGLFGHGDYIKRVVGVGGDHVVCCDREGRIRVNGRSVDESAFLYPGDRPSTVGFDVVVPDGTLFVLGDHRSGSSDSRDHLGSPGGGMIPVDRLIGRADWIVWPFGHATHLDRPDAYADVPDAEAGGVSGAAGGREASAVSGPAGEREAGGDSGAAGERAAGEDSGAAGGGVRRAESVDG | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp06098 | Signal peptidase I | MGSRGKPRGAPSSPAENLLPTGSRRTAAPSGGRSRAERRKLQRKVKRRRRRGAVKEIPLLVGVAVLIALVLKTFLVQAFVIPSGSMEQTIQIGDRVLVDKLTPWFGSEPQRGDVVVFRDPGGWLAGEQTTKQDDPVVVKQVKEGLAFIGLLPSDDEKDLIKRVVGVGGDKVKCCDTQGRVTVNGVPLTEDYLYPGDTPSRTPFEVTVPEGRLWVMGDHRSNSADSRAHQETDFGTVSEDEVVGRAMVIAWPFGHWTTLDEPKTYASVSDSVSGSTAAPRLSHRVAPYDPNAMIQLPIPAELPLVMGVVGLRRVRRGRWQRVRSWRGGCSGWRTVRTRRRGEPRTPRGDGRPGPGRSPGLRVRLRLRNRGRQGDRRTERRDPARGSGRDASRDAHPGQEAALLLEGAADPDRYRAGSRPADQDVPGPGVLDPVVLDGEHPADR | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp06103 | Signal peptidase I | MGGESTTRTAPRGGGAKNTPVGSRRGQRLSGLAVALGMVLFLGGFVWGAVVYRPYTVPTGSMTPTIAAGDRVLAERVSGSDVRRGDVVVFKDAAWADAPMVKRVVAVGGDTVSCCQKGKLQVNGKVIDEPYLPAGTPAEISDFQTVTVPEGRLFLLGDERDNSVDSTAHLTDAAGGTVSRGAVDARVDAVVWPMNGMLERPTGFETLGGLSSPGPLWTVVALVTGGAVLILGGAAYGPVAKRAEASRARRGTEAAGGR | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp06108 | Signal peptidase I | MGGTPPATPTPAKKQRSFWKELPILIGIALVLALLIKTFLVQAFSIPSSSMENTLQIGDRVLVDKLTPWFGSEPDRGEVVVFHDPDDWLAGEPTPDPNALQTVLSWIGLMPSADEKDLIKRVIGVGGDTVECNKTGPLKVNGKALNEPYVYAGNTPCSEDEQGGQFKVTVPEGKIWVMGDHRQNSRDSRYNQSDKNGGMVPVDEVVGRAIVVAWPMNRWGTLPVPETFDQDGLQARASAAALSVAPQGLAVAGVVPVVWWRRRRRAVSVETR | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp06113 | Signal recognition particle protein | MFDTLSDRLSATFKNLRGKGRLSEADIDATAREIRIALLEADVALPVVRAFIKKVKERSMGAEVSKALNPAQQVLKVVNEELVGILGGETRRLRFAKQPPTVIMLAGLQGAGKTTLAGKLGRWLKEQGHSPLLVACDLQRPNAVNQLSVVAERAGVAVYAPEPGNGVGDPVKVAKDSIEFARTKVHDLVIVDTAGRLGIDQELMQQAADIRDAVSPDEVLFVVDAMIGQDAVNTAEAFRDGVGFDGVVLSKLDGDARGGAALSIASVTGKPIMFASNGEKLEDFDAFHPDRMASRILDMGDLLTLIEQAEKTFSQEEAEKMASKLASKKGQDFTLDDFLAQMEQVRKMGSISKLLGMLPGMGQMKDQINNLDERDVDRTAAIIKSMTPGERQEPTIINGSRRARIAKGSGVDVSAVKNLIERFFEARKMMSRMAQGGGMPGMPGMPGMGGGPGRQKKQQKKAKGKQRSGNPMKRKQQEQEEAARRAAAAQGGGALGLPQQGGQDFELPEEFKKFMG | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp06149 | SsrA-binding protein | MAKEKGRKLIAQNKKARHDYQILDTYEAGLVLSGTEVKSLRQGRASLADGFVQLDGHEAWLHNVHVPEYSQGTWTNHSARRKRKLLLHRVEIDKLEAKSQETGHTIVPLALYFKDGRAKIEIALARGKKEYDKRQTLREKQDRREAERTISAIRRKQRA | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp06189 | T Peptide | TKPRKTKPRKTKPRKTKPR | Tuftsin derivative | Immune regulation | MTT/MTS assay | HT-29 | Colon cancer | 70% maximum inhibitory rate at 8 mg/kg |
| dbacp06195 | Tat | RKKRRQRRR | HIV-Tat (49-57) | Apoptosis inducing | MTT/MTS assay | HCT-116 | Colon cancer | ~10% cytotoxicity at 100 µM |
| dbacp06199 | Tat-a5 | KAQIRAMECNILGRKKRRQRRR | HIV-Tat (49-57) | Apoptosis inducing | MTT/MTS assay | HCT-116 | Colon cancer | ~80% cytotoxicity at 100 µM |
| dbacp06208 | TAT-DV3-BH3 | YGRKKRRQRRRGGGLGASWHRPDKGGGGLRRMADDLNAQY | BH3-only, Direct activators (PUMA, Bid) | Inducing apoptosis | CCK-8 assay | HCT116p53–/– | Colon cancer | Survival rate : 32.19 ± 6.42% |
| dbacp06209 | TAT-DV3-BH3 | YGRKKRRQRRRGGGLGASWHRPDKGGGGLRRMADDLNAQY | BH3-only, Direct activators (PUMA, Bid) | Inducing apoptosis | CCK-8 assay | HCT116p53+/+ | Colon cancer | Survival rate : 34.28 ± 8.93% |
| dbacp06210 | TAT-DV3-BH3 | YGRKKRRQRRRGGGLGASWHRPDKGGGGLRRMADDLNAQY | BH3-only, Direct activators (PUMA, Bid) | Inducing apoptosis | CCK-8 assay | GLC-82 | Colon cancer | Survival rate : 63.64 ± 4.80% |
| dbacp06211 | TAT-DV3-BH3 | YGRKKRRQRRRGGGLGASWHRPDKGGGGLRRMADDLNAQY | BH3-only, Direct activators (PUMA, Bid) | Inducing apoptosis | CCK-8 assay | SGC-7901 | Colon cancer | Survival rate : 64.75 ± 33.48% |
| dbacp06212 | TAT-DV3-BH3 | YGRKKRRQRRRGGGLGASWHRPDKGGGGLRRMADDLNAQY | BH3-only, Direct activators (PUMA, Bid) | Inducing apoptosis | CCK-8 assay | MDA-MB-231 | Colon cancer | Survival rate : 69.79 ± 6.71% |
| dbacp06213 | TAT-DV3-BH3 | YGRKKRRQRRRGGGLGASWHRPDKGGGGLRRMADDLNAQY | BH3-only, Direct activators (PUMA, Bid) | Inducing apoptosis | CCK-8 assay | HEK293 | Colon cancer | Survival rate : 115.85 ± 23.03% |
| dbacp06214 | TAT-DV3-BH3 | YGRKKRRQRRRGGGLGASWHRPDKGGGGLRRMADDLNAQY | BH3-only, Direct activators (PUMA, Bid) | Inducing apoptosis | CCK-8 assay | 2BS | Colon cancer | Survival rate : 124.38 ± 22.05% |
| dbacp06289 | Tetrahydrofolate synthase | MSDNPGENGQPDPSDPLDSFDEIIDAETTRDPDLAVIEAGSRTLRTQGGPPEADVPGRPEDPETDAALRAVETELATRWGETKLEPSVTRIAALMDVLGDPQRSYPSIHITGTNGKTSTARMIEALLGAFELRTGRYTSPHVQSITERISLDGAPMSAERFIETYQDIKPYVEMVDAQQEYRLSFFEVLTGMAYAAFADAPVDVAVVEVGMGGSWDATNVIDGDVAVVTPIDLDHTDRLGETPGEIATEKSGIVKQDATVILAQQPVDAAQVMLKKAVDVNATVAREGLEFGVVARQVAVGGQLATLRGLGGEYDEVYLPLHGAHQAHNAAVALAAVEAFFGVGAQRPEPLDLDTVRKAFAAVASPGRMEVVRRSPTVVLDAAHNPAGARVTAEAVGEAFQFSRLIGVVGASGDKNVRGLLEAFEPVFAEVVVTQNSSHRAMDADELAGVAVEVFGEDRVQVEPRLPDALEAAITLAEEEGEFAGGGVLVTGSVITVGEARLLMGKG | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp06297 | Tetratricopeptide repeat protein | MPRGAPARGSAHRYGDGPRFTQCPRPPGVPGREVAYCDLVDQDWEERVTAAWAAIDDYADDGAAEFRAVIDALADELPADSPLGLFERACAWDSTGHSDRAVPLYREALERGLGEVSHHKGRRAKIQLASSLRNTGHPEEGVLLLSPELVSTSDELDDAVRATLALCLSAMGRDREGLSLVLGALAPHLPRYQRSMAAYARQLVEPEDPED | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp06310 | TOMM leader peptide-binding protein | MHDEQHHGPGLGGSDGLWDEALRGLGDALDAKVVANRGWDLSWERLQWEKASADGEDLVSVRVYDDEVVVGPRWVPGTDSGCASCAEVRERTTAEHPLATALDTPRAVPRAARPLLPLLLAAAAANLADHPLGPGELYAVGAQYVRRHRVPRSFFCPACADHGSVAADDWRPEPLELPAEPLSSKDPTRGAGGAHLVEPGALRERLLDARYGPIQVIMRESDVPFAMSMCLAPDAAAPGHGRAGTFAEADPVGIIETYERLGSFPFDTPLLLERSHREVAAHALDPVTLGEHTEKQLEHPDCQVLPYTPDTPMDWVWGHDLATGEPLLVPAEAGFYQYEQRFKLSRHAARAARVEARRARAAGHRPAPGTLRKYFHDSSSGCAAGSSLTEAALHSLLELAERDAFLLSWHRREPLPRIADASITDPESRSLIDLIRTRGFDVHVLVARQDIDLPIVWVLVVNRQNPFPASYSSGGSGADPDTAIRGALREVAQLVTNKMQWNREEAEQMLDDPWKLVELEQHPQLYTLPEKLARVTEVLGGPQTTVQDAFPGWPQVLRRASGGTVRGALDHVRALYAAAGLDRIVLVNQTTREHADAGISVAKAVVPGILPMCFGHAQQRLKNLPRLVAALAGTPQENREIPYDPHPFP | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp06315 | TOMM leader peptide-binding protein | MHPMVKPALRRGWRDLNTVQFGMTPAHALTLAPVDTATGGFLELLNGTRGPALLREEGHRMDLPEGHVDRVVDRLAGAGLLDDSRGGGPAAEALREKKDVLDRLRPDLATLSLTTSAPGDAIRHLAARRALRVGVRGAGRVGAALAGLLSGAGVGEVDVRDGGCVEPWDVAPGGLPARSVGDRRDAAARRVVRAAAPGGPPRRSPAAPPDGSDPGLSLVVVAPRDDVAVHTPDPASVESLMASGTPHLYAGVVEGTGVVGPLVLPGETGCAGCLYADRTDRDPAWPRLVAQWRSGRPRPVPPCDLTLAATVAGLAAAHALAFLDGGTPAGTGVRWEVSLPALRWHARPVAAHPACPCGAAAEGKAEGKQEHIAEDGAGGATMAGQGPPSAARHGVGPTRPAGTWRAHV | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp06342 | Trigger factor | MKSAVETLNPTRVRLTVEVPFEELKDSLDAAYKKINQQVTVKGFRKGKIPARVIDQRFGRGAVLEEAVNDALPKFYTDAVNEAELNPLGQPEVDITELKDGETLNFTAEVDIRPTVEIPDYSGIEVEVDAVEVSDEDVEKSVEQLRERFASTSPVERAAQDGDVLTLDLQAKVDGEVLEDGVADGVSYTIGSGELLDGIDEAVKGLEAGGEATFASELKGGSAAGKEAEVTVKVSQVAARELPELDDDFAQLASEFDTLEELQADSRKRLAnMKQYDQATQAQERVLDKLLELVEIPVPEKLLEDEINTRKHNLEHHQLGQMGLDLEKYLELQGKTAEEFETETREAAVKGIKTQFVLDELVKQENLNVSQEELTEHLMRRASSSGMSPDQFAQAVVEQGQVPLLVGEVARGKALAAVVEKATVKDTNGEIVDLDDEEDEEPETVEAAATESADAEQADEKADDKADDKAGKAEEKTEG | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp06354 | Trp operon leader peptide | MSPERRRFENQRSRSPAQDYGVGTGAHGRAQRMRRAAHSGARPGWGTLPAMFAHPIQNWWWTAHPAAH | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp06395 | Type 2 lantipeptide synthetase LanM | MSDVQVATDARPATGPTAAADAHVVTEPQVAVEDFLPFYRNRIPRQVVVDRLRGPLSQAAAPEHAGTLVDQVWEDLVTAVEGHSLRVLIGEFHEFRQSRGLPATAGSDEAISRFRRHIEDPDNCRELLGRYDVLRRRLTVVLDRFLDAYDDLFTAFRDDRPRLVERGLLTDGGDTLASLITTGGDPHNDNRRVVGVRLAGGGRLVFKPRTLAADDFVRDLYAVVDPYLAHSLGGCVPESLSVGDHGWQSFVTPRAMTGPDQPARYFYRFGALCALFGAIGASDLHDENLLAAGEHPCVIDTEMMLRPGSGTGDGSLEQRLNNHVEASVASTMLVPNVRPESPIDVIMAGVGVSGEQVSGKMKKSALQDGGTDALRLRWEPIVYQHKENVPRLGDEKLASVRFYRDIVAGYTDALGAVRERRAIEEVIGRYAELPVRCLIRSTMVYGRFLDAATQPRYLRDAGESERFLGLLKQFPRQLAPEARAFAGEAERVAMDTGNVPYFTGRAGTTELATHTDRLPGAHPSSPADAARAGLALHAAQSDRYHRFVLEECFGELAEAAPDVMSAQSVFAPVLDTPAGEPWWPHIARILQDIQVTYSDADGVQCGWVGGVGPDRGVPTLLPGNYLSFHDNGGIVTFLQDAAEHDPRFAELYRRADRGLSALLQVYDEAQLRAPESVFTGAASMMLTRPRRQDRAWTARLLERVPERIEAGTLEKDLANGPAGLLMAVLARLEAGQDRLMDEEQLGRLCDLVLGQAATPLDRAWYDVAHGDVGMWWAVSRIGRYLGDAALSGEAADRLTERLSAGELPPVPGWCNGSAGVLLVSAEILTSAGRPEVLTGGRLAELLDGATSSRGDRPVDLSVCHGSSGVVQSLIATSRLLEDRSLLGRAAEYREQTARAAGARGFHTGCPGRTSLLGYMFGWSGIGHTDLMLDEALDGRAPAFVPVALTAAGAPEEPAPPRRPGANVRASAAR | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp06400 | Type 2 lantipeptide synthetase LanM | MRSAINYYPEFDDTEIEETITPLAAFDDEVRAVVSREPQQPAVLPSRPGVVKDWTARAEEYPFQQVVRDIAAGAADGDPLAAFPGLFADRDDALTELLDRAEARIRELYTRPLVAAVNHAREQGSLLGETPRERYRYFVDEAVRGSVASAGGLDFPVLRNLTPVVLAGTVDSVVELCSRLVADRAAIRDTFGIAVEDRLVSFGRPQGDTHHHGRAVCILAFESGTRLVYKPRDVSCEAGFAVLADEFNAAFGTRLHAVTALARDGYGYVEYVETEDVSAISERFLYESGELAAVLYLLNARDMHFENIVPTRRGPVPVDLETVLHPERIHVGPVPEADGNAYGTIGRSVYGVGILPLVMAGRRGDQGGHVDLGFLGGPGRGASPFKQMSFDEPYTDRIRLSLKAQEVSARRTVVGERTEEEILRLGRSMADGFTRTYRAVLAAPGTWTALLRKAADGLRIRYVHNPTALYSQTLRMVTGPSALDDTDTYLALLKRIAIASKTSDRTLIASELRQLAERDVPYFTVSATGTRVCDGDGREVGAAFGSSPLDLALDKAAGLGETDLGEQLRLIRSAFTAQFPDNHLTPARPTEAPSGGGADSGERAALTSLARELTDGLVATSLPDRFAHLPRTWIGPLASAEADRPWPPGVLGYDLYTGRTGIALTLAAAGRVLDDERCLAVARQIFSTTGEILASHRYETRSLQQAGYAGYTGMSGILFCLSAAGRLIGEEAWVSAAQGAVPLVLEQIRAVPVDELPLDVISGLAGVLNCFAAVADPTGSGVAAPEGREAVTEVALLLTRALGRDGALARSVLDQSGFAHGISGVVHALGRAHPLLPAEHRAPVGTALTDLVRRLDTFYDPAERNWSSQLSRQGSFATGWCHGATSVALALSGAAGVLGHETVAARRDQAVENTLRLGFGRNLTWCHGDLGNHGALRFIAGPDGSPLHDEVRQKERQWLRPEVMRRKLADPDSRYAHTNSLMVGSAGLALHLLNRIDPGLRLCPLTLTVEGR | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp06431 | UDP-N-acetylmuramate--L-alanine ligase | MAPGLPTAMDRPHFIGIGGAGMSGIAKVLAQRGAAVAGSDAKESATAGALRALGATVHIGHAAGHLADDASCVVVSSAIREDNPELARAAELGIPVVHRSDALAALMNGLRPLAVAGTHGKTTTTSMLAVSLSELGLNPSYAIGGDLDEPGSNALHGSGEIFVAEADESDRSFHKYAPEVAIVLNVELDHHANYASMDEIYESFETFADRIVPGGTLVIAADHEGARELTRRLAGTVRTVTYGESEDADVRILSVVPQGLKSEVTVVLDGAELTFGVSVPGRHYAHNAVAALAAGAALGVPAAELAAALAAYTGVKRRLQLKGEAAGVQVVDSYAHHPTEMTADLEAMRAAVGDARILVLFQPHLFSRTQELGKEMGQALALADASVVLDIYPAREDPIPGITSDLIVEAARAAGADVTPVHDKDAASAAVAGMAKAGDLVLTMGAGDVTDLGPRILDELSSQANQ | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp06436 | UDP-N-acetylmuramoyl-L-alanyl-D-glutamate--2,6-diaminopimelate ligase | MTYPGPPRPVRISATPLAELADQLGVTAPDSSAGVTGITHDSRAVRPGDLYAALPGARVHGADFATQAAGLGAAAVLTDPAGAERVSAAGLPALVVDDPRARMGELAATIYGHPGRDLLQIGITGTSGKTTTAYLVEGGLRTEKSTGLIGTVEMRIGDERIKSERTTPEATDLQALFSVMRERGTEAVAMEVSSHALVLGRVDACVFDVAVFTNLSPEHMEFHSGMEDYFQAKAQLFTPARSRLGVVNVDDEYGRRLAKEATVPVVTYSAEGHPDADWRADEVEVGPLDSTFTVLGPKGERIAAKSPLAGPFNVANTLAAIVSLAAAGLDPQTAADGVAAVPGVPGRLERVDEGQPFFAVVDYAHKTDAVESVLRALRKVTEGKLHAVLGCGGDRDTTKREPMGAAVARFADTAVLTSDNPRSEDPLAILAVMLQGAASVPAHERGEVQVFEDRAAAIAAAVARAEPGDTVVVAGKGHEQGQDIAGVVRPFDDREVLREAIQRSKA | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp06441 | UDP-N-acetylmuramoyl-tripeptide--D-alanyl-D-alanine ligase | MITLSLAEIADVVGGRMHDIPDASAQVTGPVVRDSREAGPGSLFVAFVGERVDGHDFAPAVVGAGAVAVLGSRPVGVPAIVVDDVQAALGALARHVVRRLGTTLVALTGSAGKTSTKDLIAQVLRRKAPTVFTPGSLNNEIGLPLTALTATGETRFLVLEMGARGIGHIRYLCELTPPRIGLVLNVGSAHIGEFGGREQIAQAKGELVEALPPAGEGGTAVLNADDPLVRAMASRTTAKVLLFGESGEADVRAENVRLTDSGQPSFSLHTPSGASDVTMRLYGEHHVSNALAAAAVAHELGMSADEIATALSEADSLSRWRMEVTERPDGVTVVNDAYNANPESMKAALRALVAIGGASRARGGRTWAVLGEMAELGDEALAEHDAVGRLAVRLNVSKLVAVGGREAQWLQLGAYNEGSWGEESVHVSDAQAAVDLLRSELRPGDVVLVKASRSVGLESVATALLETGTEGEVAAR | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp06446 | UDP-N-acetylmuramoylalanine--D-glutamate ligase | MPSEFSGKHVTVAGLGVSGVPAAKVLHGLGAHVTVVNDGADERARTQAAELEALGVTVRLGDGTASDSGSAAGLPEGTELIVTAPGWKPTKPLFTAAEQAGVPVWGDVELAWRLRGHGGRKAAPWLAVTGTNGKTTTVQMLASILAAAGLRTAAVGNIGVSLLDAVTGDTEYDVLAVELSSYQLHWAPSLRAHSAVVLNLAADHLDWHGSMEAYAADKGRVYEGNQVACVYNAADRATEDLVRAADVEEGCRAVGFTLGTPGPSQLGVVEGLLVDRAFVEDRHKNAQELAEVSDVNPPAPHNIANALAAAALARAYGVPAAAVRDGLRAFTPDAHRIAHVADVDGVAYVDDSKATNTHAAEASLAAYEPIVWIAGGLAKGATFDELVAGAAKRLRGAVLIGADRALIREALARHAPEVPVVDLDRTDTGAMPQAVREARRLAEPGDTVLLAPACASMDMFTNYNKRGDAFAEAVRELGA | Streptomyces sp. VN1 | Not specified | Cytotoxicity assay | HCT116 | Colon cancer | IC50 : 123.7 µM |
| dbacp06550 | Z1 | KAAKKWAKAAKKWAKAWKKAA | Synthetic | Disruption of cell membrane | MTT/MTS assay | HT-29 | Colon cancer | EC50 : > 211 µM |
| dbacp06553 | Z10 | AAKKWAKAKWAKAKKWAKAA | Synthetic | Disruption of cell membrane | MTT/MTS assay | HT-29 | Colon cancer | EC50 : > 211 µM |
| dbacp06556 | Z2 | KAAKKWAKAWKKAAKAWKKAA | Synthetic | Disruption of cell membrane | MTT/MTS assay | HT-29 | Colon cancer | EC50 : > 211 µM |
| dbacp06569 | Z3 | KAAKKAWKAWKKAAKAAWKKAA | Synthetic | Disruption of cell membrane | MTT/MTS assay | HT-29 | Colon cancer | EC50 : >211 µM |
| dbacp06572 | Z4 | KAAKKAWKAAKKAAKWWKKAA | Synthetic | Disruption of cell membrane | MTT/MTS assay | HT-29 | Colon cancer | EC50 : 173 µM |
| dbacp06585 | Z5 | KAAKKAWKWAKKAAKWAKKAA | Synthetic | Disruption of cell membrane | MTT/MTS assay | HT-29 | Colon cancer | EC50 : 67 µM |
| dbacp06588 | Z6 | KWWKKAAKAAKKAAKAAKKWA | Synthetic | Disruption of cell membrane | MTT/MTS assay | HT-29 | Colon cancer | EC50 : 31 µM |
| dbacp06591 | Z7 | KAAKKAWKAAKKAWKAAKKAA | Synthetic | Disruption of cell membrane | MTT/MTS assay | HT-29 | Colon cancer | EC50 : 21 µM |
| dbacp06594 | Z8 | AWKKWAKAWKWAKAKWWAKAA | Synthetic | Disruption of cell membrane | MTT/MTS assay | HT-29 | Colon cancer | EC50 : 23 µM |
| dbacp06597 | Z9 | AAWKWAWAKKWAKAKKWAKAA | Synthetic | Disruption of cell membrane | MTT/MTS assay | HT-29 | Colon cancer | EC50 : 13 µM |
| dbacp06605 | αs1-casein f(90_95) | RYLGYL | Bovine milk | Regulation of immune response; Apoptosis inducing | MTT/MTS assay | AZ-97 | Colon cancer | Inhibition at 12 - 15 g/l |
| dbacp06606 | β-Casomorphins 5 f(60_64) | YPFPG | Bovine milk | Regulation of immune response; Apoptosis inducing | MTT/MTS assay | AZ-97 | Colon cancer | Inhibition at 9 - 11 g/l |
| dbacp06608 | Maculatin 1.3 | GLLGLLGSVVSHVVPAIVGHF | Fringed Tree Frog, Australia | Disruption of either cancer or bacterial cell membrane integrity | Not specified | Not specified | Colon cancer | IC50 : 10−5 to 10−6 M |
| dbacp06654 | LUNA18 | Not Available | Synthetic | Not available | CellTiter-Glo Cell Viability assay | LS 180 | Colon Cancer | IC50 = 2.7 ± 0.4 nmol/L |
| dbacp06657 | LfcinB (21-25)Pal | RWQWRWQWR | LfcinB | Apoptosis inducing | MTT assay | HT-29 | Colon Cancer | IC50 = 100 μM |
| dbacp06659 | Ahx-[Pal] | Ahx-RWQWRWQWR | Synthetic | Apoptosis inducing | MTT assay | HT-29 | Colon Cancer | IC50 = 119 μM |
| dbacp06661 | 9[Orn] [Pal] | RWQWRWQWO | Synthetic | Apoptosis inducing | MTT assay | HT-29 | Colon Cancer | IC50 = 109 μM |
| dbacp06672 | Crabrolin | FLPLILRKIVTAL | European hornet (Vespa crabro) | Not available | MTT assay | HCT-116 | Colon Cancer | IC50 = 8.539 μM |
| dbacp06677 | Crabrolin-4R | FLPRILRKIVTAL | Synthetic Analog of Crabrolin | Not available | MTT assay | HCT-116 | Colon Cancer | IC50 = 47.02 μM |
| dbacp06682 | Crabrolin-4K | FLPKILRKIVTAL | Synthetic Analog of Crabrolin | Not available | MTT assay | HCT-116 | Colon Cancer | IC50 = 42.88 μM |
| dbacp06687 | Crabrolin-TR | FLPRILRKIVRAL | Synthetic Analog of Crabrolin | Not available | MTT assay | HCT-116 | Colon Cancer | IC50 = 2.810 μM |
| dbacp06692 | Crabrolin-FR | RLPRILRKIVRAL | Synthetic Analog of Crabrolin | Not available | MTT assay | HCT-116 | Colon Cancer | IC50 = 30.29 μM |
| dbacp06697 | Crabrolin-AR | RLPRILRKIVRRL | Synthetic Analog of Crabrolin | Not available | MTT assay | HCT-116 | Colon Cancer | IC50 = 29.90 μM |
| dbacp06702 | Crabrolin-PR | RLRRILRKIVRRL | Synthetic Analog of Crabrolin | Not available | MTT assay | HCT-116 | Colon Cancer | IC50 = 16.29 μM |
| dbacp06737 | Aurein 1.2_mutant (Aurm) | GLFDIIKKIIKSF | Synthetic | Necrotic activity via cell membrane lysis and apoptotic activity through disrupting mitochondrial membrane | MTT assay | SW-480 | Colon Cancer | 51.63% cell viability |
| dbacp06738 | Aurein 1.2_mutant (Aurm) | GLFDIIKKIIKSF | Synthetic | Necrotic activity via cell membrane lysis and apoptotic activity through disrupting mitochondrial membrane | MTT assay | HT-29 | Colon Cancer | 66.10% cell viability |
| dbacp06739 | Aurein 1.2_R5 (R5-Aur) | RRRRRGLFDIIKKIAESF | Synthetic | Necrotic activity via cell membrane lysis and apoptotic activity through disrupting mitochondrial membrane | MTT assay | SW-480 | Colon Cancer | 43.89% cell viability |
| dbacp06740 | Aurein 1.2_R5 (R5-Aur) | RRRRRGLFDIIKKIAESF | Synthetic | Necrotic activity via cell membrane lysis and apoptotic activity through disrupting mitochondrial membrane | MTT assay | HT-29 | Colon Cancer | 61.56% cell viability |
| dbacp06741 | Aurein 1.2_mutant_R5 (R5-Aurm) | RRRRRGLFDIIKKIIKSF | Synthetic | Necrotic activity via cell membrane lysis and apoptotic activity through disrupting mitochondrial membrane | MTT assay | SW-480 | Colon Cancer | 40.62% cell viability |
| dbacp06742 | Aurein 1.2_mutant_R5 (R5-Aurm) | RRRRRGLFDIIKKIIKSF | Synthetic | Necrotic activity via cell membrane lysis and apoptotic activity through disrupting mitochondrial membrane | MTT assay | HT-29 | Colon Cancer | 54.22% cell viability |
| dbacp06759 | p28 | LSTAADMQGVVTDGMASGLDKDYLKPDD | Pseudomonas aeruginosa | Apoptosis inducing | MTT assay | HT-29 | Colon Cancer | IC50 ~ 200 μg/ml |
| dbacp06767 | M1-21 | rrrqrrkkrg-QTQPRLGPPQTPAGGCSILIF | Synthetic | FOXM1 inhibitor | Cell Viability assay | HCT-116 | Colon Cancer | IC50 = 9.08 µM |
| dbacp06854 | WP1 | RLLRLMRLRMLLRM | Derived from RLL peptide | Apoptosis inducing | Cell Viability assay | HT-29 | Colon Cancer | IC50 = 54.6 ± 2.1 μM |
| dbacp06858 | WP2 | RLLRLLRLRRLLRL | Derived from RLL peptide | Apoptosis inducing | Cell Viability assay | HT-29 | Colon Cancer | IC50 = 42.6 ± 4.0 μM |
| dbacp06860 | ALA-A2 | KLWCKSSQVPQSR | Alpha-Lactalbumin | Not available | MTT assay | HT-29 | Colon Cancer | ~50% cell viability |
| dbacp07012 | Sansalvimide A | LXVLF | Fusarium sp. | Not Available | Not Available | HCT-116 | Colon Cancer | IC50 = 9.8 µg/ml |
| dbacp07013 | Sansalvimide A | LXVLF | Fusarium sp. | Not Available | Not Available | Colo-205 | Colon Cancer | IC50 = 3.5 µg/ml |
| dbacp07085 | HB43 | FAKLLAKLAKKLL | Synthetic | Motif-driven membrane insertion triggers cytotoxicity | AlamarBlue assay | SW-480 | Colon Cancer | IC50 = 12 ± 4 μM |
| dbacp07086 | HB43 | FAKLLAKLAKKLL | Synthetic | Motif-driven membrane insertion triggers cytotoxicity | AlamarBlue assay | SW-620 | Colon Cancer | IC50 = 10 ± 1 μM |
| dbacp07087 | HB43 | FAKLLAKLAKKLL | Synthetic | Motif-driven membrane insertion triggers cytotoxicity | AlamarBlue assay | HT-29 | Colon Cancer | IC50 = 11 ± 1 μM |
| dbacp07089 | HB43-mut2 | FAKLLAKLAKLLK | Synthetic | Motif-driven membrane insertion triggers cytotoxicity | AlamarBlue assay | SW-480 | Colon Cancer | IC50 = 34 ± 2 μM |
| dbacp07090 | HB43-mut2 | FAKLLAKLAKLLK | Synthetic | Motif-driven membrane insertion triggers cytotoxicity | AlamarBlue assay | SW-620 | Colon Cancer | IC50 = 40 ± 3 μM |
| dbacp07091 | HB43-mut2 | FAKLLAKLAKLLK | Synthetic | Motif-driven membrane insertion triggers cytotoxicity | AlamarBlue assay | HT-29 | Colon Cancer | IC50 = 50 ± 3 μM |
| dbacp07093 | HB43-mut3 | FAKLLAKLARRLL | Synthetic | Motif-driven membrane insertion triggers cytotoxicity | AlamarBlue assay | SW-480 | Colon Cancer | IC50 = 8 ± 1 μM |
| dbacp07094 | HB43-mut3 | FAKLLAKLARRLL | Synthetic | Motif-driven membrane insertion triggers cytotoxicity | AlamarBlue assay | SW-620 | Colon Cancer | IC50 = 9 ± 1 μM |
| dbacp07095 | HB43-mut3 | FAKLLAKLARRLL | Synthetic | Motif-driven membrane insertion triggers cytotoxicity | AlamarBlue assay | HT-29 | Colon Cancer | IC50 = 9 ± 1 μM |
| dbacp07278 | LCP-2 | WAHT | Laminaria japonica | Mitochondrial apoptosis via p53 activation. | MTT assay | CaCo-2 | Colon Cancer | IC50 = 100 ± 11.6 μM |
| dbacp07282 | LCP-3 | WHLV | Laminaria japonica | Mitochondrial apoptosis via p53 activation. | MTT assay | CaCo-2 | Colon Cancer | IC50 = 68.2 ± 7.11 μM |
| dbacp07316 | B1OS-L | FLPLIASLAGNVVPKIFCKITKRC | B-1OS | Not Available | MTT assay | HCT-116 | Colon Cancer | IC50 = 11.03 µM |
| dbacp07321 | B1OS-D-L | FlPLIASLAGNVVPKIFCKITKRC | B-1OS | Not Available | MTT assay | HCT-116 | Colon Cancer | IC50 = 3.721 µM |
| dbacp07348 | GA - 2 | Structure given in figure | Synthetic (glycyrrhetinic acid (GA)-based peptides) | Apoptosis induction, Bax/p53/caspase activation | MTT assay | HCT-116 | Colon Cancer | IC50 = 70.30 ± 0.9 µg/mL |
| dbacp07350 | GA - 3 | Structure given in figure | Synthetic (glycyrrhetinic acid (GA)-based peptides) | Apoptosis induction, Bax/p53/caspase activation | MTT assay | HCT-116 | Colon Cancer | IC50 = 7.40 ± 0.4 µg/mL |
| dbacp07352 | GA - 4 | Structure given in figure | Synthetic (glycyrrhetinic acid (GA)-based peptides) | Apoptosis induction, Bax/p53/caspase activation | MTT assay | HCT-116 | Colon Cancer | IC50 = 73.0 ± 1.4 µg/mL |
| dbacp07354 | GA - 5 | Structure given in figure | Synthetic (glycyrrhetinic acid (GA)-based peptides) | Apoptosis induction, Bax/p53/caspase activation | MTT assay | HCT-116 | Colon Cancer | IC50 = 5.2 ± 0.8 µg/mL |
| dbacp07356 | GA - 7 | Structure given in figure | Synthetic (glycyrrhetinic acid (GA)-based peptides) | Apoptosis induction, Bax/p53/caspase activation | MTT assay | HCT-116 | Colon Cancer | IC50 = 3.0 ± 1.1 µg/mL |
| dbacp07359 | GA - 8 | Structure given in figure | Synthetic (glycyrrhetinic acid (GA)-based peptides) | Apoptosis induction, Bax/p53/caspase activation | MTT assay | HCT-116 | Colon Cancer | IC50 = 60.70 ± 0.6 µg/mL |
| dbacp07374 | HPRP-A1 | FKKLKKLFSKLWNWK | N-terminal region of Helicobacter pylori ribosomal protein L1 | Apoptosis induction, p53-mediated cell cycle arrest | MTT assay | HT-29 | Colon Cancer | IC50 ~ 0.5 µg/mL |
| dbacp07378 | Brevinin-2DYd | GIFDVVKGVLKGVGKNVAGSLLEQLKCKLSGGC | Rana dybowskii | Not Available | MTT assay | LoVo | Colon Cancer | IC50 = 8.05 µg/ml |
| dbacp07382 | Ranatuerin-2Lb | GILSSIKGVAKGVAKNVAAQLLDTLKCKITGC | Rana luteiventris | Not Available | MTT assay | LoVo | Colon Cancer | IC50 = 59.78 µM |
| dbacp07386 | Odorranain-C1 | GVLGAVKDLLIGAGKSAAQSVLKTLSCKLSNDC | Odorrana grahami | Not Available | MTT assay | LoVo | Colon Cancer | IC50 = 55.22 µM |
| dbacp07390 | Brevinin-2DYb | GLFDVVKGVLKGAGKNVAGSLLEQLKCKLSGGC | Rana dybowskii | Not Available | MTT assay | LoVo | Colon Cancer | IC50 = 35.05 µM |
| dbacp07394 | Ranatuerin-2 | GLFLDTLKGAAKDVAGKLEGLKCKITGCKLP | Rana catesbeiana | Not Available | MTT assay | LoVo | Colon Cancer | IC50 = 128 µM |
| dbacp07424 | GP-1 | FKEHGY | Ginseng Leaf Peptide | Mitochondrial apoptosis via p53 activation | MTT assay | CaCo-2 | Colon Cancer | IC50 = 104 ± 11.3 µM |
| dbacp07425 | GP-1 | FKEHGY | Ginseng Leaf Peptide | Mitochondrial apoptosis via p53 activation | MTT assay | Colo-320 | Colon Cancer | IC50 = 111 ± 12.0 µM |
| dbacp07427 | GP-2 | EGFHL | Ginseng Leaf Peptide | Mitochondrial apoptosis via p53 activation | MTT assay | CaCo-2 | Colon Cancer | IC50 = 154 ± 15.8 µM |
| dbacp07428 | GP-2 | EGFHL | Ginseng Leaf Peptide | Mitochondrial apoptosis via p53 activation | MTT assay | Colo-320 | Colon Cancer | IC50 = 142 ± 14.9 µM |
| dbacp07430 | GP-3 | FSHTYV | Ginseng Leaf Peptide | Mitochondrial apoptosis via p53 activation | MTT assay | CaCo-2 | Colon Cancer | IC50 = 162 ± 17.1 µM |
| dbacp07431 | GP-3 | FSHTYV | Ginseng Leaf Peptide | Mitochondrial apoptosis via p53 activation | MTT assay | Colo-320 | Colon Cancer | IC50 = 149 ± 15.2 µM |
| dbacp07469 | Protonectin | ILGTILGLLKGL | Parachartergus fraternus | Cell penetration without toxic accumulation | Resazurin dye assay | HCT-116 | Colon Cancer | CC50 = 8.0 ± 0.5 µM |
| dbacp07471 | Protonectin-F | IFGTILGFLKGL | Protonoectin | Cell penetration without toxic accumulation | Resazurin dye assay | HCT-116 | Colon Cancer | CC50 = 9.8 ± 1.2 µM |
| dbacp07474 | MzDef | MSSSNCANVCQTENFPGGECKAEGATRKCFCKNC | Zea mays L. | Disulfide-stabilized peptide disrupts pathogens | MTT assay | HCT-116 | Colon Cancer | IC50 = 29.85 µg/mL |
| dbacp07478 | (LLKK)4 linear peptide | LLKKLLKKLLKKLLKK | Synthetic | Apoptosis, drug-resistance reversal, tumor suppression | MTT assay | HCT-116 | Colon Cancer | Cell Viability (%) ~ 10.73 ± 2.4 at 30 µg/mL |
| dbacp07482 | 2-arm branched peptide | [LLKKLLKK]2kC | Synthetic | Apoptosis, drug-resistance reversal, tumor suppression | MTT assay | HCT-116 | Colon Cancer | Cell Viability (%) ~ 78.6 ± 10.5 at 30 µg/mL |
| dbacp07486 | 4-arm branched peptide | {[LLKKLLKK]2kC}2 | Synthetic | Apoptosis, drug-resistance reversal, tumor suppression | MTT assay | HCT-116 | Colon Cancer | Cell Viability (%) ~ 67.6 ± 5.8 at 30 µg/mL |
| dbacp07504 | Brevinin-1Ha | FALGAVTCLIRTKCKVLPKLF | Analogue of Brevinin-1H | α-helix enhances antimicrobial, anticancer activity | MTT assay | HCT-116 | Colon Cancer | IC50 = 342.8 µM |
| dbacp07508 | Brevinin-1HY | FALGAVTKVLYKLFCLITRKC | Analogue of Brevinin-1H | α-helix enhances antimicrobial, anticancer activity | MTT assay | HCT-116 | Colon Cancer | IC50 = 3.583 µM |
| dbacp07511 | YT12 | YFYPKDFTPGCT | Arthrospira platensis | ROS scavenging induces cancer cell death | MTT assay | HT-29 | Colon Cancer | IC50 = 12.5 μM |
| dbacp07536 | AEM-28 | LRKLRKRLLRDWLKAFYDKVAEKLKEAF | Synthetic | LPA reduction suppresses tumor growth | MTS assay | ID8 | Colon Cancer | ~60% cell viability at 10 μg/mL |
| dbacp07539 | AEM-28 | LRKLRKRLLRDWLKAFYDKVAEKLKEAF | Synthetic | LPA reduction suppresses tumor growth | MTS assay | CaCo-2 | Colon Cancer | ~70% cell viability at 10 μg/mL |
| dbacp07542 | AEM-28–2 | Aha-LRRLRRRLLRDWLKAFYDKVAEKLKEAF | Synthetic | LPA reduction suppresses tumor growth | MTS assay | ID8 | Colon Cancer | ~20% cell viability at 10 μg/mL |
| dbacp07545 | AEM-28–2 | Aha-LRRLRRRLLRDWLKAFYDKVAEKLKEAF | Synthetic | LPA reduction suppresses tumor growth | MTS assay | CaCo-2 | Colon Cancer | ~60% cell viability at 10 μg/mL |
| dbacp07546 | Sur-X | YGRKKRRQRRRKDHRISTFKNWPFLEGCACTPERM | Synthetic | Disrupts XIAP-survivin, induces apoptosis/necroptosis | MTT assay | HCT-116 | Colon Cancer | 20% cell viability at at 20 μM |
| dbacp07547 | Sur-X | YGRKKRRQRRRKDHRISTFKNWPFLEGCACTPERM | Synthetic | Disrupts XIAP-survivin, induces apoptosis/necroptosis | MTT assay | HCT-15 | Colon Cancer | Not Available |
| dbacp07548 | Sur-X | YGRKKRRQRRRKDHRISTFKNWPFLEGCACTPERM | Synthetic | Disrupts XIAP-survivin, induces apoptosis/necroptosis | MTT assay | RKO | Colon Cancer | 25% cell viability at at 20 μM |
| dbacp07549 | Sur-X | YGRKKRRQRRRKDHRISTFKNWPFLEGCACTPERM | Synthetic | Disrupts XIAP-survivin, induces apoptosis/necroptosis | MTT assay | HT-29 | Colon Cancer | Not Available |
| dbacp07551 | NMANF2 | KAIGLVIPEIDGKLDGGAQRV | Staphylococcus hominis strain MANF2 | GAPDH-like protein disrupts survival | MTT assay | HT-29 | Colon Cancer | IC50 = 48.9 µg/mL |
| dbacp07802 | Longicalycinin A cyclic analogue 18 | FSPAG | Synthetic Analogue of Longicalycinin A | Cyclization enhances apoptosis via lysosomes | MTT assay | HT-29 | Colon Cancer | 22.8% Cell death at 100 µg/ml |
| dbacp07890 | H-58 | IKLSKKTKKNLKKVLKGS5IKGS5IAVAKMV | Synthetic | Cell entry, DNA damage, apoptosis. | MTT assay | HCT-116 | Colon Cancer | IC50 = 1.29 ± 0.08 μM |
| dbacp07893 | H-57 | IKLSKKTKKNLKKVLKGS5IKGS5IAVAKMV | Synthetic | Cell entry, DNA damage, apoptosis. | MTT assay | HCT-116 | Colon Cancer | IC50 = 1.29 ± 0.08 μM |
| dbacp07896 | H-18 | IKLSKKTKKNLKKVLKGS5IKGS5IAVAKMV | Synthetic | Cell entry, DNA damage, apoptosis. | MTT assay | HCT-116 | Colon Cancer | IC50 = 1.11 ± 0.21 μM |
| dbacp07899 | H-21 | IKLSKS5TKKS5LKKVLKGS5IKGS5IAVAKMV | Synthetic | Cell entry, DNA damage, apoptosis. | MTT assay | HCT-116 | Colon Cancer | IC50 = 3.05 ± 0.21 μM |
| dbacp07902 | H-20 | IKLSPS5TKKS5LKKVLKGS5IKGS5IAVAKMV | Synthetic | Cell entry, DNA damage, apoptosis. | MTT assay | HCT-116 | Colon Cancer | IC50 = 2.63 ± 0.35 μM |
| dbacp07905 | H-19 | IKLSKETKKNLKKVLKGS5IKGS5IAVAKMV | Synthetic | Cell entry, DNA damage, apoptosis. | MTT assay | HCT-116 | Colon Cancer | IC50 = 1.78 ± 0.35 μM |
| dbacp07908 | H-17 | IKLSKS5TKKS5LKKVLKGAIKGAIAVAKMV | Synthetic | Cell entry, DNA damage, apoptosis. | MTT assay | HCT-116 | Colon Cancer | IC50 = 1.49 ± 0.45 μM |
| dbacp07911 | H-16 | IKLSPS5TKKS5LKKVLKGAIKGAIAVAKMV | Synthetic | Cell entry, DNA damage, apoptosis. | MTT assay | HCT-116 | Colon Cancer | IC50 = 2.65 ± 0.35 μM |
| dbacp07914 | H-15 | IKLSKS5TKDS5LKKVLKGAIKGAIAVAKMV | Synthetic | Cell entry, DNA damage, apoptosis. | MTT assay | HCT-116 | Colon Cancer | IC50 = 2.95 ± 0.25 μM |
| dbacp07917 | H-10 | IKLSPS5TKDS5LKKVLKGS5IKGS5IAVAKMV | Synthetic | Cell entry, DNA damage, apoptosis. | MTT assay | HCT-116 | Colon Cancer | IC50 = 3.51 ± 0.37 μM |
| dbacp07920 | H-5 | IKLSPETKDNLKKVLKGS5IKGS5IAVAKMV | Synthetic | Cell entry, DNA damage, apoptosis. | MTT assay | HCT-116 | Colon Cancer | IC50 = 4.16 ± 0.21 μM |
| dbacp07923 | H-2 | IKLSPS5TKDS5LKKVLKGAIKGAIAVAKMV | Synthetic | Cell entry, DNA damage, apoptosis. | MTT assay | HCT-116 | Colon Cancer | IC50 = 3.54 ± 0.72 μM |
| dbacp08018 | Peptide4 Gonearrestide | ADAPGNYPLDARGKSYYC | Androctonus australis | Gonearrestide induces G1 cell-cycle arrest | MTT assay | HCT-116 | Colon Cancer | Not Available |
| dbacp08019 | Peptide4 Gonearrestide | ADAPGNYPLDARGKSYYC | Androctonus australis | Gonearrestide induces G1 cell-cycle arrest | MTT assay | DLD-1 | Colon Cancer | Not Available |
| dbacp08020 | Peptide4 Gonearrestide | ADAPGNYPLDARGKSYYC | Androctonus australis | Gonearrestide induces G1 cell-cycle arrest | MTT assay | HKe-3 | Colon Cancer | Not Available |
| dbacp08021 | Peptide4 Gonearrestide | ADAPGNYPLDARGKSYYC | Androctonus australis | Gonearrestide induces G1 cell-cycle arrest | MTT assay | Dks8 | Colon Cancer | Not Available |
| dbacp08023 | Peptide6 Gonearrestide | KLSAIISKIRDE | Androctonus australis | Gonearrestide induces G1 cell-cycle arrest | MTT assay | HCT-116 | Colon Cancer | Not Available |
| dbacp08024 | Peptide6 Gonearrestide | KLSAIISKIRDE | Androctonus australis | Gonearrestide induces G1 cell-cycle arrest | MTT assay | DLD-1 | Colon Cancer | Not Available |
| dbacp08025 | Peptide6 Gonearrestide | KLSAIISKIRDE | Androctonus australis | Gonearrestide induces G1 cell-cycle arrest | MTT assay | HKe-3 | Colon Cancer | Not Available |
| dbacp08026 | Peptide6 Gonearrestide | KLSAIISKIRDE | Androctonus australis | Gonearrestide induces G1 cell-cycle arrest | MTT assay | Dks8 | Colon Cancer | Not Available |
| dbacp08028 | Peptide10 Gonearrestide | NDADKDEMQSVYRGKANDDNSRGSKTNHRF | Androctonus mauritanicus | Gonearrestide induces G1 cell-cycle arrest | MTT assay | HCT-116 | Colon Cancer | Not Available |
| dbacp08029 | Peptide10 Gonearrestide | NDADKDEMQSVYRGKANDDNSRGSKTNHRF | Androctonus mauritanicus | Gonearrestide induces G1 cell-cycle arrest | MTT assay | DLD-1 | Colon Cancer | Not Available |
| dbacp08030 | Peptide10 Gonearrestide | NDADKDEMQSVYRGKANDDNSRGSKTNHRF | Androctonus mauritanicus | Gonearrestide induces G1 cell-cycle arrest | MTT assay | HKe-3 | Colon Cancer | Not Available |
| dbacp08031 | Peptide10 Gonearrestide | NDADKDEMQSVYRGKANDDNSRGSKTNHRF | Androctonus mauritanicus | Gonearrestide induces G1 cell-cycle arrest | MTT assay | Dks8 | Colon Cancer | Not Available |
| dbacp08033 | Peptide13 Gonearrestide | WCYKLPDRVSIKEKGRCN | Androctonus mauritanicus | Gonearrestide induces G1 cell-cycle arrest | MTT assay | HCT-116 | Colon Cancer | IC50 ~ 100 μM/L |
| dbacp08034 | Peptide13 Gonearrestide | WCYKLPDRVSIKEKGRCN | Androctonus mauritanicus | Gonearrestide induces G1 cell-cycle arrest | MTT assay | DLD-1 | Colon Cancer | Not Available |
| dbacp08035 | Peptide13 Gonearrestide | WCYKLPDRVSIKEKGRCN | Androctonus mauritanicus | Gonearrestide induces G1 cell-cycle arrest | MTT assay | HKe-3 | Colon Cancer | Not Available |
| dbacp08036 | Peptide13 Gonearrestide | WCYKLPDRVSIKEKGRCN | Androctonus mauritanicus | Gonearrestide induces G1 cell-cycle arrest | MTT assay | Dks8 | Colon Cancer | Not Available |
| dbacp08043 | Silk Fibroin peptide | Not Available | Silkworm Cocoons | SFP induces S-phase cell-cycle arrest | MTT assay | HT-29 | Colon Cancer | IC50 = 11.55 ± 3.33 mg/ml |
| dbacp08060 | TAT-327 | RKKRRQRRREFLDCFQKF | Peptide-327 | Peptide 327 blocks Eps8–EGFR | CCK-8 assay | Colo-320 | Colon Cancer | EC50 = 68.40 ± 0.42 μM |
| dbacp08061 | TAT-327 | RKKRRQRRREFLDCFQKF | Peptide-327 | Peptide 327 blocks Eps8–EGFR | CCK-8 assay | HT-29 | Colon Cancer | EC50 = 74.08 ± 0.63 μM |
| dbacp08114 | FR-15 | FRRFFKWFRRFFKFF | Synthetic | Proline-substituted AMP triggers mitochondrial apoptosis | MTT assay | DLD-1 | Colon Cancer | IC50 = 6.7 μM |
| dbacp08118 | FR4P | FRRPFKWFRRFFKFF | Analogue of FR-15 | Proline-substituted AMP triggers mitochondrial apoptosis | MTT assay | DLD-1 | Colon Cancer | IC50 = 9.4 μM |
| dbacp08122 | FR8P | FRRFFKWPRRFFKFF | Analogue of FR-15 | Proline-substituted AMP triggers mitochondrial apoptosis | MTT assay | DLD-1 | Colon Cancer | IC50 = 10.8 μM |
| dbacp08126 | FR11P | FRRFFKWFRRPFKFF | Analogue of FR-15 | Proline-substituted AMP triggers mitochondrial apoptosis | MTT assay | DLD-1 | Colon Cancer | IC50 = 12.9 μM |
| dbacp08130 | FR4,8P | FRRPFKWPRRFFKFF | Analogue of FR-15 | Proline-substituted AMP triggers mitochondrial apoptosis | MTT assay | DLD-1 | Colon Cancer | IC50 = 15.3 μM |
| dbacp08134 | FR8,11P | FRRFFKWPRRPFKFF | Analogue of FR-15 | Proline-substituted AMP triggers mitochondrial apoptosis | MTT assay | DLD-1 | Colon Cancer | IC50 = 22 μM |
| dbacp08172 | Peptide - 1 | GF(A6c)G(A6c)KK(A6c)G(A6c)F(A6c)G(A6c)GKK(A6c)KKKK | Synthetic | Not Available | CellTiter-Glo assay | COLO-205 | Colon Cancer | IC50 = 5.4 µM |
| dbacp08173 | Peptide - 1 | GF(A6c)G(A6c)KK(A6c)G(A6c)F(A6c)G(A6c)GKK(A6c)KKKK | Synthetic | Not Available | CellTiter-Glo assay | DLD-1 | Colon Cancer | IC50 > 7.5 µM |
| dbacp08184 | Peptide - 2 | GF(A6c)G(A6c)R(A6c)G(A6c)F(A6c)G(A6c)GR(A6c)RRRR | Synthetic | Not Available | CellTiter-Glo assay | COLO-205 | Colon Cancer | IC50 = 6.6 µM |
| dbacp08185 | Peptide - 2 | GF(A6c)G(A6c)R(A6c)G(A6c)F(A6c)G(A6c)GR(A6c)RRRR | Synthetic | Not Available | CellTiter-Glo assay | DLD-1 | Colon Cancer | IC50 = 6.4 µM |
| dbacp08192 | Peptide - 3 | GF(A6c)G(A6c)Orn(A6c)G(A6c)F(A6c)G(A6c)GOrn(A6c)Orn-Orn- Orn- Orn | Synthetic | Not Available | CellTiter-Glo assay | COLO-205 | Colon Cancer | IC50 = 3.2 µM |
| dbacp08193 | Peptide - 3 | GF(A6c)G(A6c)Orn(A6c)G(A6c)F(A6c)G(A6c)GOrn(A6c)Orn-Orn- Orn- Orn | Synthetic | Not Available | CellTiter-Glo assay | DLD-1 | Colon Cancer | IC50 = 6.2 µM |
| dbacp08200 | Peptide - 4 | GF(A6c)G(A6c)Dab(A6c)G(A6c)F(A6c)G(A6c)GDab(A6c)Dab-Dab-Dab-Dab | Synthetic | Not Available | CellTiter-Glo assay | COLO-205 | Colon Cancer | IC50 = 6.4 µM |
| dbacp08201 | Peptide - 4 | GF(A6c)G(A6c)Dab(A6c)G(A6c)F(A6c)G(A6c)GDab(A6c)Dab-Dab-Dab-Dab | Synthetic | Not Available | CellTiter-Glo assay | DLD-1 | Colon Cancer | IC50 = 2.6 µM |
| dbacp08208 | Peptide - 6 | GF(A5c)G(A5c)K(A5c)G(A5c)F(A5c)G(A5c)GK(A5c)KKKK | Synthetic | Not Available | CellTiter-Glo assay | COLO-205 | Colon Cancer | IC50 > 7.5 µM |
| dbacp08209 | Peptide - 6 | GF(A5c)G(A5c)K(A5c)G(A5c)F(A5c)G(A5c)GK(A5c)KKKK | Synthetic | Not Available | CellTiter-Glo assay | DLD-1 | Colon Cancer | IC50 > 7.5 µM |
| dbacp08216 | Peptide - 7 | GF(A5c)G(A5c)R(A5c)G(A5c)F(A5c)G(A5c)GR(A5c)RRRR | Synthetic | Not Available | CellTiter-Glo assay | COLO-205 | Colon Cancer | IC50 > 7.5 µM |
| dbacp08217 | Peptide - 7 | GF(A5c)G(A5c)R(A5c)G(A5c)F(A5c)G(A5c)GR(A5c)RRRR | Synthetic | Not Available | CellTiter-Glo assay | DLD-1 | Colon Cancer | IC50 > 7.5 µM |
| dbacp08224 | Peptide - 8 | GF(A6c)G(Tic)K(A6c)G(Tic)F(A6c)G(Tic)GK(Tic)KKKK | Synthetic | Not Available | CellTiter-Glo assay | COLO-205 | Colon Cancer | IC50 > 7.5 µM |
| dbacp08225 | Peptide - 8 | GF(A6c)G(Tic)K(A6c)G(Tic)F(A6c)G(Tic)GK(Tic)KKKK | Synthetic | Not Available | CellTiter-Glo assay | DLD-1 | Colon Cancer | IC50 > 7.5 µM |
| dbacp08232 | Peptide - 9 | GF(A6c)G(Oic)K(A6c)G(Oic)F(A6c)G(Oic)GK(Oic)KKKK | Synthetic | Not Available | CellTiter-Glo assay | COLO-205 | Colon Cancer | IC50 > 7.5 µM |
| dbacp08233 | Peptide - 9 | GF(A6c)G(Oic)K(A6c)G(Oic)F(A6c)G(Oic)GK(Oic)KKKK | Synthetic | Not Available | CellTiter-Glo assay | DLD-1 | Colon Cancer | IC50 > 7.5 µM |
| dbacp08240 | Peptide - 10 | GF(A5c)G(A6c)K(A5c)G(A6c)F(A5c)G(A6c)GK(A5c)KKKK | Synthetic | Not Available | CellTiter-Glo assay | COLO-205 | Colon Cancer | IC50 > 7.5 µM |
| dbacp08241 | Peptide - 10 | GF(A5c)G(A6c)K(A5c)G(A6c)F(A5c)G(A6c)GK(A5c)KKKK | Synthetic | Not Available | CellTiter-Glo assay | DLD-1 | Colon Cancer | IC50 > 7.5 µM |
| dbacp08248 | Peptide - 11 | KKKKGF(A6c)G(A6c)K(A6c)G(A6c)F(A6c)G(A6c)GK(A6c) | Synthetic | Not Available | CellTiter-Glo assay | COLO-205 | Colon Cancer | IC50 = 6.7 µM |
| dbacp08249 | Peptide - 11 | KKKKGF(A6c)G(A6c)K(A6c)G(A6c)F(A6c)G(A6c)GK(A6c) | Synthetic | Not Available | CellTiter-Glo assay | DLD-1 | Colon Cancer | IC50 > 7.5 µM |
| dbacp08259 | Tr3 | Not Available | Protein extraction from Spirulina platensis | Not Available | MTT assay | HT-29 | Colon Cancer | IC50 = 112.89 μg/mL |
| dbacp08262 | HR | HVLSRAPR | Fraction identified from Tr1 | Not Available | MTT assay | HT-29 | Colon Cancer | IC50 = 99.88 μg/mL |